Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ACBT Annual Report 2018

Jul 19, 2019

52387_rns_2019-07-19_7bca808a-ce5a-4e73-929a-1f5a8d2dfdc0.pdf

Annual Report

Open in viewer

Opens in your device viewer

Stock Code4148

[全宇生技控股有限公司] All Cosmos Bio-Tech Holding Corporation

ANNUAL REPORT 2018

Company website: http://www.allcosmos.com

Taiwan Stock Exchange Website: http://mops.twse.com.tw

Published on April 30, 2019

  • 1.0 Name And Title Of The Spokesman And Deputy Spokesman, Telephone And Email

Address

Spokesman Janice Cheow Telephone +607-252-3788 Title Chief Financial Officer Email address [email protected] Deputy Spokesman Janice Cheow (temporary) Telephone: (02)2715-7586

Title : Chief Financial Officer Email Address [email protected]

  • 2.0 Address and telephone number of the head office, branch office and factory

  • 2.1 The Company

Company name All Cosmos Bio-Tech Holding Corporation

Website www.allcosmos.com Telephone +607-252-3788

Address 190 Elgin Avenue, George Town, Grand Cayman KY1-9005, Cayman Islands.

  • 2.2 Malaysia Subsidiary Company

Company Name All Cosmos Industries Sdn. Bhd.

Website www.allcosmos.com Telephone +607-252-3788

  • Address PLO 650, Jalan Keluli, Pasir Gudang Industrial Estate, 81700 Pasir Gudang, Johor, Malaysia.

Company Name Sabah Softwoods Hybrid Fertiliser Sdn. Bhd.

Website www.sshf.com.my Telephone +608-986 3280

Address Lot 50 & 51, Phase 2, Jalan Tengah Nipah, 5.5KM, 91100 Lahad Datu, Sabah, Malaysia.

Company Name Arif Efektif Sdn. Bhd. Telephone +607-252-3788 Address PLO 539, Jalan Keluli, Pasir Gudang Industrial Estate, 81700 Pasir Gudang, Johor, Malaysia.

Company Name Kinabalu Life Sciences Sdn. Bhd. Telephone +6089-767600 Address MPT 4604, 3[rd] Floor, Lot 15-16, Block B, Bandaran Baru, Jalan Baru, 91000 Tawau, Sabah, Malaysia

Company Name Sawit Ecoshield Sdn. Bhd. Telephone +6088-235811

Address Jalan Kelapa Sawit, Off KM 4, Jalan Tuaran, 88300 Kota Kinabalu, Sabah, Malaysia.

Company Name Cosmos Biowood Sdn. Bhd. Telephone +607-3558833

Address 12A, Jalan Dedap 17, Taman Johor Jaya, 81100 Johor Bahru, Johor, Malaysia.

Company Name GK Bio International Sdn. Bhd. Telephone +603-61421139 Address 42-2, Jalan PJU 5/11, Dataran Sunway, Kota Damansara, 47810 Petaling Jaya, Selangor, Malaysia.

  • 2.3 Indonesia Subsidiary Company

  • Company Name PT All Cosmos Indonesia Telephone +6261-8201288 Address Ira Building Jl. Cactus Raya Blok J No.1 Komp. Perumahan Taman Setia Budi Indah Medan - 20131, Sumatera Utara – Indonesia

Company Name PT All Cosmos Biotek

Address Jalan Kelapa Sawit – Nomor 1, KEK Sei Mangkei, Kecamatan Bosar Maligas, Kabupaten Simalungun, Sumatera Utara, Indonesia.

  • 2.4 Taiwan Subsidiary Company

  • Address Room 201, 15th Floor, 99 Fuxing North Road, Taipei, R.O.C. Telephone (02)2715-7585

  • 3.0 Name, Address, Website And Telephone Number of The Stock Transfer Institution Company Name SinoPac Securities Corporation

  • Address 3F., No.17, Bo’ai Rd., ZhongZheng Dist., Taipei City 100, Taiwan, R.O.C. Website www.sinopacsecurities.com Telephone (02)2381-6288

  • 4.0 Latest Annual Financial Report of CPA, Firm Name, Address, Website And Telephone Number

CPA’s Name Chen, Chiang-Hsun Yu, Cheng-Chuan

  • Firm Name Deloitte & Touche

Address 20F, No. 100, Songren Road, Xinyi District, Taipei City, Taiwan, R.O.C.

  • Website www.deloitte.com.tw

Telephone (02)2725-9988

  • 5.0 Overseas Securities And Stock Exchange Enquiries : None.

  • 6.0 Company Website www.allcosmos.com

7.0 List Of Board of Directors

April 30, 2019

April 30, 2019
Title Name Nationality or
place of
registration
Education and Professional Qualifications
Chairman All Cosmos
Investment Ltd
Republic of
Seychelles
Ph.D candidate, Institute of Wood Science
and Technology, University of Putra,
Malaysia
Master of Business Administration,
Honolulu University, Hawaii
Representative :
Peng Shih Hao
Republic of
China
Director Sheng Hua Ltd Republic of
Seychelles
GuanXi Agriculture High School
Representative
Peng Sheng
Ching
Republic of
China
Director Maxtrength
Corporation
Republic of
Seychelles
Shixin Journalism and Communiation
College
Director of Clinical Research, Quintiles
Maxtrength Corporation Director
GK Bio International Sdn Bhd Director
Representative :
Peng Chia Lin
Republic of
China
Director Hsu Ken Tsai Republic of
China
Private School of Technology, Enterprise
Management Division
General Manager of TachongGas Station
Director Chang Lu Chang Republic of
China
Bachelor of Finance and Taxation,
National Chengchi University
YiChen International Pte Ltd Director
Director Chee Kheng Hoy Malaysia Doctor of Forest Diseases, University of
Auckland
Researcher and Head of Rubber Research
Institute
Arif Efektif Sdn. Bhd. Director
Director of Malaysia Rubber Research
Institute
Independent
Director
Lo Tzu Wu Republic of
China
National Chung Hsing University Institute
of Law
Weiyang Law Firm Lawyer
Huayi Electronics (Stock) Co., Ltd -
Supervisor
Xieyi Machinery Industry Co., Ltd -
Supervisor
Shiwei Technolofy (Stock) Supervisor
Hongsheng Investment Co., Ltd Supervisor
Shiwei Co., Ltd Director
Independent
Director
Yang Yung Cheng Republic of
China
Master in Finance, Fu Ren University
Chartered Accountant
Certified Public Accountant of MRICPA
Hongkai Optoelectronics Co., Ltd
Supervisor
MRICPA Certified Public Accountants
Independent
Director
Yeh Chung
Chuan
Republic of
China
Master of Plant Pathology, National Chung
Hsing University
Bachelor of Plant Pathology, University of
Illinois, USA
Deputy Executive of Agricultural
Development Committee for Agricultural
Administrative Department at Tainan
District

Table of Contents

1.0 Business Report…………………………………………………………... 1
2.0 Company Profile………………………………………………………….
2.1 Date of Incorporation……………………………………………………………….
2.2 Company History……………………………………………………………………
5
5
5
3.0 Corporate Governance Report…………………………………………..
3.1 Organization System………………………………………………………………...
3.2 Information on Directors, Supervisors, President, Vice Presidents, and Management
Team………………………………………………………………………………...
3.3 Remuneration paid to directors, supervisors, president and vice presidents for the
recent years………………………………………………………………………….
3.4 Corporate Governance Operational Situation……………………………………….
3.5 Information on CPA Professional Fees………………………………………………
3.6 Information on replacement of CPA: Announcement of accountants replacement
shall be made within these two years and thereafter………………………………..
3.7 Where the company's chairperson, general manager, or any managerial officer in
charge of finance or accounting matters has in the most recent year held a position
at the accounting firm of its certified public accountant or at an affiliated enterprise
of such accounting firm……………………………………………………………
3.8 Any transfer of equity interests and/or pledge of or change in equity interests (during
the most recent fiscal year or during the current fiscal year up to the date of printing
of the annual report) by a director, supervisor, managerial officer, or shareholder
with a stake of more than 10 percent during the most recent fiscal year or during the
current fiscal year up to the date of printing of the annual report………………….
3.9 Relationship information, if among the company's 10 largest shareholders any one
Is a related party or a relative within the second degree of kinship of another…….
3.10 The total number of shares held by the capital business, and the combined
calculation of the comprehensive shareholding ratio which involved companies,
company directors, supervisors, managers directly or indirectly………………….



8
8
10
14
18
46
47
48
48
49
50
4.0 Capital Overview………………………………………………………….
4.1 Capital and shares…………………………………………………………………...
4.2CorporateBonds…………………………………………………………………….
52
52
57
4.3 Preferred Stocks……………………………………………………………………..
4.4 Overseas Depositary Receipts……………………………………………………….
4.5 Employee Stock Options…………………………………………………………….
4.6 Restriction Of Employees Rights On New Shares Status…………………………...
4.7 Status Of New Shares Issuance In Connection With Mergers And Acquisitions……
4.8 Financing Plans And Implementation……………………………………………….

57
57
57
59
59
59
5.0 Operational Overview……………………………………………………
5.1 Business Content…………………….......................................................................
5.2 Overview of Market, Production And Sales…………….........................................
5.3 The distribution ratio of number of employees, average service years, average age
of employees, and education qualification who have been employed in the past
two years and up to the date of publication ..............................................................
5.4 Distributed information of environmental protection................................................
5.5 The relationship of Employers and Employees .........................................................
5.6 Important contracts………………………................................................................
60
60
78
92
92
93
93
6.0 Financial Overview.....................................................................................
6.1 The Condensed Balance Sheets and Comprehensive Income Statements for the
Recent five years and Certified public accountants and audit opinions ..................
6.2 Financial Analysis over the Recent Five Years.........................................................
6.3 Auditing Report by Supervisors on Financial Statements over the Recent Years…..
6.4 Latest annual financial report of the parent company ................. ………………….
6.5 The company and its affiliates shall disclose the impact on their financial status
in the most recent year and up to and including the date of publication of the
annual report...............................................................................................................

99
99
101
104
105
105
7.0 Financial Status, Review and Analysis of Financial Performance and
Risks………………………………………………………………………..
7.1 Financial status………………………………….......................................................
7.2 Financial performance................................................................................................
7.3 Cash flow....................................................................................................................
7.4 Impact to the Financial Business by the Significant Capital Expenditures in the
Previous Year.............................................................................................................
7.5 The most recent years of investment policy, the main reason for its profit or loss,
the improvement and investment plan for the following year………………………
7.6 Analysis and assessment of risk factors in the most recent year and at the
106
106
107
109
111
111
publication date of the annual report........................................................................
7.7 Other important matters…………………………………………………………….
112
120
8.0 Special Records...........................................................................................
8.1 Affiliate Information .................................................................................................
8.2 Private placements of securities in the most recent year and as of the publish date of
the annual report ........................................................................................................
8.3 Shares of the Company that are held or disposed by a subsidiary in the most recent
year and as of the publish date of the annual report ..................................................
8.4 Other necessary descriptions......................................................................................
8.5 Significant impact on shareholders' equity or securitiesprices matter incurred as
per Article 36- 2- 2 of the Securities Exchange Law ................................................
8.6 A statement of significant differences from the provisions of the shareholders'
rights and interests of the Republic of China.............................................................
121
121
123
123
123
124
124

1.0 Business Report 2018

Dear Shareholders

2018 is the first time in 20 years that All Cosmos has faced multiple external challenges. However, with the contribution of new corporate customers’ sales, this year’s revenue can still maintain its growth trend, and it will be implemented steadily in the future biological vaccine factory and Indonesian plant. All Cosmos’ long-term growth trend remains unchanged. Although at this point in time, the overall mid-stream and downstream industries are facing short-term challenges of sustained and significant growth, all short and mid-term plans of the Company are still in a stable layout and in progress. Therefore, the Company still has its confidence for the long-term development. In addition, the Company has already begun to actively develop the different crops and areas, and it is expected that the products will be effectively dispersed in the future with its mixamization. Therefore, All Cosmos recently established a branch office in Taiwan, and in the future it is expected to contribute to the patent technology of the Company’s unique microbial biochemical compound fertilizer in Taiwan’s agriculture. It is our honour to present the Company’s past year’s operating results and the future prospects to the Shareholders.

1. 2018 Operating Results

1.1 Business plan implementation results

Unit NT$ in Thousand %

2018 2017 Increase
(Decrease)
Amount
Change Ratio
Operating
Revenue
2,687,581 2,263,652 423,929 18.73%
Gross Profit 774,594 751,521 23,073 3.07%
Net Profit For
The Year
305,058 322,873 (17,815) (5.52%)

In 2018, the Company’s revenue increased by 18.73% or NT$423,929 as compared with 2017. It mainly increased in the sales of chemical fertilizers. The customers are Corporate companies with a large scale of oil palm plantations. The orders of these corporate customers are mostly from tender. The bidding price is given according to the formula and product type that is regulated. Since it is necessary to have business deal with these corporate customers, the company must enter its supply chain with accommodate the customers’ requirement with sacrificing the margin, after building up certain relationship, we will then gradually promote our bio fertilisers to them or recommendations for field trials. Due to the competition in chemical

  • 1 -

fertilizer bidding prices, the gross profit margin is low. Therefore, although the revenue is increased in 2018, it is mainly due to the increase in chemical fertilizers sales, which affect the reduction of gross profit. In addition, due to the heavy decline in palm oil prices and affecting the income of the plantation, in order to control its costs, planters prefer to choose the lower cost chemical fertilizers even though lower efficiency.

In the operation expenses-selling and distribution expenses, there was an increase in warehouse storage charges in 2018 as compared to 2017, this is due to subsidiary – ACI set up the warehousing services in Philippines in order to response to the shipment demand of the corporate customer Sumifru, thus increasing the storage management fee at USD 35 per metric ton, in total is about NT$ 11.293 thousands for the year.

In anticipation of credit impairment losses, in 2018, it increased by NT$ 26,048 thousands as compared to 2017, it is mainly due to the increase in Accounts Receivable outstanding. The price of palm oil befan to weaken in 2018 and fell below MYR 2,000 in the fourth quarter. The revenue of planters was greatly affected and caused out the customers began to extend the payment to the Company. In addition, in May 2018, Malaysia experienced the first time of changing of government in 60 years, most of the top management of the public enterprises were replaced, which also affected the internal operations. Payment arrangements, decision-making and others have caused the delay, hence the Company’s Accounts Receivable Aging getting longer in the third quarter.

Subsidiary Co-ACI has met the requirements of Income Tax (Exemption) (No. 17) for its research and development, and has been approved by the Ministry of Finance of Malaysia to entitle 100% of its taxable income for 10 years. The credit period is from March 27, 2008 until March 26, 2018. As due to the expiration of the credit period, it is started to pay income tax in 2018.

1.2 Financial Revenue and Profitability

Financial Revenue and Profitability Financial Revenue and Profitability
Financial Ratio Item 2018 2017
Financial
Structure
(%)
Debt to Asset Ratio 14.75 12.73
Long-Term Capital to Fixed
Assets Ratio
460.25 444.78
Solvency
(%)
Current Ratio 545.97 738.57
Quick Ratio 368.88 592.35
Profitability
(%)

Return on Assets
11.28 13.88

Return on Equity
14.49 19.15
Earning Per Share (NT$) 4.76 5.31
  • 2 -

2. 2019 Operating Plan Summary

Continued the fall in palm oil prices in the fourth quarter of last year and political changes in major markets, this year will be a challenging year for the Company in 2019, and it is also an important year to be globalization. All Cosmos’s key core microbial technology, mastering the acquisition of organic materials or chemical raw materials, and the customer resources that have been cultivated for 20 years which have formed a strong backing and solid foundation under the combination of the three. The Company has its peak performance since 2009, and will continue to create a future prosperity.

The international palm oil price has stabilized, as the two major palm oil exporting countries of Indonesia and Malaysia have adopted the relevant policy to response , and the Company is still paying close attention to its follow-up trend. In additiona to actively exploring the new oil palm market in Indonesia and using the Company’s core microbial technology to develop high-value crops such as rubber, papaye and durian, the Company is actively participate into the market of high-value crops. In addition to the Company’s operational performance to be more stable and diversify, the two major layouts of the green circular economy will gradually contribute, as the Company’s short and mid-term growth mementum.

The Green Circular Economy has established a joint venture with major customers to set up two companies to assist in setting up a specialized treatment plant around its refinery, directly recycling the remaining organic matter in the oil extraction process, in addition to effectively reducing the cost of freight, and investing differently for different needs. Microorganisms, customized, and made into professional microbial compound fertilizer for preventing plant diseases and pest and ganoderma diseases. The second layout of the green recycle economy, through recyling of the surplus by-products, introduces a professional microbial compound fertilizer that can improve soil pH, not only can effectively protect the environment, but also enhance the soil’s ability to absorb nutrients, while having low unit price and high margin. The green circular economy will be one of the Company’s future operational priorities.

After 20 years of deep cultivation in the Malaysian compound fertilizer market, All Cosmos has grown in the past with higher average growth rate of the overall fertilizer industry and has become a pioneer in the global bio-compound fertilizer industry. The Company has more than 500 kinds of microbial strains and two patented technologies with high-end agricultural technology, including quantitative microbial technology and stabilzer technology platform. The Company will use the technology resources with more effectively and to expand the markets and industries with high growth potential. Global environmental awareness and sustainable agriculture are gradually rising, coupled with soil deterioration and ecological problems, and it is bound to require All Cosmos’s advanced biotechnology and agricultural technology to help improve and maintain the environment. All Cosmos will continue to strive to improve and research effective microbial populations. While continuously creating technologically leading milestones, it will accumulate the experience and integrate all technical resources to provide a solid foundation for the Company’s future market operation strategy.

We hope that we can show our business results to our shareholders with our peers’ efforts and our dedication. We will enbrace the spirit of continuous improvement and maintain a continuous improvement attitude. Under the cautious efforts of step by step, we will meet up the expectations

  • 3 -

of the shareholders. Finally, we would like to thanks our partners, sharheolders and hardworking staffs for their long-standing support. I would like to express my sincere gratitude!

All Cosmos Bio-Tech Holding Corporation Chairman Peng Shih Hao

  • 4 -

2.0 Company Profile

2.1 Date of Incorporation : March 26, 2010

2.2 Company And Group History

All Cosmos Bio-Tech Holding Corporation (hereinafter referred to as the Company) was established in the Cayman Islands on March 26, 2010, and is one of the public listing company in Taiwan. The All Cosmos Group owns several subsidiary companies in Malaysia and Indonesia, the main product is biochemical compound fertilizer combined with organic matter, beneficial microorganisms and chemical raw materials. The sales market extends to South East Asia such as Malaysia, China, Indonesia, Vietnam and Taiwan.

The Group's products draw on the advantages of various unit fertilizers and strive to solve and replace the severe environmental pollution caused by traditional chemical fertilizers. Due to the high technical threshold, the Group is the first company in Malaysia to have beneficial microorganisms to be added into fertilizer. In addition, the Group cooperated with the Malaysian Palm Oil Board (MPOB) to develop the fertilizer MPOB F4, which is suitable for the local major agricultural cash crops, and was approved by the Malaysian Oil Palm Board and authorized to use its trademark. In addition to biochemical compound fertilizer, the Group's products were jointly developed with the Malaysian Oil Palm Bureau in 2012 to combat the treatment of the main disease of oil palm tree Ganoderma lucidum. The Group's products have been extended from crop production to pest control.

The important notes of the company are as follows:

Year Items
1999 Incorporation of All Cosmos Industries Sdn Bhd in Johor, Malaysia, and
established a biochemical compound fertilizerplant
2003 Obtained ISO2001 and ISO2000 certification
2003 In order to develop the market in East Malaysia, Hybrid Generation Sdn.
Bhd was incorporated in Sabah, Malaysia.
2008 Awarded 10 years tax exemption with BioNexus Status certification
Developed MPOB F4 three-in-one biochemical compound fertilizer in
cooperation with Malaysia Oil Palm Bureau(MPOB)
Received the Golden Bull Award for Overseas Outstanding Enterprise
Award
2009 MOA was signed with the Malaysian University of Technology (UTM) to
developa nitrogen-fixingbacteriaproductionplatform
Awarded the Product Innovation Award from the Malaysia International
Commodities Exhibition (MICCOS), the Asia-Pacific International
Entrepreneur Elite Award 2008-2009, and the NanyangBusiness Daily
  • 5 -
Year Items
Golden Bull Award
2010 Incorporation of All Cosmos Bio-Tech Holdings Corporation in Cayman
Islands
Awarded the Asia Pacific Bio Fertilizer Award from Frost & Sullivan
Incorporation of Sabah Softwoods Hybrid Fertiliser Sdn Bhd in Sabah,
Malaysia, toproduce and engagingsale at Sabah and Indonesia markets
2011 Co-developing microbial fertilizers containing phage with the Malaysian
Institute for Agricultural Research and Development(MARDI)
The company's products are certified as green fertilizer products by the
Malaysian Ministryof Science and TechnologyInnovation(MOSTI)
Appointed by the Ministry of Science and Technology of Malaysia as an
agriculturalgreen consultant, the only private enterprise consultant
Awarded the Best Product Innovation Award Card in Malaysia;
Double Gold Medal in International Consumption;
Model Award of Taiwan Overseas Chinese Enterprise;
Best International Overseas Enterprise Award in Taiwan;
and Individual OutstandingProduct Award in China.
2012 Joint development of 4-in-1 biochemical compound fertilizer with the
Malaysian Palm Oil Board (MPOB)
Awarded the Outstanding Brand Award from the Asian Entrepreneurship
Alliance (AEA)
2013 Awarded the top three companies of BioNexus and the BioNexus Excellence
Award from Biotech Corp.
Awarded the Sin Chew Business Excellence Award 2013 for outstanding
product and service quality
Awarded the Gold Medal Best Agriculture Award and the Malaysian
Innovation Product Award (ITEX'13)
2014 GanoEF products won the third place in the Patent Group Award
Co-developed MPOB F4 Premium Biochemical Compound Fertilizer with
Malaysia Palm Oil Board (MPOB)
Won the 46th Outstanding Business Award from FMM
All Cosmos Industries Sdn Bhd established the Second Plant in Johor, West
Malaysia
2015 Awarded the 47th Outstanding Business Award from FMM
2016 Received the 48th Outstanding Business Award from FMM and the
Outstanding Award for Quality of Fertilizer Products in Malaysia
Granted the Patent for "Bio-Actual Fertilizer Technology" in Taiwan
  • 6 -
Year Items
Granted the Patent for "Endophytic Fungus Production Technology" in
Thailand
2017 All Cosmos Biotech-KY officially listed in Taiwan Stock Exchange on June
8
Awarded the Bioeconomic Excellence Award from Biotech Corp
Subsidiary company of All Cosmos Industries Sdn Bhd and Sabah
Softwoods Hybrid Fertiliser Sdn Bhd have established a joint venture with
Sawit Kinabalu Group, a subsidiary of the East Malaysian government, to
establish aprofessional treatmentplant to developbiological vaccines
2018 Established an Indonesian joint venture with YPJ Plantations Sdn. Bhd., a
subsidiary of the Johor State Government of Malaysia, to produce and
engage sales for Indonesian market.
Signed the “Liquor Cellulose Depolymerization Patent and Technology
Licensing and Service Plan Contract” with the Industrial Technology
Research Institute
Subsidiary Company Arif Efektif signed a technical sales contract with
MARDI Malaysian Agricultural Research and Development Agency to
obtain the use of induced resistant system for papaya seedlings to control
papaya disease
2019 Signed a joint venture contract with Grape King Biotech Co., Ltd. and Mr.
Chiu Hsien Chih to expand the health food biotechnology business in
ASEAN countries
  • 7 -

3.0 Corporate Governance Report

3.1 Organization System

3.1.1 Organizational Structure

==> picture [425 x 284] intentionally omitted <==

3.1.2 Business Operations of Major Departments

Department name
Operation
Board of Directors Establish policy directives and target policies for the company's
business operations
Audit Committee Supervise the company's business and financial status, the company's
financial statements, and the effective implementation of internal
control
Remuneration
Committee
Regularly review the policies, systems, standards and structures of
directors and managers' performance, appraisal and salary
remuneration, and regularly assess and determine the remuneration of
directors and managers.
Internal Audit
Department
Research, planning and implementation of internal control and auditing
systems, reporting of audit reports and tracking regularly improvements
and audit errors
Purchasing
Department
To communicate with supplier regardding the purchase and supply of
dailydomesticprocurement and raw materialprocurement
Quality Control
Department
Ensure product quality meets standards, performs quality control
operations, and tracks corrective actions
  • 8 -
Production
Department
Implement production planning, control production schedule and
material status, maintain work safety and environmental requirements
at production site, control and improve product quality and production
progress
Warehouse
Department
To manage the warehouse inventory quantity and ensure the quantity of
goods receivingand delivery
Administrative
Department
Responsible for the management of the company's human resources
Sales Department
To establish and maintain relationships with major customer and
strategic partners, and the management of domestic and international
marketingchannels and channelproviders
Development
Department
To maintain customer relationships, expand new markets, and develop
the company's brand
Marketing
Department
To promote products in the market and increasing product exposure
through various means.
Research
Department
To develop the process and progress of the research plan and develop
newproducts
Financial
Department
To handle the company's accounting, calculation and analysis of
production costs, preparation and analysis of various financial,
accounting, and cost statements, various tax returns and other matters.
  • 9 -
Executives, Directors or
Supervisors Who Are
Spouses or within Two
Degrees of Kinship
Relatio
nship
- Father
Sister
- Son
Daught
er
-
Name - Peng Sheng
Ching
Peng Chia
Lin
- Peng Shih
Hao
Peng Chia
Lin
-
Title - Director
Director
- Chairman
Director
-
Other Positions in
The Company and/or Other
Companies - - ACI – Director cum CEO
- SSHF-Director
- All Cosmos Investment Ltd.-Chairman
- Grains & Greens Sdn Bhd-Director
- Kinabalu Life Sciences Sdn Bhd-Director
- Sawit Ecoshield Sdn Bhd-Director
- GK Bio International Sdn Bhd-Director
- PT All Cosmos Biotek-Director
- - ACI-Chairman
- SHENG HUA LTD.-Chairman
-
Experience and Education - - Ph.D candidate, Institute of Wood Science and
Technology, University of Putra, Malaysia
- Master of Business Administration, Honolulu
University, Hawaii
- - GuanXi Agriculture High School - Private School of Technology, Enterprise
Management
Division
Education
and
Professional Qualifications
- General Manager of Tachong Gas Station
Shareholding by
Nominee
Arrangement
% - 35.14% - 3.9% -
Shares - 22,500 - 2,500 -
Spouse & Minor
Children
Shareholding
% - - - 0.06% -
Shares - - - 40 -
Current
Sharesholding
% 35.14% 0.2% 3.9% - 0.05%
Shares 22,500 139 2,500 - 30
Shareholding When
Elected
% 39.82% - 4.42% - 0.05%
Shares 22,500 - 2,500 - 30
Terms 3yrs 3yrs 3yrs 3yrs 3yrs
Election
(Accession)
Date 2016.6.30 2016.6.30 2016.6.30 2016.6.30 2016.6.30
Date First
Elected
2010.3.26 2010.3.26 2014.6.30 2012.9.29 2012.9.29
Nationality Republic
of
Seychelles
R.O.C Republic
of
Seychelles
R.O.C R.O.C
Gender - Male - male male
Name All Cosmos
Investment Ltd
Representative:
Peng Shih Hao
SHENG HUA Ltd Representative:
Peng Sheng Ching
Hsu Ken Tsai
Title Chairman Director Director
Executives, Directors or
Supervisors Who Are
Spouses or within Two
Degrees of Kinship
Relatio
nship
- - Father
Brother
- - - -
Name - - Peng Sheng
Ching
Peng Shih
Hao
- - - -
Title - - Director
Director
- - - -
Other Positions in
The Company and/or Other
Companies - YiChen Internanational Pte Ltd-Director - - MAXTRENGTH CORPORATION- Director
- GK Bio International Sdn Bhd -Director
- AESB-Director
- Director of Malaysia Rubber Research Institute
- Huayi Electronics (Stock) Co., Ltd-Supervisor
- Xieyi Machinery Industry Co., Ltd-Supervisor
- Shiwei Technology (Stock)-Supervisor
- Hongsheng Investment Co., Ltd-Supervisor
- Shiwei Co., Ltd-Director
- Hongkai Optoelectronics Co., Ltd-Supervisor
- Yongcheng Construction(Stock) Co.,
Ltd-Supervisor
-
Experience and Education - Bachelor of Finance and Taxation, National
Chengchi University
- - Shixin Journalism and Communication College
- Director of Clinical Research, Quintiles
- Ph.D of Forest Diseases, University of
Auckland
- Researcher and Head of Rubber Research
Institute
- National Chung Hsing University Institute of
Law
- Weiyang Law Firm Lawyer
- Master in Finance, Fu Ren University
- Chartered Accountant
- Certified Public Accountant of MRICPA
- Master of Plant Pathology, National Chung
Hsing University
- Bachelor of Plant Pathology, University of
Illinois, USA
- Agricultural Improvement Field Committee in
Tainan District-Deputy Director
Shareholding by
Nominee
Arrangement
% - - 7.03% - - - -
Shares - - 4,500 - - - -
Spouse & Minor
Children
Shareholding
% - - 0.06% - - - -
Shares - - 40 - - - -
Current
Sharesholding
% 0.05% 7.03% 0.02% - - - -
Shares 30 4,500 12 - - - -
Shareholding When
Elected
% 0.05% 7.96% 0.02% - - - -
Shares 30 4,500 10 - - - -
Terms 3yrs 3yrs 3yrs 3yrs 3yrs 3yrs 3yrs
Election
(Accession)
Date 2012.6.30 2016.6.30 2016.6.30 2016.6.30 2016.6.30 2016.6.30 2016.10.19
Date First
Elected
2012.9.29 2014.6.30 2014.6.30 2014.6.30 2012.9.29 2014.6.30 2016.10.19
Nationality R.O.C Republic
of
Seychelles
R.O.C Malaysia R.O.C R.O.C R.O.C
Gender male - Female male male male male
Name Chang Lu Chang MAXTRENGTH
CORPORATION
Representative:
Peng Chia Lin
Chee Kheng Hoy Lo Tze Wu Yang Yung Cheng Yeh Chung Chuan
Title Director Director Director Independent
Director
Independent
Director
Independent
Director

3.2.1.2 The name of the corporate shareholder and the top ten shareholder name and its shareholding ratio:

tio:
Corporate Shareholder Name Major Shareholder of
Corporate Shareholder
Shareholding ratio
(%)
All Cosmos Investment Ltd PengShih Hao 100%
ShengHua Ltd PengShengChing 100%
Maxtrength Corp PengChia Lin 100%
  • 3.2.1.3 The major shareholders of the corporate shareholder's is corporate shareholder: None.

  • 3.2.1.4 Status of the professional knowledge and independency of the directors and supervisors (the company does not have a supervisor)

company does not have a supervisor) company does not have a supervisor) company does not have a supervisor)
Condition
Name
More than 5-year Work Experience
and Professional Qualifications as Below
Independency Criteria Number of other
public companies
in which the
Individual is
concurrently
serving as an
independent
director
An Instructor or
Higher Position in
a Department of
Commerce, Law,
Finance,
Accounting, or
Other Academic
Department
Related to the
Business Needs of
the Company in a
Public or Private
College
A Judge, Public
Prosecutor, Attorney,
Certified Public
Accountant, or Other
Professional or Technical
Specialist Who has
Approved a National
Examination and Been
Awarded a Certificate in a
Profession Necessary for
the Business of the
Company
Have Work
Experience in
the Areas of
Commerce,
Law, Finance,
or Accounting,
or Otherwise
Necessary for
the Business of
the Company
1 2 3 4 5 6 7 8 9 10
PengShih Hao - - -
PengShengChing - - -
Hsu Ken Tsai - - -
ChangLu Chang - - -
PengChia Lin - - -
Chee KhengHoy - - -
Lo Tze Wu - -
YangYungCheng - -
Yeh ChungChuan - - -

Note : Please mark “ ” at the beginning of the following conditions that various directors and supervisors match in two years before appointment and during their tenure.

  • (1) Not an employee of the Company or any of its affiliates.

(2) Not a director or a supervisor of the Company or its affiliated company (However, the independent director that the Company or its parent company or subsidiary sets according to this law or local law is not subject to this limit).

(3) Not a natural-person shareholder who holds shares, together with those held by the person's spouse, minor children, or held by the person under others' names, in an aggregate amount of 1% or more of the total number of outstanding shares of the Company or ranking in the top 10 in holdings.

(4) Not a spouse, relative within the second degree of kinship, or lineal relative within the fifth degree of kinship, of any of the persons in the preceding three subparagraphs.

(5) Not a director, supervisor, or employee of a corporate shareholder that directly holds 5% or more of the total number of outstanding shares of the Company or that holds shares ranking in the top 5 in holdings.

(6) Not a director, supervisor, officer, or shareholder holding 5% or more of the share, of a specified company or institution that has a financial or business relationship with the Company.

(7) Not a professional person who provides business, legal, financial, and accounting services for the Company or its affiliated company, an owner, a partner, a director, a supervisor, a manager of wholly-owned or partnership company/institution, or its spouse. However, the compensation committee member stated in Article 7 Fulfillment of Authority, Methods for Compensation Committee Setting Up and Authority Exercising of Stock Exchange Listing Company or Company Traded at Securities Dealer Business Office is not subject to this limit.

(8) Not having a marital relationship, or a relative within the second degree of kinship to any other director of the Company.

(9) Not a person of any conditions defined in Article 30 of the Company Law.

(10) Not a governmental body, juridical person or its representative as defined in Article 27 of the Company Law.

  • 12 -
April 30, 2019, Unit of Share: in Thousand Manager
obtains
employee
stock
option
certificate
Manager
obtains
employee
stock
option
certificate
150 150 150 150 - 40 - 10
Managers as Spouse or within
2-Degree Kinship
Relatio
nship
Father In Law Sister - - - - -
Name Peng Sheng
Ching
Tan Teck
Siong
Peng Yi Fen - - - - -
Title ACI Chairman ACI Marketing
Manager
ACI PA to
Chairman
- - - - -
Other Positions in other Companies ACI-CEO
SSHF-Director
ALL COSMOS INVESTMENT LTD.-Chairman
GRAINS & GREENS Sdn Bhd-Director
Kinabalu Life Sciences Sdn Bhd-Director
Sawit Ecoshield Sdn Bhd-Director
GK Bio International Sdn Bhd-Director
PT All Cosmos Biotek-Director
SSHF-Director
ACI-Chief Financial Officr
Oasis Panel Sdn. Bhd.-Director
Kinabalu Life Sciences Sdn Bhd -Director
GK Bio International Sdn Bhd-Director
PT All Cosmos Biotek-Director
SSHF General Manager - AESB Director cum CEO PT ACI Director cum CEO
Experience and Education Ph.D. candidate, Institute of Wood Science and Technology,
University of Putra, Malaysia
Master of Business Administration, Honolulu University,
Hawaii
Griffith University, Brisbane Major Accounting
Dominant Enterprise Berhad Account Executive
Chong & Associate Audit Senior Associate
Major in Accountancy (University of Canterbury, New
Zealand)
BLOOM FOSS PTE LTD OPERATION MANAGEMENT
Master in Manufacturing and Production Management
Training & Development Acquired During Service
Ph.D. candidate, Institute of Wood Science and Technology,
University of Putra, Malaysia
ACI Quality Control and R&D Manager
University Pertanian Malaysia Bachelor Degree In
Agriculture (hons)
MPOB Research Station Sessang, Saratok , Sarawak.
Research Officer
MPOB HQ Bangi. Agronomist & Extension Unit
Shareholding
by Nominee
Arrangement
% 35.14% - - - - -
Shares 22,500 - - - - -
Spouse &
Minor Children
Shareholding
% - - - - - -
Shares - - - - - -
Shareholding % 0.2% - - - - -
Shares 139 - - - - -
就任日期
Election
(Accession)
Date
2012.9.28 2016.4.22 2017.1.1 2015.1.1. 2009.11.9 2009.2.16
Nationality R.O.C Malaysia Singapore Malaysia Malaysia Malaysia
Gender Male Female Male Male Male Male
Name Peng Shih Hao Janice Cheow Ling Siu Hung Lai Chan Wai WAN AZHA BIN
WAN MUSTAPHA
Roslan Bin Arshad
Title ACBT CEO ACBT CFO ACBT Group
General
Manager
ACI
General
Manager
(Manufacturing)
ACI
R&D Manager
ACI Sales &
Technical
Manager
Get Any
Remuneratio
n from the
Invested
Businesses
Other than
Subsidiaries
Other than
Subsidiaries
371 371 371 371 371 371 371 371 371 Except as disclosed in the above table, the recent directors of the company provided services for all companies in the financial report (such as consultants who are not employees): NIL.
Ratio of Total
Remuneration
(A+B+C+D+E+F+
G) to Net Profit After Tax(%)

All
companies in
the financial
report
8.33%
The Company
Remuneration to Concurrent Emplotees Remuneration to employee (G) All companies in the
financial report
Stock
Cash 6,740
The Company Stock
Cash
Retirement Pension
Fund(F)

All
companies
in the
financial
report
The
Company
Salary, Bonus &
Allowance etc.
(E)
All
companies
in the
financial
report
10,111

The
Company
Ratio of Total
Remuneration
(A+B+C+D) to
Net Profit After Tax (%)
All companies
in the
financial
report
2.8%
The
Company
Directors’ Remuneration Business Execution
Expense (D)
All
companies in
the financial
report
131
The
Company
Directors’
Remuneration
(C)

All
companies in
the financial
report
6,419
The
Company
Retirement Pension
Fund (B)
All
companies
in the
financial
report
The
Company

Salary (A) All
companies in
the financial
report
2,000
The
Company
Name Peng Shih Hao Peng Sheng
Ching
Hsu Ken Tsai Chang Lu
Chang
Peng Chia Lin Chee Kheng
Hoy
Lo Tze Wu Yang Yung
Cheng
Yeh Chung
Chuan
Title Chairman Director Director Director Director Director Independent
Director
Independent
Director
Independent
Director
Remuneration Scale Table
Unit: NT$
Name of Directors Total of (A+B+C+D+E+F+G) All Companies in the
Financial Report
Peng Chia Lin,
Chee Kheng Hoy,
Hsu Ken Tsai,
Chang Lu Chang,
Lo Tze Wu,
Yang Yung Cheng,
Yeh Chung Chuan
Peng Shih Hao,
Peng Sheng Ching
9
The Company
Total of (A+B+C+D) All Companies in the
Financial Report
Peng Shih Hao,
Peng Sheng Ching,
Peng Chia Lin,
Chee Kheng Hoy,
Hsu Ken Tsai,
Chang Lu Chang,
Lo Tze Wu,
Yang Yung Cheng,
Yeh Chung Chuan
9
The Company
The range of each director’s remuneration Below NT$2,000,000 NT$2,000,000 (inclusive) ~ NT$5,000,000 (exclusive) NT$5,000,000 (inclusive) ~ NT$10,000,000 (exclusive) NT$10,000,000 (inclusive) ~ NT$15,000,000 (exclusive) NT$15,000,000 (inclusive) ~ NT$30,000,000 (exclusive) NT$30,000,000 (inclusive) ~ NT$50,000,000 (exclusive) NT$50,000,000 (inclusive) ~ NT$100,000,000 (exclusive) Above NT$100,000,000 Total
Received The
Remuneration
From The
Subsidiary
Company
Received The
Remuneration
From The
Subsidiary
Company
Received The
Remuneration
From The
Subsidiary
Company
Remuneration Scale Table
Unit: NT$
Names of General Managers and Deputy General managers All Companies in the Financial Report Janice Cheow Ling Siu Hung, Peng Shih Hao 3
The ratio of the total of
A+B+C+D to the
Net Profit After Tax
(%)
All
Companies
in the
Financial
Report
5.33%
The
Company
Remuneration to employee (D) All Companies in the
Financial Report
Shares
Amount
Cash
Amount
3,662
The Company
The Company Shares
Amount
Cash
Amount
Bonus &
Allowance etc.
(C)
All
Companies
in the
Financial
Report
2,552
The
Company
Retirement Pension
Fund(B)
All
Companies
in the
Financial
Report
Remuneration of The General Manager and Deputy General Manager Below NT$2,000,000 NT$2,000,000 (inclusive) ~ NT$5,000,000 (exclusive) NT$5,000,000 (inclusive) ~ NT$10,000,000 (exclusive) NT$10,000,000 (inclusive) ~ NT$15,000,000 (exclusive) NT$15,000,000 (inclusive) ~ NT$30,000,000 (exclusive) NT$30,000,000 (inclusive) ~ NT$50,000,000 (exclusive) NT$50,000,000 (inclusive) ~ NT$100,000,000 (exclusive) Above NT$100,000,000 Total
The
Company
Salary (A) All
Companies
in the
Financial
Report
10,052
The
Company
Name Peng Shih
Hao
Ling Siu
Hung
Janice
Cheow
Title ACBT CEO ACBT Group
General
Manager
ACBT CFO
3.3.4 Name of Managers and their Distribution of Employee Remuneration
March 31, 2019 2019 Unit: NT$ in Thousand; %
Manager
CEO
Peng Shih Hao

3,662
3,662
1.20%
CFO
Janice Cheow
Group General Manager
Ling Siu Hung
ACI General Manager (Manufacturing)
Lai Chan Wai
ACI R&D Manager
Wan Azha Bin Wan
Mustapha
ACI Sales & Technical Manager
Roslan Bin Arshad
3.3.5 Comparison for the total amount of remuneration of the Directors, Supervisors, General Managers and Deputy General Managers of the
company in the past two years accounted for the net profit after tax ratio of individual or individual financial reports and explained the
payment of remuneration, relevance of policies, standards and portfolios, procedures for determining emoluments and business
performance
3.3.5.1 Analysis of the company's and the consolidated report for the total amount of remuneration paid to the Directors, Supervisors,
General Managers and Deputy General Managers of the company in the last two years to the net profit after tax of individual or
Individual financial reports
Unit: NT$ in Thousand
Manager
CEO
Peng Shih Hao

3,662
3,662
1.20%
CFO
Janice Cheow
Group General Manager
Ling Siu Hung
ACI General Manager (Manufacturing)
Lai Chan Wai
ACI R&D Manager
Wan Azha Bin Wan
Mustapha
ACI Sales & Technical Manager
Roslan Bin Arshad
3.3.5 Comparison for the total amount of remuneration of the Directors, Supervisors, General Managers and Deputy General Managers of the
company in the past two years accounted for the net profit after tax ratio of individual or individual financial reports and explained the
payment of remuneration, relevance of policies, standards and portfolios, procedures for determining emoluments and business
performance
3.3.5.1 Analysis of the company's and the consolidated report for the total amount of remuneration paid to the Directors, Supervisors,
General Managers and Deputy General Managers of the company in the last two years to the net profit after tax of individual or
Individual financial reports
Unit: NT$ in Thousand
Manager
CEO
Peng Shih Hao

3,662
3,662
1.20%
CFO
Janice Cheow
Group General Manager
Ling Siu Hung
ACI General Manager (Manufacturing)
Lai Chan Wai
ACI R&D Manager
Wan Azha Bin Wan
Mustapha
ACI Sales & Technical Manager
Roslan Bin Arshad
3.3.5 Comparison for the total amount of remuneration of the Directors, Supervisors, General Managers and Deputy General Managers of the
company in the past two years accounted for the net profit after tax ratio of individual or individual financial reports and explained the
payment of remuneration, relevance of policies, standards and portfolios, procedures for determining emoluments and business
performance
3.3.5.1 Analysis of the company's and the consolidated report for the total amount of remuneration paid to the Directors, Supervisors,
General Managers and Deputy General Managers of the company in the last two years to the net profit after tax of individual or
Individual financial reports
Unit: NT$ in Thousand
Manager
CEO
Peng Shih Hao

3,662
3,662
1.20%
CFO
Janice Cheow
Group General Manager
Ling Siu Hung
ACI General Manager (Manufacturing)
Lai Chan Wai
ACI R&D Manager
Wan Azha Bin Wan
Mustapha
ACI Sales & Technical Manager
Roslan Bin Arshad
3.3.5 Comparison for the total amount of remuneration of the Directors, Supervisors, General Managers and Deputy General Managers of the
company in the past two years accounted for the net profit after tax ratio of individual or individual financial reports and explained the
payment of remuneration, relevance of policies, standards and portfolios, procedures for determining emoluments and business
performance
3.3.5.1 Analysis of the company's and the consolidated report for the total amount of remuneration paid to the Directors, Supervisors,
General Managers and Deputy General Managers of the company in the last two years to the net profit after tax of individual or
Individual financial reports
Unit: NT$ in Thousand
Manager
CEO
Peng Shih Hao

3,662
3,662
1.20%
CFO
Janice Cheow
Group General Manager
Ling Siu Hung
ACI General Manager (Manufacturing)
Lai Chan Wai
ACI R&D Manager
Wan Azha Bin Wan
Mustapha
ACI Sales & Technical Manager
Roslan Bin Arshad
3.3.5 Comparison for the total amount of remuneration of the Directors, Supervisors, General Managers and Deputy General Managers of the
company in the past two years accounted for the net profit after tax ratio of individual or individual financial reports and explained the
payment of remuneration, relevance of policies, standards and portfolios, procedures for determining emoluments and business
performance
3.3.5.1 Analysis of the company's and the consolidated report for the total amount of remuneration paid to the Directors, Supervisors,
General Managers and Deputy General Managers of the company in the last two years to the net profit after tax of individual or
Individual financial reports
Unit: NT$ in Thousand
Manager
CEO
Peng Shih Hao

3,662
3,662
1.20%
CFO
Janice Cheow
Group General Manager
Ling Siu Hung
ACI General Manager (Manufacturing)
Lai Chan Wai
ACI R&D Manager
Wan Azha Bin Wan
Mustapha
ACI Sales & Technical Manager
Roslan Bin Arshad
3.3.5 Comparison for the total amount of remuneration of the Directors, Supervisors, General Managers and Deputy General Managers of the
company in the past two years accounted for the net profit after tax ratio of individual or individual financial reports and explained the
payment of remuneration, relevance of policies, standards and portfolios, procedures for determining emoluments and business
performance
3.3.5.1 Analysis of the company's and the consolidated report for the total amount of remuneration paid to the Directors, Supervisors,
General Managers and Deputy General Managers of the company in the last two years to the net profit after tax of individual or
Individual financial reports
Unit: NT$ in Thousand
Item
Total
Remuneration
Ratio on Net Profit After Tax of
Consolidated Financial Report
Total
Remuneration
Ratio on Net Profit After Tax of
Consolidated Financial Report
Director
12,566
3.89%
8,550
2.80%
General Manager and
Deputy General Manager
18,407
5.70%
18,162
5.95%
3.3.5.2 Policies, standards and combinations for payment of honoraria, procedures for determining remuneration, and correlation
with business performance and future risks
The Company is following the guideline of “Employee Salary, Benefits and Other Remuneration Survey Report” which is published by the
Federation of Malaysian Manufacturers (FMM) and the Malaysian Employers' Federation (MEF) and is used as a reference for the
remuneration of the directors and managers of the company, based on the position and the contribution of the company and the profitability of
the company determine the amount of salary compensation. In addition, the company also has a Remuneration Committee, which is a member
of all independent directors, which regularly reviews and evaluates the policies, systems, standards and structures of directors and managers'
performance and salary remuneration.
Item
Total
Remuneration
Ratio on Net Profit After Tax of
Consolidated Financial Report
Total
Remuneration
Ratio on Net Profit After Tax of
Consolidated Financial Report
Director
12,566
3.89%
8,550
2.80%
General Manager and
Deputy General Manager
18,407
5.70%
18,162
5.95%
3.3.5.2 Policies, standards and combinations for payment of honoraria, procedures for determining remuneration, and correlation
with business performance and future risks
The Company is following the guideline of “Employee Salary, Benefits and Other Remuneration Survey Report” which is published by the
Federation of Malaysian Manufacturers (FMM) and the Malaysian Employers' Federation (MEF) and is used as a reference for the
remuneration of the directors and managers of the company, based on the position and the contribution of the company and the profitability of
the company determine the amount of salary compensation. In addition, the company also has a Remuneration Committee, which is a member
of all independent directors, which regularly reviews and evaluates the policies, systems, standards and structures of directors and managers'
performance and salary remuneration.
Item
Total
Remuneration
Ratio on Net Profit After Tax of
Consolidated Financial Report
Total
Remuneration
Ratio on Net Profit After Tax of
Consolidated Financial Report
Director
12,566
3.89%
8,550
2.80%
General Manager and
Deputy General Manager
18,407
5.70%
18,162
5.95%
3.3.5.2 Policies, standards and combinations for payment of honoraria, procedures for determining remuneration, and correlation
with business performance and future risks
The Company is following the guideline of “Employee Salary, Benefits and Other Remuneration Survey Report” which is published by the
Federation of Malaysian Manufacturers (FMM) and the Malaysian Employers' Federation (MEF) and is used as a reference for the
remuneration of the directors and managers of the company, based on the position and the contribution of the company and the profitability of
the company determine the amount of salary compensation. In addition, the company also has a Remuneration Committee, which is a member
of all independent directors, which regularly reviews and evaluates the policies, systems, standards and structures of directors and managers'
performance and salary remuneration.
The Proportion Of Total Amount To Net
Profit After Tax
1.20%
2018 Ratio on Net Profit After Tax of
Consolidated Financial Report
2.80% 5.95%
Total 3,662
Total
Remuneration
8,550 18,162
Cash
amount
3,662
Shares
amount
2017 Ratio on Net Profit After Tax of
Consolidated Financial Report
3.89% 5.70%
Name Peng Shih Hao Janice Cheow Ling Siu Hung Lai Chan Wai Wan Azha Bin Wan
Mustapha
Roslan Bin Arshad
Title CEO CFO Group General Manager ACI General Manager (Manufacturing) ACI R&D Manager ACI Sales & Technical Manager
Total
Remuneration
12,566 18,407
Year Item Director General Manager and
Deputy General Manager
Manager

3.4 Corporate Governance Operation

3.4.1 Operation of The Board of Directors

3.4.1.1 In the most recent year (2018) and up to the date of publication of the annual report, the Board of Directors convened 7 meetings, the attendance were listed as follows:

Title Name Actual
Attendance
Entrusted To
Attend
Frequency
Actual
Attendance Rate
(%)
Remarks
Chairman
PengShih Hao 7 0 100.00 Re-election on 2016.6.30
Director

Peng Sheng
Ching
5 2 71.43 Re-election on 2016.6.30
Director
Peng Chia Lin 7 0 100.00 Re-election on 2016.6.30
Director

Chee Kheng
Hoy
7 0 100.00 Re-election on 2016.6.30
Director

Chang Lu
Chang
7 0 100.00 Re-election on 2016.6.30
Director
Hsu Ken Tsai 7 0 100.00 Re-election on 2016.6.30
Independent
Director
Lo Tze Wu 7 0 100.00 Re-election on 2016.6.30
Independent
Director

Yang Yung
Cheng
7 0 100.00 Re-election on 2016.6.30
Independent
Director

Yeh Chung
Chuan
7 0 100.00 By-election on 2016.10.19

3.4.1.2 Other matters to be recorded

  • (1) The matters listed in Article 14(3) of the Securities Exchange Act and other matters of the Board Of Directors that have been rejected or retained by Independent Directors and have a record or written statement shall state the date, time, contents of the proposal and the opinions of all Independent Directors. And the company's handling of the opinions of Independent Directors:
Date of Meeting Meeting Content All Independent Directors'
opinions and companies
handling of opinions of
Independent Directors
June 12, 2018 Subsidiary All Cosmos Industries
Sdn Bhd and Geosat Technology
Co., Ltd. set up a joint venture
company proposal
All Directors' resolutions the
proposal shall be discussed in
the context of the cooperation
plan andthe contract.
March 26, 2019 In the 2018 surplus distribution
case, the original proposal was
distribution of a cash dividend of
NT$2.10 per share
The Independent Directors
suggested a dividend of
NT$2.35 to NT$2.40 per
share. The Board Of Directors
resolved to distribute
NT$2.40 pershare
  • 18 -

  • (2) For the implementation of the director's withdrawal of the interest bill, the

  • directors shall state the name of the directors, the content of the proposal, the reasons for avoiding the interests, and the participation in the voting.

Date of Meeting Meeting Content Reasons for avoidance of
interests and participation in
voting
November 13,
2018
Appointment of the person in
charge for the Taiwan branch
Director Peng Chia Lin
evaded due to interest, and the
chairman consulted the
opinions of the directors
present and passed the
resolution without objection.
December 21, 2018 The 2018 year-end bonus of the
group company distribution case
Director Peng Shih Hao and
Director Peng Sheng Ching
evaded the interest
relationship, and the agency
of chairman consulted other
directors’ opinion and passed
the resolution without
objection
  • (3) Assessment of the objectives and performance of the Board of Directors for the current and recent years:

The Board of Directors of the company authorized the Audit Committee and the Remuneration Committee to assist the Board of Directors in performing their supervisory duties. The Committee consists entirely of three Independent Directors. The chairman of the committees report their activities and resolutions to the Board of Directors on a regular basis.

3.4.2 Information on the Operation of the Audit Committee:

3.4.2.1 In the most recent year (2018) and as of the printing date of the annual report, the Audit Committee convened 7 meetings. The attendance of the Audit Committee is as follows:



as follows:
Title Name Actual
Attendance
Entrusted To
Attend
Frequency
Attendance Rate
(%)

Remarks
Independent
Director
Lo Tze Wu 7 0 100.00 Re-elction on 2016.6.30
Independent
Director
Yang Yung
Cheng
7 0 100.00 Re-elction on 2016.6.30
Independent
Director
Yeh Chung
Chuan
7 0 100.00 By-election on 2016.10.19

3.4.2.2. Other matters to be recorded

  • (1) The matters listed in Article 14(5) of the Securities Exchange Law and other matters that have not been approved by the Audit Committee and approved by more than two-thirds of all directors shall state the date, time, contents of the resolution, and the results of the Audit Committee. The results of the

  • 19 -

resolution and the company's handling of the Audit Committee’s opinion:

Meeting Date Meeting Content The results of the Audit
Committee's resolution
and the company's
handling of the Audit
Committee's opinions
March 16, 2018 2017 annual consolidated financial
statements and business report
resolution
All Independent
Directors approved the
resolutions
2017 "Internal Control System
Statement" resolution
2018 Annual External Auditors’ Fee and
its qualification and independency
assessment resolution
Amendment to the "Operating
Procedures for Acquisition or
Dispositionof Assets" resolution
May 10, 2018 Consolidated financial statements for
the first quarter of 2018
All Independent
Directors approved the
resolution
August 8, 2018 Consolidated financial statements for
the secondquarter of 2018
All Independent
Directors approved the
resolution
For the subsidiary company All Cosmos
Industries Sdn Bhd endorsement
guaranteeresolution
November 13, 2018 Consolidated financial statements for
thethird quarterof 2018
All Independent
Directors approved the
resolution
For the subsidiary company All Cosmos
Industries Sdn Bhd endorsement
guarantee resolution
March 26, 2019 2018 annual consolidated financial
statements and business report
All Independent
Directors approved the
resolution
In the 2018 surplus distribution
resolution, the original proposal was
distribution a cash dividend of NT$2.10
The audit committee
recommended to
distribute a dividend of
NT$2.35 to NT$2.40
per share. The board of
directors resolved to
distribute NT$2.40
2018 "Internal Control System
Statement"resolution
All Independent
Directors approved the
resolution
2019 Annual External Auditors’ Fee and
its qualification and independency
assessment resolution
Revision of the "Operating Procedures
for Acquisition or Disposition of Assets
" resolution
Revision of the "Operating Procedures
for Governing Lending of Funds"
resolution
  • 20 -

Revision of the "Operating Procedures for Endorsements and Guarantees" resolution Engaged in derivative commodity trading quotas and trading resolution

(2) The independent directors shall state the name of the independent directors, the content of the proposal, the reasons for avoiding the interests, and the participation in the voting situation: None.

(3) Communication between the Independent Directors and the Internal Audit Supervisors and Accountants (including major issues, methods and results of communication on the company's financial and business conditions):

The auditing unit of the company provides the audit report of the internal audit of the Independent Directors in accordance with the regulations, and reports the latest audit situation through the Board of Directors. The Independent Directors have to check the financial and business execution status of the company at any time. If there is any doubts about the related operations of the company, it can be deal with the relevant unit Supervisor immediately for review and improvement.

In addition, in the case of communication with external auditors, if the Independent Director has any doubts about the financial and business conditions of the company, he/she must deal with the accountant of the company at any time and guide the relevant units of the company to conduct review and improvement. The company's external auditors were present at the Annual Audit Committee on March 16, 2018 and March 26, 2019. During the meeting, the financial statements of the year and other related legal requirements are reported. If there are special circumstances, they will report to the members of the Audit Committee immediately. There is no such special situation in 2018. The audit committee of the company communicated well with the external auditors.

  • 21 -
Differences and its
Reasons of the Code of
Practice for Corporate
Governance as compared
withother listed
companies and OTC
companies
Differences and its
Reasons of the Code of
Practice for Corporate
Governance as compared
withother listed
companies and OTC
companies
No major differences
No major differences
No major differences
No major differences
No major differences
- 22 -
Operation circumstances (Note 1) Abstracts The company has established a code of practice for governance and
disclosed it on the company's website.
(i) The Company has established relevant internal procedures and
set up a spokespers on to deal with matters such as shareholder
suggestions, doubts or disputes.
(ii) The company's shareholder register provided by the stock agent
holds the list of shareholders and regularly tracks the list of final
controllers.
(iii) The Company has established a trading management method
for the related enterprises and has implemented it in order to
achieve the risk control mechanism.
(iv) The Company has established relevant internal control system
and announced it at the meeting to prevent insider trading.
No
Yes
ˇ
ˇ
ˇ
ˇ
ˇ
Assessed Items (1) Does the company formulate and
expose the Code of Practice for
Corporate Governance in
accordance with the Code of
Practice for Corporate Governance
in Listed Companies?
(2) the company's shareholding
structure and shareholders' equity
(i) Does the company stipulate
internal operating procedures to
deal with shareholders'
suggestions, doubts, disputes and
litigation matters, and implement
them according to procedures?
(ii) Does the company have a list of
the ultimate controllers of the
major shareholders and major
shareholders of the actual control
company?
(iii) Does the company establish,
implement and control the risk
control and firewall mechanism
Differences and its
Reasons of the Code of
Practice for Corporate
Governance as compared
withother listed
companies and OTC
companies
Differences and its
Reasons of the Code of
Practice for Corporate
Governance as compared
withother listed
companies and OTC
companies
No major differences
Future implementation as
appropriate
Future implementation as
appropriate
No major differences
- 23 -
Operation circumstances (Note 1) Abstracts (i) The Company currently has nine directors, including one female
director. Both have the necessary competency requirements for
performing their duties and have a diverse background.
(ii) The Company will establish other various functional committees
in due course according to the company's business development
and legal requirements.
(iii) The Company has not yet established the measures and methods
for the performance evaluation of the Board of Directors. In the
future, it will be determined as appropriate according to the actual
situation of the company.
(iv) On March 16, 2018, the Company reported the independency
assessment of the appointment of External Auditors in 2018 to the
Board of Directors and the Audit Committee for deliberation. All
the directors passed the resolution that Deloitte & Touche, Cheng
Chiang Hsun and Yu Cheng Chuan are in line with the company's
independence and eligibility assessment criteria. The review is
based on the “Chartered Accountant Review and Evaluation
No ˇ
ˇ
Yes
ˇ
ˇ
Assessed Items between the enterprises?
(iv) Does the company stipulate
internal regulations and prohibit
insiders from using the
undisclosed information on the
market to buy and sell securities?
(3) the composition and duties of the
board of directors
(i) Does the board of directors
formulate a diversified
policy and implement it in
terms of membership?
(ii) Does the company voluntarily set
up other functional committees in
addition to the salary remuneration
committee and the audit
committee?
(iii) Does the company stipulate the
performance appraisal methods of
the board of directors and their
assessment methods, and conduct
performance evaluations every
year and regularly?
(iv) Does the company regularly
Differences and its
Reasons of the Code of
Practice for Corporate
Governance as compared
withother listed
companies and OTC
companies
Differences and its
Reasons of the Code of
Practice for Corporate
Governance as compared
withother listed
companies and OTC
companies
No major differences - 24 -
Operation circumstances (Note 1) Abstracts Form” prepared by the Company and the “Accountant's
independence statement” issued by the accountant.
The specific indicators and assessments of the review assessment
form are as follows:
1. Accountant independency
2. Accountant's moral behavior
3. Financial report quality, timeliness
4. Auditor professionalism
5. Assess the various risks that exist or potential to monitor the
company
6. Communication with management
7. Rationality of Audit Fee
The company has set up a part-time person in charge for corporate
governance to handle corporate governance related matters.
No
Yes ˇ
Assessed Items assess the independence of the
Chartered Accountant?
4. Does the listing company has set up
a corporate governance special
(part-time) unit or personnel
responsible for corporate
governance related matters
(including but not limited to
providing information required by
directors and supervisors to conduct
business, and handling matters
related to meetings of the board of
directors and shareholders meeting
in accordance with the law, handling
company registration and change
Differences and its
Reasons of the Code of
Practice for Corporate
Governance as compared
withother listed
companies and OTC
companies
Differences and its
Reasons of the Code of
Practice for Corporate
Governance as compared
withother listed
companies and OTC
companies


No major differences
No major differences No major differences
No major differences
Operation circumstances (Note 1) Abstracts The company has set up a stakeholder area on the company's website
(www.allcosmos.com) and maintains a good communication channel to
respond effectively to all concerns of stakeholders.
The company has appointed the stock affairs agent of SinoPac
Securities Corporation to handle the affairs of the shareholders'
meeting.
(i) The Company has set up the company website
(www.allcosmos.com) and disclosed financial business and
corporate governance information for investors to understand the
inquiry.
(ii) The Company has assigned personnel to be responsible for
information collection and disclosure, and has selected suitable
personnel to serve as spokespersons and deputy spokespersons.
No
Yes ˇ ˇ ˇ
ˇ
Assessed Items registration, making board of
directors and shareholders meeting,
etc.)?
5. Does the company establish
communication channels with
interested parties (including but not
limited to shareholders, employees,
customers and suppliers), set up
stakeholder areas on the company's
website, and respond appropriately
to important corporate societies of
concern to stakeholders?
Responsibility issues?
6. Does the company appoint a
professional stock agency to handle
the affairs of the shareholders'
meeting?
7. information disclosure
(i) Does the company set up a
website to expose financial
business and corporate
governance information?
(ii) Does the company adopts other
methods of information
Differences and its
Reasons of the Code of
Practice for Corporate
Governance as compared
withother listed
companies and OTC
companies
Differences and its
Reasons of the Code of
Practice for Corporate
Governance as compared
withother listed
companies and OTC
companies
No major differences - 26 -
Operation circumstances (Note 1) Abstracts (i) Employees' rights and interests: The company has established
employee codes in accordance with the law, as the basis for the
company and employees to protect the legitimate rights and
interests of employees.
(ii) Employee care: Establish an employee welfare system and an
education and training system, and hold activities not on a regular
basis.
(iii) Investor Relationship: The Company has a spokesperson system
and exposes or announces relevant information in accordance with
regulations.
(iv) Supplier relationship: The company maintains long-term good
relations with suppliers.
(v) Rights of interested parties: The company has a company website
and a spokesperson to provide opinions to stakeholders to
safeguard their rights and interests.
(vi) The situation of directors and supervisors for further study: The
No
Yes ˇ
Assessed Items disclosure (such as setting up an
English website, designating a
person to be responsible for the
collection and disclosure of
company information,
implementing the spokesperson
system, and placing the company
website during the legal person
briefing process)?
8. Does the company have other
important information that helps to
understand the operation of
corporate governance (including but
not limited to employee rights,
employee care, investor relations,
supplier relationships, stakeholder
rights, directors and supervisors'
training, The implementation of risk
management policies and risk
measurement standards, the
implementation of customer
policies, the company's purchase of
liability insurance for directors and
supervisors, etc.)?
Differences and its
Reasons of the Code of
Practice for Corporate
Governance as compared
withother listed
companies and OTC
companies
Differences and its
Reasons of the Code of
Practice for Corporate
Governance as compared
withother listed
companies and OTC
companies
9. Please indicate the improvement of the corporate governance evaluation results of the Corporate Governance and Management Center of the
Taiwan Securities Exchange Co., Ltd. in the recent year, and propose priority strengthening measures for those who have not yet improved:

Improvement and Implementation Situation/Circumstances
The 2019 shareholders' meeting has prepared an English version
of the meeting notice, and uploads at the same time.
The 2019 shareholders' meeting has prepared an English version
of the handbook and supplementary information for the meeting,
Operation circumstances (Note 1) Abstracts directors of the Company have been regularly studied according to
the regulations. (For details, please refer to pages 38~39 of this
annual report)
(vii) Implementation of risk management policies and risk
measurement standards: Various internal regulations are formulated
according to law to conduct various risk management and
evaluation.
(viii) Implementation of customer policy: The company maintains a
stable and good relationship with its customers.
(ix) The company purchased liability insurance for directors and
supervisors: The company has purchased liability insurance for
directors in accordance with the company's articles of association.

Corporate Governance Review Items
Does the company upload the English version of the
meeting notice 30 days before the meeting of the
shareholders' meeting?
Does the company upload the English version of the
discussion manual and the supplementary information
No
Yes
Assessed Items
Corporate
Governance
Evaluation
No.
1.9 1.10
Differences and its
Reasons of the Code of
Practice for Corporate
Governance as compared
withother listed
companies and OTC
companies
Differences and its
Reasons of the Code of
Practice for Corporate
Governance as compared
withother listed
companies and OTC
companies
Note 1: Regardless of whether the operation is checked "Yes" or "No", it should be stated in the summary description field.
and uploads at the same time. The 2019 Annual General Meeting of Shareholders has prepared
an annual report in English and uploaded it at the same time.
In the 2018 Annual Report - Other matters to be recorded in the
operation of the Audit Committee, the matters listed in Article 14
(5) of the Securities Exchange Act and other matters not
approved by the Audit Committee and approved by more than
two-thirds of all directors, The date, period, content of the
proposal, the outcome of the audit committee resolution, and the
company's handling of the opinions of the audit committee have
been described in the form.
It has been stated in the annual report of 2018: On March 16,
2018, the independency assessment of the appointment of
external auditors in 2018 will be reported to the Board of
Directors and the Audit Committee for deliberation. All directors
had passed the resolution of Deloitte & Touche, Chen Chiang
Hsun and Yu Cheng Chuan are in compliance with the company's
independency and eligibility assessment criteria.
Operation circumstances (Note 1) Abstracts
of the meeting before the 21st meeting of the
shareholders' meeting?
Does the company upload an English version of the
annual report before the 7th meeting of the
shareholders' meeting?
Does the company disclose in detail the results of the
resolutions of the audit committee on major resolutions
and the company's comments on the audit committee
in the annual report?
Does the company's board of directors regularly (at
least once a year) assess the independence of the
Chartered Accountant and disclose the assessment
process in detail in the annual report?
No
Yes
Assessed Items
1.11 2.11 2.17

3.4.4 Composition, responsibilities and operation of the remuneration committee:

3.4.4.1. Remuneration Committee member information

Identity
(Note
1)
Condition
Name
More than 5-year Work Experience
and Professional Qualifications as Below
More than 5-year Work Experience
and Professional Qualifications as Below
More than 5-year Work Experience
and Professional Qualifications as Below
Independency Criteria
(Note 2)
Independency Criteria
(Note 2)
Independency Criteria
(Note 2)
Independency Criteria
(Note 2)
Independency Criteria
(Note 2)
Independency Criteria
(Note 2)
Independency Criteria
(Note 2)
Independency Criteria
(Note 2)
Number of other
public
companies
in which the
Individual is
concurrently
serving as an
independent
director

Remarks
An
Instructor
or
Higher
Position in
a
Departmen
t of
Commerce
, Law,
Finance,
Accountin
g, or
Other
Academic
Departmen
t
Related to
the
Business
Needs of
the
Company
in a
Public or
Private
College
A Judge,
Public
Prosecutor,
Attorney,
Certified
Public
Accountant, or
Other
Professional or
Technical
Specialist Who
has
Approved a
National
Examination
and Been
Awarded a
Certificate in a
Profession
Necessary for
the Business of
the
Company

Have Work
Experience
in
the Areas of
Commerce,
Law,
Finance,
or
Accounting,
or Otherwise
Necessary
for
the Business
of
the Company

1
2 3 4 5 6 7 8
Conve
ner
Lo Tze Wu No
Commi
ttee
Yang Yung
Cheng
No
Commi
ttee
Yeh Chung
Chuan
No

Note 1: Please fill in the identity as a director, independent director or others.

Note 2: Please mark “  ” at the beginning of the following conditions that various directors and supervisors match in two years before appointment and during their tenure

(1) Not an employee of the Company or any of its affiliates.

(2) Not a director or a supervisor of the Company or its affiliated company (However, the independent director that the Company or its parent company or subsidiary sets according to this law or local law is not subject to this limit).

(3) Not a natural-person shareholder who holds shares, together with those held by the person's spouse, minor children, or held by the person under others' names, in an aggregate amount of 1% or more of the total number of outstanding shares of the Company or ranking in the top 10 in holdings. (4) Not a spouse, relative within the second degree of kinship, or lineal relative within the third degree of kinship, of any of the persons in the preceding three subparagraphs.

(5) Not a director, supervisor, or employee of a corporate shareholder that directly holds 5% or more of the total number of outstanding shares of the Company or that holds shares ranking in the top 5 in holdings.

(6) Not a director, supervisor, officer, or shareholder holding 5% or more of the share, of a specified company or institution that has a financial or business relationship with the Company.

(7) Not a professional person who provides business, legal, financial, and accounting services for the Company or its affiliated company, an owner, a partner, a director, a supervisor, a manager of wholly-owned or partnership company/institution, or its spouse.

(8) Not a person of any conditions defined in Article 30 of the Company Law.

  • 29 -

In order to improve corporate governance and improve the company's directors and managers' salary and remuneration system, the company has taken into account the Republic of China “Stock Listing Or The Establishment And Exercise Of Powers And Responsibilities Of The Company's Remuneration Committee For Securities Firms' Business Premises”, on September 28, 2012. After the resolution of the board of directors, the establishment of the salary compensation committee, and the establishment of the salary and remuneration committee organization rules, in order to facilitate compliance. Members of the Compensation and Remuneration Committee include Independent Director Lo Tze Wu, Independent Director Yang Yung Cheng and Independent Director Yeh Chung Chuan.

3.4.4.2 Remuneration Committee duties

The Remuneration Committee faithfully performs the following functions and duties and submits the recommendations to the Board of Directors for discussion:

  • (1) Establish and regularly review the policies, systems, standards and Structures for performance evaluation and remuneration of directors and managers.

  • (2) Regularly assess and determine the remuneration of directors and managers.

3.4.4.3 Remuneration Committee operation

  • (1) The company's remuneration committee has 3 members.

  • (2) The term of office of the current members: June 30, 2016 to June 29, 2019, the most recent year (2018) to March 31, 2019, the salary remuneration committee convened 5 times meeting (A). The attendance is as follows:

Title Name
()
Actual attendance
(B)

Entrusted To
Attend
Frequency
Actual
attendance rate
(%)
(B/A)(Note)

Remarks
Convener Lo Tze
Wu
5 0 100.00 Re-election on
2016.6.30
Committee Yang
Yung
Cheng
5 0 100.00 Re-election on
2016.6.30
Committee Yeh
Chung
Chuan
4 1 80.00 New Appointed on
2016.11.11
  • 30 -

Other items to be recorded:

  1. If the Board of Directors does not adopt or amend the recommendations of the Salary and Remuneration Committee, it shall state the date and time of the Board of Directors, the content of the proposal, the outcome of the resolution of the Board of Directors and the company's handling of the opinions of the Salary and Remuneration Committee (eg the salary remuneration approved by the Board of Directors is better than the Remuneration Committee, the recommendations should state the difference and the reasons): None.

  2. The resolutions of the Salary and Remuneration Committee, if the members have objections or reservations and have a record or written statement, the date, period, content of the proposal, opinions of all members and comments on the members shall be stated: None.

3.4.5 Fulfilling Social Responsibility

Assessed Items Operational circumtances Differences and its
Reasons of the
Code of Practice
for Social
Responsibility as
compared with
other listed
companies and
OTC
companies
Yes No
Abstracts
1. Implementing corporate
governance
(i) Does the company formulate
corporate social
responsibility policies or
systems and review the
effectiveness of
implementation?
(ii) Does the company regularly
hold social responsibility
education training?
(iii) Does the company set up a
special (part-time) unit for
promoting corporate social
responsibility, which is
authorized by the board of
directors to handle the


ˇ
ˇ
ˇ
ˇ
(i) The Company has established a
corporate social responsibility
policy as a basis for the
implementation of corporate
responsibility, and will review the
results in the future.
(ii) The company will announce to the
colleagues from time to time, and
will be placed on the company's
website for reference by the
colleagues.
(iii) In order to improve the
management of corporate social
responsibility, the company is
handled by a employee of the
Administrative department hold a
concurrentpost to take charge of




No major
differences
No major
differences
No major
differences
- 31 -
Assessed Items Operational circumtances Differences and its
Reasons of the
Code of Practice
for Social
Responsibility as
compared with
other listed
companies and
OTC
companies
Yes No Abstracts
management level and
report the situation to the
board of directors?
(iv) Does the company
formulate a reasonable
salary remuneration policy,
and combine the employee
performance appraisal
system with the corporate
social responsibility policy,
and establish a clear and
effective reward and
disciplinarysystem?
the promotion and implementation
of the corporate social
responsibility policy.
(iv) The Company has established a
reasonable salary remuneration
policy with reference to market
practice and has established a clear
and effective reward and
disciplinary system.
No major
differences
2. The development of a
sustainable environment
(i) Is the company committed
to improve the utilization
efficiency of various
resources and using
recycled materials with low
impact on the
environmental load?
(ii) Does the company establish
a suitable environmental
management system based
on its industrial
characteristics?
(iii) Does the company pay
attention to the impact of
climate change on
operational activities, and
implement greenhouse gas
inventory, formulate
corporate energy
conservation and carbon
reduction and greenhouse
gas reduction strategies?
ˇ
ˇ
ˇ
(i) The Company has made good use
of the efficiency of various
resources in order to reduce the
impact on the environmental load.
(ii) The company has passed a
number of ISO certifications, and
has established system
specifications for safety, health
and environmental protection.
(iii) The Company pay attention to
and adjust the air-conditioning
temperature and opening hours of
the business premises at any time
in response to the trend of energy
saving and carbon reduction.
No Major
differences
No Major
differences
No Major
differences
3. Maintain social welfare
  • 32 -
Assessed Items Operational circumtances Differences and its
Reasons of the
Code of Practice
for Social
Responsibility as
compared with
other listed
companies and
OTC
companies
Yes No
Abstracts
(i) Does the company formulate
relevant management
policies and procedures in
accordance with relevant
laws and regulations and
international human rights
conventions?
(ii) Does the company establish
an employee complaint
mechanism and channel and
properly handle it?
(iii) Does the company provide
a safe and healthy working
environment for employees
and regularly implement
safety and health education
for employees?
(iv) Does the company
establish a mechanism for
employee’s regular
communication and notify
the employees of the
business changes that may
have a significant impact on
employees in a reasonable
manner?
(v) Does the company establish
an effective career
development training
program for employees?
(vi) Does the company
formulate relevant
consumer protection
policies and appeal
procedures for research and
development, procurement,
production, operations and
serviceprocesses?



ˇ
ˇ
ˇ
ˇ
ˇ
ˇ
ˇ
ˇ
ˇ (i) The company follows relevant
labor regulations and formulates
relevant personnel management
regulations to protect employees'
basic rights.
(ii) The company has a complaint
mailbox, which is handled by a
special assigned person in a
timely manner, and the
labor-management dialogue is
smooth.
(iii) The company provides
employees with a safe and healthy
working environment in
accordance with various safety
regulations, and conducts
employee education training and
health checkups regularly.
(iv) The company regularly holds
departmental meetings, organizes
employee networking and
exchange activities, and has a
bulletin board for timely
information on the company.
(v) The company provides employees
with external professional training
subsidies and internal education
courses every year to enhance the
professional
development
of
employees.
(vi) The company has a complaint
system to provide customer
service directly and adjust various
processes in a timely manner.
(vii) The marketing and labeling of
the main products of the Company
are in compliance with relevant
laws and international standards.






No Major
differences
No Major
differences
No Major
differences
No Major
differences
No Major
differences
No Major
differences
No Major
differences
  • 33 -
Assessed Items Operational circumtances Operational circumtances Operational circumtances Differences and its
Reasons of the
Code of Practice
for Social
Responsibility as
compared with
other listed
companies and
OTC
companies
Yes No Abstracts
(vii) Does the company comply
with relevant regulations
and international standards
for the marketing and
labeling of products and
services?
(viii) Before the company and
the supplier, do they assess
whether the supplier has
any record of affecting the
environment and society in
the past?
(ix) If the contract between the
company and its major
suppliers includes suppliers
who violate their corporate
social responsibility
policies and have
significant environmental
and social impacts, they
may terminate or terminate
the terms of the contract at
anytime?
(viii) The Company will conduct an
overall assessment before dealing
with supplier. If there is a record
affecting the environment and
society, the Company will
strengthen the prudent assessment.
(ix) Although the company's contract
does not specify the supplier's
corporate social responsibility, it
has been included in the supplier's
assessment and will be
implemented as appropriate in the
future.

No Major
differences
Future
implementation as
appropriate
4. Strengthen Information
Disclosure
(i) Does the company disclose
relevant information on
corporate social
responsibility with
relevance and reliability on
its website and public
information observatories?
ˇ (i) The Company will disclose
relevant information on corporate
social responsibility in the public
information observatory and the
annual report of the shareholders'
meeting.
No Major
differences
5. If the company has its own corporate social responsibility code based on the Code of Practice
for Corporate Social Responsibility of Listed Companies, please describe the difference
between its operation and the code: The company has established relevant measures and
implemented it accordingly. There are no significant differences.
6. Other important information that helps to understand the operation of corporate social
responsibility:
  1. If the company has its own corporate social responsibility code based on the Code of Practice for Corporate Social Responsibility of Listed Companies, please describe the difference between its operation and the code: The company has established relevant measures and implemented it accordingly. There are no significant differences.

  2. Other important information that helps to understand the operation of corporate social responsibility:

  3. 34 -

Assessed Items Operational circumtances Operational circumtances Operational circumtances Differences and its
Reasons of the
Code of Practice
for Social
Responsibility as
compared with
other listed
companies and
OTC
companies
Yes No Abstracts
(i) The Company implemented and strengthened environmental management in accordance
with environmental protection laws and regulations. In May 2011, it was recommended by
the Malaysian Ministry of Agriculture Promotion to be appointed as the “Green Industry
Consultant” by the “Technology and Innovation Association” headed by the Prime Minister
of Malaysia. The only private company in the consultant.
(ii) The company provides employees with a response channel and holds meetings from time to
time, such as employer-employee meetings and employee symposiums, so that all
departments and employees can fullyexpress their opinions.
7. If the company's corporate social responsibility report has passed the verification criteria of the
relevant verification agency, it should be stated: at the moment the company has not prepared
a corporate social responsibilityreport.
  • (ii) The company provides employees with a response channel and holds meetings from time to time, such as employer-employee meetings and employee symposiums, so that all departments and employees can fully express their opinions.

    1. If the company's corporate social responsibility report has passed the verification criteria of the relevant verification agency, it should be stated: at the moment the company has not prepared a corporate social responsibility report.
  • 35 -

3.4.6 The company fulfills its integrity and conducts its operations and adopts measures

Assessed Items Operation Circumstances Differences and
its Reasons of
the Conducts of
Integrity as
compared with
other listed
companies and
OTC
companies
Yes No Abstracts
1. Establishing integrity
management policies and
programs
(i) Does the company express its
commitment to integrity
management policies and
practices in its regulations and
external documents, as well as
the commitment of the board
of directors and management
to actively implement business
policies?
(ii) Does the company formulate a
plan to prevent dishonesty, and
specify operating procedures,
behavior guidelines,
disciplinary and grievance
systems for violations in each
program, and implement
them?
(iii) Does the company adopt
preventive measures for the
business activities of the
seventh paragraph of Article 7
(2) of the “Code of Integrity of
Listed Companies” or other
business activities with high
risk of dishonesty?



ˇ
ˇ
ˇ
(i) The Company has established a
code of good faith management and
conduct publicity to implement it
from time to time.
(ii) The Company has established
relevant standards and penalties in
the staff code, and conduct
propaganda and education training
to implement the act of preventing
dishonesty from time to time.
(iii) The company follows the code of
good faith management, prohibits
major fraud or improper
acceptance, and has internal control
and internal auditing system to
prevent the risk of related
untrustworthy behavior.


No Major
differences
No Major
differences
No Major
differences
2. The Implementation Of Integrity
Management
(i) Does the company assess the
integrity record of the object of
the transaction and specify the
terms of good faith in the
contract with the transaction
partner?
(ii)Does the companyset upa

ˇ
ˇ (i) The company will conduct acredit
report searching to evaluate its
records before trading with
important customers.
(ii) The Company has not yet set up a
special (concurrent) unit for the
promotion of corporate integrity
management under the Board of
Directors,but it continues to
No Major
differences
Future
implementation
as appropriate
  • 36 -
Assessed Items Operation Circumstances Differences and
its Reasons of
the Conducts of
Integrity as
compared with
other listed
companies and
OTC
companies
Yes No Abstracts
special (part-time) unit that
promotes the integrity
management of the company
under the board of directors,
and regularly reports its
implementation to the board of
directors?
(iii) Does the company formulate
a policy to prevent conflicts of
interest, provide a proper
presentation channel, and
implement it?
(iv) Has the company established
an effective accounting system
and internal control system for
the implementation of credit
management, and the internal
auditing unit regularly checks
it, or entrusts an accountant to
perform the check?
(v) Does the company regularly
hold education training inside
and outside of integrity
management?
ˇ
ˇ
ˇ
promote and follow relevant
policies.
(iii) The Company has established a
code of good faith operation, has a
system of directors' avoidance and
has a complaint mailbox to
provide a statement pipeline and
implement it.
(iv) The Company has established an
accounting system and an internal
control system, and implemented
them, and entrusted independent
accountants to conduct regular
checks.
(v) The Company enhances
employees' awareness of honesty
and behavior through education
and training from time to time.






No Major
differences
No Major
differences
No Major
differences
3. The Operation Of The
Company's Reporting System
(i) Does the company have a
specific reporting and reward
system, and establish a
convenient reporting channel,
and assign appropriate
personnel to the respondents?
(ii) Does the company stipulate
the operational procedures for
investigation and the relevant
confidentiality mechanism for
accepting the report?
(iii) Does the company take
measures toprotect the
ˇ
ˇ
ˇ
(i) The company has a complaint
mailbox. When employees find
violations of laws and regulations,
they may report it at any time and
the company will report it to the
relevant unit as soon as possible.
(ii) The company has a complaint
mailbox to accept the report, and
the relevant materials are handled
confidentially.
(iii) The company takes protective
measures against the informant
and does not dispose of it due to
the report.
No Major
differences
No Major
differences
No Major
differences
  • 37 -
Assessed Items Operation Circumstances Operation Circumstances Operation Circumstances Differences and
its Reasons of
the Conducts of
Integrity as
compared with
other listed
companies and
OTC
companies
Yes No Abstracts
prosecutor from improper
handlingdue to the report?
4. Strengthen Information
Disclosure
(i) Does the company exposes the
contents of its integrity
management code and
promotes its effectiveness on its
website and public information
observatories?

ˇ
(i)
The
Company
will
disclose
information on the Code of Good
Practice in the public information
observatory and the annual report
of the shareholders' meeting.




No Major
differences
5. If the company has its own code of conduct in accordance with the Code of Conduct for the
Listing of Companies in the Listed Companies, please describe the difference between its
operation and the code. The company has established relevant measures and implemented them
accordingly. No major difference.
6. Other important information that helps to understand the company's integrity operation: (If the
companyreviewsandamendsits established code ofconduct, etc.): None.
  1. If the company has its own code of conduct in accordance with the Code of Conduct for the Listing of Companies in the Listed Companies, please describe the difference between its operation and the code. The company has established relevant measures and implemented them accordingly. No major difference.

  2. Other important information that helps to understand the company's integrity operation: (If the company reviews and amends its established code of conduct, etc.): None.

  3. (7) If the company has established a corporate governance code and related regulations, it should disclose its inquiry method:

  4. The company has established a corporate governance code and related regulations, which have been published on the company's website (http://allcosmos.com) and the public information observatory (http://mops.twse.com.tw) for inquiry.

  5. (8) Other important information that is sufficient to enhance the understanding of the operation of corporate governance must be disclosed together:

  6. Directors' training status

Title Name Training Date Organiser Course taken Credit
hours
Total
training
hours as
per report
Corporate
Shareholder
Representati
ve
Peng
Shih Hao
2018.8.8 Taiwan
Corporate
Governance
Association
Intellectual property rights
and business secrets
3 6
2018.11.13 Patent attack and defense 3
Corporate
Shareholder
Representati
ve
Peng
Sheng
Ching
2018.8.8 Taiwan
Corporate
Governance
Association
Intellectual property rights
and business secrets
3 6
2018.11.13 Patent attack and defense 3
Corporate
Shareholder
Representati
ve
Peng
Chia Lin
2018.1.24 Youth
Career
Develoment
Association,
PwC
Taiwan,
PuHua
Corporate M&A Practice
Course
7.5 13.5
  • 38 -
Title Name Training Date Organiser Course taken Credit
hours
Total
training
hours as
per report
Finance
Consultant
2018.8.8 Taiwan
Corporate
Governance
Association
Intellectual property rights
and business secrets
3
2018.11.13 Patent attack and defense 3
Director Chang
Lu
Chang
2018.8.8 Taiwan
Corporate
Governance
Association
Intellectual property rights
and business secrets
3 6
2018.11.13 Patent attack and defense 3
Director Hsu Ken
Tsai
2018.8.8 Taiwan
Corporate
Governance
Association
Intellectual property rights
and business secrets
3 6
2018.11.13 Patent attack and defense 3
Director Chee
Kheng
Hoy
2018.8.8 Taiwan
Corporate
Governance
Association
Intellectual property rights
and business secrets
3 6
2018.11.13 Patent attack and defense 3
Independent
Director
Lo Tze
Wu
2018.8.8 Taiwan
Corporate
Governance
Association
Intellectual property rights
and business secrets
3 12
2018.11.13 Patent attack and defense 3
Independent
Director
Yang
Yung
Cheng
2018.2.26 CPA
Associations
R.O.C.
(Taiwan)
Understanding Consumer
Protection Law from
Consumer Disputes
2 18
2018.3.1 Income tax revision focus 2
2018.3.7 2017 annual income tax
returnpoints and doubts
7
2018.7.17 Analysis of the rules and
practice changes in the first
half of 2018
7
Independent
Director
Yeh
Chung
Chuan
2018.8.8 Taiwan
Corporate
Governance
Association
Intellectual property rights
and business secrets
3 6
2018.11.13 Patent attack and defense 3

2. Manager training status

Title Name Training Date Organiser Course taken Credit
hours
Total
training
hours as
per report
Chief
Financial
Officer
Janice
Cheow
2018.11.1~201
8.11.2
Taiwan
Accounting
Research and
Development
Foundation
Issuer Securities Dealer Stock
Exchange Accounting
Supervisor Continuing
Education Course
12 12
Audit
Manager
Tai Hong
Wen
2018.12.21 The Institute
of
Internal
Auditors-Chi
nese Taiwan
Business secrets and anti
competition recent cases and
development
6 12
2018.12.22 Taiwan
Securities &
Futures
Institute
How to use the EXCEL
function to enhance the audit
efficiency practice workshop
6
  • 39 -

  • (9) The implementation status of the internal control system should disclose the following matters

  • Company to the Public Declation for Internal Control Statement

All Cosmos Bio-Tech Holding Corporation Public Declaration for Internal Control System

Date: March 26, 2019 With respect to the internal control system for 2018, based on the self inspection result, we hereby represent as follows:

I. The Company is aware that the establishment, implementation and maintenance of the internal control system is the responsibility of the board of directors and managers of the company. The Company has established this system. The purpose is to provide reasonable results in terms of operational effectiveness and efficiency (including profitability, performance and asset security, etc.), reporting reliability, timeliness, transparency, compliance with relevant regulations and compliance with relevant laws and regulations.

II. The internal control system has its inherent limitations. Regardless of how well the design is perfected, an effective internal control system can only provide reasonable assurance of the achievement of the above three objectives; and, due to changes in the environment and conditions, the effectiveness of the internal control system may change. However, the company's internal control system has a self-monitoring mechanism. Once the identification is missing, the company will take corrective action.

III. The Company judges whether the design and implementation of the internal control system is effective based on the judgment item of the effectiveness of the internal control system as stipulated in the “Guidelines for the Establishment of Internal Control System for Public Offering Companies” (hereinafter referred to as “Processing Guidelines”). The internal control system judgment project used in the “processing criteria” is based on the process of management control, and the internal control system is divided into five components: 1. Environment Control, 2. Risk assessment, 3. Operation control, 4. Information and communication, and 5. Operations Supervision. Each component also includes several items. Please refer to the “Handling Guidelines” for the above items.

IV. The company has adopted the above internal control system to judge the project and evaluate the effectiveness of the design and implementation of the internal control system.

V. Based on the results of the previous assessment, the Company believes that the internal control system (including supervision and management of subsidiaries) of the Company on December 31, 2018, including the understanding of the effectiveness and efficiency objectives of the operation, and reporting the design and implementation of the internal control system, which is reliable, timely, transparent and in compliance with relevant regulations and laws, is effective and can reasonably ensure the achievement of the above objectives.

VI. The Company entrusted the accountant to review the opening period and external financial reports in accordance with Article 25 of the “Handling Guidelines” and Article 4 of the “Measures for the Post-IPO Management of Foreign Issuers of Taiwan Stock Exchange Co., Ltd.” The internal control system relating to the reliability and security of the assets (such that the assets are not obtained, used or disposed of without authorization), as described in the

  • 40 -

preceding paragraph, is effective in designing and executing, and has no impact on the financial information. The processing, aggregation, and reporting of major deficiencies in reliability have no impact on the security of assets, and the significant loss of assets acquired, used, or disposed of without authorization.

VII. This statement will become the main content of the company's annual report and public statement, and will be made public. If the content of the above disclosure is illegal or concealed, it will involve legal liabilities such as Articles 20, 32, 171 and 174 of the Securities Exchange Law.

VIII. This statement was approved by the board of directors of the Company on March 26, 2019. Among the 9 directors present, there was 0 person holding dissent, and the others all agreed upon the contents of this Declaration.

All Cosmos Bio-Tech Holding Corporation

Chairman: Signature & seal

General Manager : Signature & seal

  • 41 -

  • If the entrusted accountant project examines the internal control system, the CPA's review report shall be disclosed:

Internal Control System Review Report

Attached to All Cosmos Bio-Tech Holding Corporation on March 26, 2019, the internal control system that was assessed to be related to external financial reporting and asset security was effectively designed and implemented on December 31, 2018, the statement was reviewed by the accountant. Maintaining an effective internal control system and assessing its effectiveness is the responsibility of the company's management. The accountant's responsibility is to express an opinion on the effectiveness of the company's internal control system and the company's internal control system statement based on the results of the review.

The accountant plans and performs the review in accordance with the “Guidelines for the Establishment of Internal Control Systems for Public Offering Companies” and the generally accepted auditing standards of the Republic of China to ensure that the company's internal control system remains effective in all material aspects. This review includes understanding the company's internal control system, assessing the process by which management assesses the effectiveness of the overall internal control system, testing and evaluating the effectiveness of the design and implementation of the internal control system, and other review procedures that the accountant deems necessary. The accountant believes that this review can provide a reasonable basis for the opinions expressed.

Any internal control system has its inherent limitations. Therefore, the above internal control system of All Cosmos Bio-Tech Holding Corporation may still fail to prevent or detect any errors or frauds that have occurred. In addition, the future environment may change, and the degree of compliance with the internal control system may also be reduced. Therefore, the effective internal control system in this period does not mean that it will be effective in the future.

Based on the opinions of the accountant, the internal control system judged by All Cosmos Bio-Tech Holding Corporation and external financial reports and asset security in accordance with the internal control effectiveness judgment project of the “Public Issuance of Internal Control System Processing Guidelines”, the design and implementation of December 31, 2018 can maintain its effectiveness in all major aspects; All Cosmos Bio-Tech Holding Corporation issued on March 26, 2019, that the above-mentioned and external financial reports and asset security were evaluated. The declaration of the effective design and implementation of the relevant internal control system is permitted in all material respects.

Deloitte & Touche

CPA, Cheng Chiang Hsun

CPA, Yu Cheng Chuan

  • 42 -

  • (10) In the most recent year at the end of the annual report, the company and its internal personnel were punished according to law, and the company violated the internal control system for penalties, major defects and improvement of its internal personnel: None.

  • (11) Important resolutions of the shareholders' meeting and the board of directors in the most recent year at the end of the annual report:

  • Important resolutions and implementation of the shareholders' meeting and shareholders' temporary meeting

March 31,2019 March 31,2019
Meeting
Date
Important resolutions Implementation
situation
2018.6.12 Recognition
1. Recognize the business report for 2017 and the
consolidated financial statements for 2017.
Has been
implemented
according to the
resolution
2. Recognize the 2017 surplus distribution case The 2017 surplus
distribution of cash
dividends of
NT$2.65 per share
was distributed on
July27,2018.
Discussion items
1. Adoption of amendments to the company's
articles of association
The resolution was
passed and has been
implemented in
accordance with the
resolution of the
shareholders'
meeting.
2. Amendment of the "Operating Procedures of
Acquisition Or Disposal Of Assets"
The resolution was
passed and has been
implemented in
accordance with the
resolution of the
shareholders'
meeting.
3. By dissolving the prohibition of competition for
directors and their representatives.
The resolution was
passed and has been
implemented in
accordance with the
resolution of the
shareholders'
meeting.

2. Important Resolution Of The Board Of Directors

March 31, 2019


March 31,2019
Meeting Date Important resolutions
2018.3.16 1. Passed the 2017 annual remuneration for employees and directors
2. Passed the company's 2017 consolidated financial statements and
business report
3. Passed the company's 2017 surplus distribution case
4. Passed the company's 2017 Internal Control System Statement
5. Passed of the company's external auditors’ fee and its applicabilityand
  • 43 -
Meeting Date Important resolutions
independency assessment
6. Passed the addition of a new board of directors through subsidiary All
Cosmos Industries Sdn Bhd
7. Passed the directors and their representatives’s non-competition
prohibition resolution
8. Passed the manager’s non-competition prohibition resolution
9. Passed the proposal to establish Indonesian joint venture company
through cooperation with YPJ Plantations Sdn. Bhd., a subsidiary of the
Johor State Government of Malaysia
10. Passed the adoption of the 2018 annual salary adjustment case for the
Group
11. Passed the amendments of the Company's "Directors' Meeting Rules",
"Audit Committee's Terms of Reference", "Independent Directors'
Establishment and Measures to Be Followed"
12. Passed the amendments of the Company's "acquisition or disposal of
assets handling procedures"
13. Passed the adoption of amendments to the company charter
14. Passed the setting of the company's 2018 shareholders' meeting
related matters
2018.5.10 Discussion items
1. Passed the adoption of the company's consolidated financial statements
for thefirstquarterof 2018
2018.6.12 Discussion items
1. Passed the adoption of the company's 2018 ex-dividend benchmark day
2. Retained the discussion on the establishment of a joint venture
company between All Cosmos Industries Sdn Bhd and Geosat
Technology Co., Ltd.
3. Passed the amendments of the Group's 2018 annual remuneration for
employee and directors' ratio
2018.8.8 1. Passed the adoption of the company's consolidated financial statements
for the second quarter of 2018
2. Passed the company as a subsidiary company All Cosmos Industries
Sdn Bhd endorsement guarantee resolution
3.Passedthe company setupabranch in Taiwan
2018.11.13 1. Passed the adoption of the company's consolidated financial statements
for the third quarter of 2018
2. Passed the company as a subsidiary company All Cosmos Industries
Sdn Bhd endorsement guarantee resolution
3. Passed the company's intention to authorize Bank SinoPac to act as a
custody bank in Taiwan
4. Passed the appointment of the person in charge of the Taiwan branch
through the company
2018.12.21 1. Passed the adoption of the 2018 year-end bonus case of the Group
2. Passed the adoption of the Group's 2019 Budget
3. Passed the 2019 annual internal auditplan of the Group's company
2019.3.26 1. Passed 2018 annual distribution of remuneration for employee and
director
2. Passed the company's 2018 consolidated financial statements and
business report
3. Passed the company's 2018 surplus distribution case
4. Passed the company's 2018 "Internal Control System Statement"
5. Passed the adoption of the company's visa accountant compensation
  • 44 -
Meeting Date Important resolutions
and its applicability and independence assessment
6. Passed the adoption of amendments to the company charter
7. Passed the amendments of the Company's "Operating Procedures for
Acquisition or Disposal of Assets"
8. Passed the amendments of the Company's "Operating Procedures for
Governing Lending of Funds" resolution
9. Passed the adoption of amendments to the Company's "Operating
Procedures for Endorsements and Guarantees"
10. Passed the adoption of amendments to the Company's "Rules of
Shareholders' Meeting"
11. Passed the adoption of amendments to the Company's Code of
Practice on Corporate Governance
12. Passed the company engaged in derivative commodity trading quotas
and trading cases
13. Passed the company's comprehensive re-election and nomination of
candidates for directors (including independent directors) in 2019
14. Passed the request of the lifting of the new director and its
representative's non-competition restrictions
15. Passed the setting of the date, time, place and other related matters of
shareholders in 2019
  • (12) In the most recent year and at the date of publication of the annual report, the director or supervisor has different opinions on the board of directors through important resolutions and has a record or written statement. The main contents are: None.

  • (13) Summary of the resignation of the company's chairman, general manager, accounting supervisor, financial supervisor, internal audit supervisor and R&D supervisor in the most recent year and at the date of publication of the annual report: None.

  • 45 -

3.5 Information on CPA Professional Fees

Information of Professional Fees to CPA By Fee

Name of CPA firm Name of CPA Name of CPA Duration of audit Remarks
Deloitte & Touche Chen
Chiang
Hsun
Yu
Cheng
Chuan
2018.01.01-2018. 12.31 -

Unit: NT$ in Thousand

Fee category
Range of amount
Fee category
Range of amount
Audit fee Non-audit
fee
Total
1 Below NT$2,000 ˇ
2 NT$2,000 (inclusive) ~ NT$4,000
(exclusive)
3 NT$4,000 (inclusive) ~ NT$6,000
(exclusive)
ˇ ˇ
4 NT$6,000 (inclusive) ~ NT$8,000
(exclusive)
5 NT$8,000 (inclusive) ~ NT$10,000
(exclusive)
6 Above NT$10,000(inclusive)
  • (1) When non-audit fee paid to the certified public accountant, to the accounting firm of the certified public accountant, and/or to any affiliated enterprise of such accounting firm are one quarter or more of the audit fees paid thereto, the amounts of both audit and non-audit fees as well as details of non-audit services shall be disclosed:

CPA’s Professional Fee Information

Unit: NT$ in Thousand

Name of CPA
firm
Name of
CPA
Audit Fee Non-audit Fee Non-audit Fee Non-audit Fee Non-audit Fee Non-audit Fee Duration of audit Remar
ks
System
Design
Busine
ss
Registr
ation
Human
Resour
ces
Other
(note)
Subto
tal
Deloitte &
Touche
Cheng
Chiang
Hsun
4,200 - - - 600 600 2018.1.1~2018.12.31 Note
Yu Cheng
Chuan

Note: Service content is an internal control system review

  • (2) The replacement of the accounting firm and the audit public fee paid in the replacement year shall be disclosed as the reduction of the audit public fee and the reasons for the decrease of the audit public fee in the previous year: None

  • (3) If the audit public fee is reduced by more than 15% compared with the previous year, the amount, proportion and reason for the audit public fee reduction shall be disclosed: None.

  • 46 -

3.6. Replacement of CPA information: If the company has changed the accountant in the last two years and after the period, it should disclose the matter:

  • (1) Regarding the former certified public accountant:
Date of Replacement September 27, 2017 September 27, 2017 September 27, 2017
Replacement reason and
explanation

Deloitte & Touche’s Internal adjustment
Whether it was the certified
public accountant that
voluntarily ended the
engagement or declined
further engagement

Party
Conditions

CPA
Appointed
person
Voluntarily ended
the engagement
Not applicable Not applicable
Declined further
engagement
Not applicable Not applicable
Comments and reasons for
issuing audit reports other
than unqualified opinions
in the latest two years
None
Any disagreement between
the Company and the
former certified public
accountant
None
Other matters shall be
disclosed
(Matters as specified in the
Articles 10, 6, 4, and 7 of
this Code should be
disclosed)
None
  • (2) Regarding the successor certified public accountant:
Name of CPAs firm Deloitte & Touche
Name of CPA Cheng Chiang Hsun, Yu Cheng Chuan
Date of engagement September 27, 2017
Prior to the formal engagement of
the successor certified public
accountant, the Company consulted
the newly engaged accountant
regarding the accounting treatment
of or application of accounting
principles to a specified
transaction, or the type of audit
opinion that might be rendered on
the Company’s financial report, the
company shall state and identify
the subjects discussed during those
consultations and the consultation

Not applicable
  • 47 -

results. The Company shall consult and obtain written views from the successor certified public accountant regarding the matters Not applicable on which the company did not agree with the former certified public accountant, and shall make disclosure thereof.

  • (3) Former CPA’s reply to the matter stated in Items 1 and 2, Paragraph 5, Article 10 of this code : None.

  • 3.7. Where the company’s chairperson, general manager, or any managerial officer in charge of finance or accounting matters has in the most recent year held a position at the accounting firm of its certified public accountant or at an affiliated enterprise of such accounting firm : N/A

  • 3.8 Any transfer of equity interests and/or pledge of or change in equity interests (during the most recent fiscal year or during the current fiscal year up the the date of printing of the annual report) by a director, supervisor, managerial officer, or shareholder with a stake of more than 10 percent during the most recent fiscal year or during the current fiscal year up the date of printing of the annual report.

  • (1) Changes in the shareholding of Directors, Supervisors, Managers and major shareholders

Title Name 2018 2018 As at March 31, 2019 As at March 31, 2019
Holding
Increase
(Decrease)
Pledged
Holding
Increase
(Decrease)
Holding Increase
(Decrease)
Pledged Holding
Increase
(Decrease)
Chairman All Cosmos
Investment Ltd
(Representative:
PengShih Hao)
- - - -
Director Sheng Hua Ltd
(Representative:
Peng Sheng
Ching)
- - - -
Director Hsu Ken Tsai - - - -
Director Chang Lu Chang - - - -
Director Maxtrength Corp
(Representative:
PengChia Lin)
- - - -
Director Chee Kheng Hoy - - - -
Independent
Director
Lo Tze Wu - - - -
Independent
Director
Yang Yung Cheng
-
- - -
Independent
Director
Yeh Chung
Chuan
- - - -
  • 48 -
Title Name 2018 2018 As at March 31, 2019 As at March 31, 2019
Holding
Increase
(Decrease)
Pledged
Holding
Increase
(Decrease)
Holding Increase
(Decrease)


Pledged Holding
Increase
(Decrease)
ACBT CEO Peng Shih Hao 9,000 - - -
ACBT CFO Janice Cheow - - - -
ACBT
Group General
Manager
Ling Sui Hung - - - -
ACI
Production
General
Manager
Lai Chan Wai - - - -
ACI
R & D Manager

WAN AZHA BIN
WAN
MUSTAPHA

-
- - -
ACI
Sales &
Technical
Manager
Roslan Bin
Arshad
- - - -
  • (2) Directors, Supervisors, Managers and shareholders who hold more than 10% of the shareholdings are related persons: none.

  • (3) Changes in the pledge of shares of directors, supervisors, managers and shareholders holding more than 10% of the shares: None.

3.9. Shareholders who hold the top ten shareholdings, who are related to each other or relatives within the relationship of spouse, second parent, etc.

April 21, 2019; Unit of Shares in Thousand

NAME Shareholding Shareholding Spouse &
Minor Children
Shareholding
Spouse &
Minor Children
Shareholding
Shareholding
by Nominee
Arrangement
Shareholding
by Nominee
Arrangement
Relationship information, if among the
company's 10 largest shareholders any one is a
related party or a relative within the second
degree of kinship
Relationship information, if among the
company's 10 largest shareholders any one is a
related party or a relative within the second
degree of kinship
Remar
ks
Shares % Shares % Shares % Name Relationship
All Cosmos
Investment Ltd
(Represantative: Peng
Shih Hao)
22,500 35.14% - - - - Oil Palm Plantation Ltd Siblings -
Maxtrength Corp Siblings
Jade Field Holdings Inc Relatives
Asia Win Development Ltd Sibling
Sheng Hua Ltd Parents
Oil Palm Plantation
Ltd
(Represantative: Peng
Shih Chieh)
7,500 11.71% - - - - All Cosmos Investment Ltd Siblings -
Maxtrength Corp Siblings
Jade Field Holdings Inc Relatives
Asia Win Development Ltd Siblings
Sheng Hua Ltd Parents
Maxtrength Corp
(Represantative:
Peng Chia Lin)
4,500 7.03% - - - - All Cosmos Investment Ltd Siblings -
Oil Palm Plantation Ltd Siblings
Jade Field Holdings Inc Relatives
Asia Win Development Ltd Siblings
Sheng Hua Ltd Parents
Jade Field Holdings 3,260 5.09% - - - - All Cosmos Investment Ltd Relatives -
  • 49 -
NAME
Inc
(Represantative: Peng
Yu Tao)
Shareholding Shareholding Spouse &
Minor Children
Shareholding
Spouse &
Minor Children
Shareholding
Shareholding
by Nominee
Arrangement
Shareholding
by Nominee
Arrangement
Relationship information, if among the
company's 10 largest shareholders any one is a
related party or a relative within the second
degree of kinship
Relationship information, if among the
company's 10 largest shareholders any one is a
related party or a relative within the second
degree of kinship
Remar
ks
Shares % Shares % Shares % Name Relationship
Oil Palm Plantatio Ltd Relatives
Maxtrength Corp Relatives
Asia Win Development Ltd Relatives
ShengHua Ltd Siblings
Merryard Ltd.
(Represantative: Peng
Hsiu Lang)
3,000 4.69% - - - - - - -
Asia Win
Development Ltd
((Represantative: Peng
Yi Fen)

2,500
3.90% - - - - All Cosmos Investment Ltd Siblings -
Oil Palm Plantation Ltd Siblings
Maxtrength Corp Siblings
Jade Field Holdings Inc Relatives
Sheng Hua Ltd Parents
Sheng Hua Ltd
(Represantative: Peng
Sheng Ching)
2,500 3.90% - - - - All Cosmos Investment Ltd Parents -
Oil Plam Plantation Ltd Parents
Maxtrength Corp Parents
Jade Field Holdings Inc Siblings
Asia Win Delevopment Ltd Parents
First Venture Capital
Co.,Ltd.
1,115 1.74% - - - - - - -
Innovative Industrial
Technology Transfer
Co.,Ltd.
800 1.25% - - - - - - -
SinoPac Commercial
Bank –All Cosmos
Bio-Tech Holding
Corporation Employee
Collective Trust
Account

226
0.35% - - - - - - -
  • 3.10 The number of shares held by the company, the company's directors, supervisors, managers and the company directly or indirectly controlled by the company for the same investment business, and the combined calculation of the comprehensive shareholding ratio
December 31,2018 Unit: Shares;%
Investment by the
Company
Investments by
directors,
supervisors,
managerial
officers and directly
or
indirectly controlled
enterprises
Total investment
Shares
%
Shares
%
Shares
%
30,000,000
100
-
-
30,000,000
100
33,000,000
55
-
-
33,000,000
55
December 31,2018 Unit: Shares;%
Investment by the
Company
Investments by
directors,
supervisors,
managerial
officers and directly
or
indirectly controlled
enterprises
Total investment
Shares
%
Shares
%
Shares
%
30,000,000
100
-
-
30,000,000
100
33,000,000
55
-
-
33,000,000
55
December 31,2018 Unit: Shares;%
Investment by the
Company
Investments by
directors,
supervisors,
managerial
officers and directly
or
indirectly controlled
enterprises
Total investment
Shares
%
Shares
%
Shares
%
30,000,000
100
-
-
30,000,000
100
33,000,000
55
-
-
33,000,000
55
December 31,2018 Unit: Shares;%
Investment by the
Company
Investments by
directors,
supervisors,
managerial
officers and directly
or
indirectly controlled
enterprises
Total investment
Shares
%
Shares
%
Shares
%
30,000,000
100
-
-
30,000,000
100
33,000,000
55
-
-
33,000,000
55
December 31,2018 Unit: Shares;%
Investment by the
Company
Investments by
directors,
supervisors,
managerial
officers and directly
or
indirectly controlled
enterprises
Total investment
Shares
%
Shares
%
Shares
%
30,000,000
100
-
-
30,000,000
100
33,000,000
55
-
-
33,000,000
55
December 31,2018 Unit: Shares;%
Investment by the
Company
Investments by
directors,
supervisors,
managerial
officers and directly
or
indirectly controlled
enterprises
Total investment
Shares
%
Shares
%
Shares
%
30,000,000
100
-
-
30,000,000
100
33,000,000
55
-
-
33,000,000
55
Reinvested Entities Investment by the
Company
Investments by
directors,
supervisors,
managerial
officers and directly
or
indirectly controlled
enterprises
Total investment
Shares % Shares % Shares %
ALL COSMOS
INDUSTRIES SDN
BHD(“ACI”)
30,000,000 100 - - 30,000,000 100
SABAH
SOFTWOODS
HYBRID
FERTILISER SDN
33,000,000 55 - - 33,000,000 55
  • 50 -
BHD(“SSHF”)
PT ALL COSMOS
BIOTEK
(“PTACB”)
8,400 60 - - 8,400 60
PT ALL COSMOS
INDONESIA (“PT
ACI”)
79,200 99 800 1 80,000 100
ARIF EFEKTIF
SDN BHD
(“AESB”)
- - 245,000 49 245,000 49
KINABALU LIFE
SCIENCES SDN
BHD (“KLSSB”)
(Note 1)
- - 6 60 6 60
COSMOS
BIOWOOD SDN
BHD
400,000 80 400,000 80
GK BIO
INTERNATIONAL
SDN BHD
(Note2)
- - 10 100 10 100
SAWIT
ECOSHIELD SDN
BHD
4 40 4 40

Note 1: Registration is established, no capital has been invested as of December 31, 2018.

Note 2: GK BIO was registered on October 11, 2018

  • 51 -

4.0 Capital Overview

4.1 Capital and Shares

4.1.1 Source of equity

4.1.1.1 The formation of equity

March 31, 2019 Unit of Shares in Thousand, NT$ in Thousand

Date Issued
Price(N
T$)
Authorized Capital Authorized Capital Paid-up Capital Paid-up Capital Remarks Remarks
Shares Amount Shares Amount Source of
capital
Offset with
property
other than
cash
Oth
ers
2010.03 10 600,000 6,000.000 0.001
0.01
Set up share
capital
None
2010.06 10 600,000 6,000,000 30,000 300,000
Equity
conversion
(Note)
None
2012.09 10 600,000 6,000,000 50,000 500,000
Convert
Surplus to
Capital
increase
None
2014.08 10 600,000 6,000,000 55,000 550,000
Capital
increase by
Cash
None
2015.05 10 600,000 6,000,000 56,500 565,000
Employee
stock option
conversion
None
2017.06 10 600,000 6,000,000 64,034 640,340
Capital
increase by
Cash
None

Note: For the restructuring of the group, the company and the subsidiary ACI carry out a 100% equity conversion.

4.1.1.2 Type of shares

March 31, 2019 Unit of Shares: in Thousand


March 31, 2019Unit of

March 31, 2019Unit of

March 31, 2019Unit of
Shares: in Thousand
Shareholding
Category
Authorized Capital Remark
Issued shares Un-issued shares Total
Common Stock 64,034 535,966 600,000 Listed stocks

4.1.1.3 General information on the general declaration system: not applicable

  • 52 -

4.1.2 Structure of Shareholders

April 21, 2019 Unit of Shares : in Thousand

Structure
Amount
Government
body

Financial
institutions
Other juridical
persons
Individuals Foreign
institutions &
foreigners
Total
Members - 2 16 3,141 24 3,183
Sharesheld - 100 2,386 15,203 46,345 64,034
Percentage(%) - 0.16 3.73 23.74 72.37 100.00

Note: The company has no Mainland China shareholders

4.1.3 Shareholding Distribution Status

April 21, 2019 Unit Shares, %

Range of shares held Number of
shareholders
Shares held Percentage (%)
1
-
999
97 9,360 0.01
1,000
-
5,000
2,479 4,990,840 7.80
5,001
-
10,000
319 2,472,000 3.86
10,001
-
15,000
86 1,104,800 1.73
15,001
-
20,000
73 1,373,000 2.14
20,001
-
30,000
47 1,210,000 1.89
30,001
-
50,000
33 1,310,000 2.05
50,001
-
100,000
26 1,857,000 2.90
100,001
-
200,000
13 1,806,000 2.82
200,001
-
400,000
1 226,000 0.35
400,001
-
600,000
- - -
600,001
-
800,000
1 800,000 1.25
800,001
-
1,000,000
- - -
Above 1,000,001 8 46,875,001 73.20
Total 3,183 64,034,001 100.00
  • 53 -

4.1.4 List of major shareholders

1.4 List of major shareholders 1.4 List of major shareholders 1.4 List of major shareholders 1.4 List of major shareholders
April 21, 2019Unit of Shares, in Thousand
Shareholding
Major Shareholders
Registed Place
Shares held
Percentage
(%)
All Cosmos Investment Ltd
Republic of
Seychelles
22,500
35.14%
Oil Palm Plantation Ltd
British Virgin
Islands
7,500
11.71%
Maxtrength Corp.
Republic of
Seychelles
4,500
7.03%
Jade Field Holdings Inc.
Samoa
3,260
5.09%
Merryard Ltd.
Republic of
Seychelles
3,000
4.69%
Sheng Hua Ltd.
Republic of
Seychelles
2,500
3.9%
Asia Win Development Ltd.
British Virgin
Islands
2,500
3.9%
First Venture Capital Co., Ltd.
Republic of
China
1,125
1.74%
Innovative Industrial Technology
Transfer Co.,Ltd.
Republic of
China
800
1.25%
SinoPac Commercial Bank –All
Cosmos Bio-Tech Holding
Corporation Employee Collective
Trust Account
Republic of
China
226
0.35%
Shareholding
Major Shareholders
Registed Place Shares held Percentage
(%)
All Cosmos Investment Ltd Republic of
Seychelles
22,500 35.14%
Oil Palm Plantation Ltd British Virgin
Islands
7,500 11.71%
Maxtrength Corp. Republic of
Seychelles
4,500 7.03%
Jade Field Holdings Inc. Samoa 3,260 5.09%
Merryard Ltd. Republic of
Seychelles
3,000 4.69%
Sheng Hua Ltd. Republic of
Seychelles
2,500 3.9%
Asia Win Development Ltd. British Virgin
Islands
2,500 3.9%
First Venture Capital Co., Ltd. Republic of
China
1,125 1.74%
Innovative Industrial Technology
Transfer Co.,Ltd.
Republic of
China
800 1.25%
SinoPac Commercial Bank –All
Cosmos Bio-Tech Holding
Corporation Employee Collective
Trust Account
Republic of
China
226 0.35%
  • 54 -

4.1.5 Market Price, Net Value, Earnings, Dividends Per Share of the Latest Two Fiscal Years, and Related Information

UnitNT$Thousand Shares UnitNT$Thousand Shares UnitNT$Thousand Shares
Item Year 2017 2018 As of March 31,
2019(Note)
Market
price
per share
Max. 137 148 64.80
Min. 60.3 52.60 54.00
Average 94.22 101.83 59.82
Net value
per share
Before distribution 36.63 33.93 34.66

After distribution
36.63 33.93 34.66
Earnings
per share
Weighted Average
Shares
60,793 64,034 64,034


Before Retrospectative
Adjustment
5.31 4.76 0.01
After Retrospectative
Adjustment
5.31
Dividends
per share
Cash Dividend 2.65 2.4()
Free
placement
Stock Dividend
from Retained
Earnings

Stock Dividend
from Capital
Reserve

Accumulated
undistributed dividends
Return on
Investmen
t analysis
Price-earnings ratio 17.74 21.39
Price-dividend ratio 35.55 42.43
Cash dividend yield rate
(%)

2.81%
2.35%

Note: The 2018 surplus distribution case was approved by the board of directors on March 26, 2019, but as of the date of publication of the annual report, it has not yet been resolved by the shareholders' meeting.

4.1.6 Company Dividend Policy And Implementation Status

1. The Dividend policy as set forth in the company's articles of association

According to Article 129 of the Company's Articles of Association, the main provisions of the dividend policy are as follows:

Except as otherwise provided by the Listing Cabinet Act, if the company makes a profit before tax in the year, the company should make a profit before tax: (1) up to 10% (10%), the lowest is One (1%) as an employee's remuneration (including employees of the company and/or related employees) (hereinafter referred to as "employee remuneration"); and (2) up to 10% (10%) as director's remuneration (hereinafter referred to as " Director's remuneration"). Regardless of the above, if the company still has accumulated losses in previous years, the company should reserve the amount of remuneration before the employee's remuneration and directors' remuneration. Employees' remuneration and director's remuneration are available in cash and/or in accordance with the provisions of the laws of the British Cayman Islands, the provisions of the Listing Rules and the resolutions of the board of directors, which are more than two-thirds of the directors' attendance and the majority of the directors' consents. Employee remuneration and Director remuneration can be paid in cash and/or stock. The above-mentioned

  • 55 -

resolutions on the issuance of employee remuneration and directors' remuneration shall be reported to the shareholders at the shareholders' meeting after the resolution of the board of directors is passed.

Except as otherwise provided by the Company Law and the Listing Act, if the company's annual total final accounts have a surplus, the Board of Directors shall formulate the surplus distribution case and submit it to the shareholders' meeting in the following manner and order:

  • (1) The tax payable in accordance with the law;

  • (2) make up for the accumulated losses of previous years (if any);

  • (3) 10% of the provisions of the Listing Rules Act is the statutory surplus reserve, except when the statutory surplus reserve reaches the paid-up capital of the company;

  • (4) to make a special surplus reserve in accordance with the requirements of the Listing Cabinet Act or the Administration; and

  • (5) According to the amount of the current year's surplus after deducting the above items (1) to (4), the accumulated undistributed surplus in the previous period is the available surplus, and the available surplus can be distributed by the Board of Directors. The shareholders' meeting will be distributed according to the resolution of the listing cabinet law. Dividend distribution can be issued in cash dividends and/or stock dividends. Under the laws of the British Cayman Islands, the minimum dividend amount should be at least 10% of the current year's surplus minus items (1) to (4) above, and the proportion of cash dividend distribution shall not be less than 50% of the total shareholder's dividend.

2. Status of implementation

The Company's 2018 surplus distribution case was approved by the shareholders' meeting on June 12, 2018 with a cash dividend of NT$2.65, totaling NT$169,690,103, which was fully paid out.

  • 4.1.7 The impact of the proposed free share placement on the company's operating performance and earnings per share

The company did not have a free share placement this year, so this assessment is not applicable.

  • 4.1.8 Remuneration for Employees, Directors and Supervisors

  • The employee's remuneration and the number or scope of remuneration of Directors and Supervisors as set out in the company's articles of association: If there is any pre-tax profit in the year specified in the articles of association of the company, it should be paid in the pre-tax profit: (1) Maximum is 10%, minimum is 1% as employee remuneration; and (2) maximum 10% as Director's remuneration.

  • 56 -

  • In the current period, the estimated basis of the remuneration for employees, directors and supervisors, is calculated based on the number of shares of employees paid by stocks and the actual distribution amount are accounted for when there is a difference between the estimated number of shares and the estimated number of shares.

The Company will estimate the remuneration amount of employees and directors and the allotment of shares according to the company's articles of association. If the actual amount of the allotment and the estimated number of shares are different, the accounting treatment will be included in the actual annual adjustment of the cost.

  1. The Board of Directors through the distribution of remuneration:

  2. (1) The Company's 2017 annual regulations and the board of directors approved the distribution of employees' remuneration of NT$17,547,462 and the directors' remuneration of NT$10,528,477 by March 16, 2018 respectively, accounting for 5% and 3 net profit before tax. The difference between the distribution amount of the board of directors and the estimated number of items on the account is the change in accounting estimates, and the adjustment is recognized in the profit and loss of 2018.

  3. (2) The proportion of employees' remuneration paid by stocks to the total net profit after tax and the total amount of employees' remuneration: not applicable.

  4. The actual allotment of the employee's dividends in the previous year and the directors' and supervisors' remuneration (including the number of shares, the amount and the share price), the difference with the amount, reason and handling situation between the employee's dividends, the director's, and the supervisor's remuneration shall be stated:

  5. (1) Remuneration for employees in 2017 is NT$17,547,462 and Directors' remuneration is NT$10,528,477

  6. (2) The above amount is different from the recognition of the remuneration of employees, directors and supervisors and should state the difference, cause and resolution: no difference.

  7. 4.1.9 The situation in which the company bought back the shares of the company: None.

4.2. the company debt (including overseas corporate bonds) handling situation: none

4.3. Preferred Stocks handling situation: None.

4.4. The situation of overseas depositary receipts: None.

4.5. Employee stock option certificate and restrictions on employee rights:

  • (1) Employee stock options certificate of the company that has not expired: None.

  • 57 -

  • (2) The names, acquisitions and subscriptions of the top ten employees who have obtained the employee stock option certificate and the number of the top ten employees who can obtain the warrants:

Unit:Thousand Shares;NT$in Thousand Unit:Thousand Shares;NT$in Thousand Unit:Thousand Shares;NT$in Thousand Unit:Thousand Shares;NT$in Thousand Unit:Thousand Shares;NT$in Thousand Unit:Thousand Shares;NT$in Thousand Unit:Thousand Shares;NT$in Thousand Unit:Thousand Shares;NT$in Thousand
Designation Name
Number
of
shares
acquired


The
number
of
shares
acquired
to the
total
number
of
issued
shares
Executed Not executed



Subscription
Quantity
Subscription
price
(NT$)
Subscription
Amount

The
number of
shares
subscribed
to the total
number of
issued
shares




Subs
cripti
on
Quan
tity
Subs
cripti
on
Price

Subs
cripti
on
Amo
unt
The
number
of
shares
acquired
to the
total
number
of
issued
shares
M
a
n
a
g
e
r
CEO Peng
Shih
Hao
961
64% 961 30 28,830 1.70%
CFO Janice
Cheow
Senior
manager
Lim
Tau
Boon
PA(Note) Jack Yu
ACI
Chirman
Peng
Sheng
Ching
ACI
General
Manager
Lai
Chan
Wai
ACI
Manager
ROSLA
N
ARSHA
D
SSHFmana
ger(note)
Pan Chi
Yang
E
m
p
l
o
y
e
e
Staff Tai
Hong
Wen
539
36% 539 30 16,170 0.95%
Staff Chun
Choon
Hong
Staff Peng Yi
Fen
Staff Tai
Fook
Leong
Staff Gan
Lee
Poh
Staff Tee
Hwee
Yin
Staff Kuek
Lee
Chin
Staff Cheong
Sit Lee
  • 58 -
Staff Choo
LeeHia
Staff Tan
Teck
Siong

Note: As of the publication of the annual report, the employee has resigned and does not currently serve in the group.

The accumulated balance of employee stock option certificates issued by the Company until

the date of publication of the annual report has not exceeded 15% of the total number of issued shares.

  • (3) The situation of private equity employee stock option certificates in the last three years and up to the date of publication of the annual report: None.

4.6 Restricting the rights of employees to deal with new shares: None.

4.7 New shares issuance in connection with mergers and acquisitions : None.

4.8 Implementation of the fund utilization plan:

As of the first quarter of the annual report, the previous issue or private placement of securities has not been completed or has been in the last three years.

Completed and the project benefits have not been revealed: not applicable

  • 59 -

5.0 Operational Overview

5.1 Business content

5.1.1 Business scope

  • (1) Main contents of the business

The company is a professional biochemical compound fertilizer manufacturer, mainly engaged in the R&D, manufacturing and sales of bio-composite fertilizers of organic, microbial and chemical raw materials. The main business base is in Malaysia.

(2) Business share

Unit NT$ in Thousand

Year
Products
2016 2016 2017 2017 2018 2018

Net
revenue
Operating
Proportion

Net
revenue
Operating
Proportion

Net
revenue
Operating
Proportion
Amount Ratio(%) Amount Ratio(%) Amount Ratio(%)
Biochemical
Compound
Fertilizer
1,695,828 82.10 1,835,774
79.80
1,941,665 72.25
Chemical
Fertilizer
349,630 16.93 410,942
19.23
708,234 26.35
Others 20,085 0.97 16,936
0.97
37,682 1.40
Total 2,065,543 100.00 2,263,652
100.00
2,687,581 100.00
  • (3) Current Commodity Items Of The Company
Item Description
Biochemical
Compound
Fertilizer
A three-in-one compound fertilizer of organic matter, microorganisms
and chemical raw materials, mainly used in oil palm planting.
Chemical
Fertilizer
A single or compound fertilizer composed of chemical elements such
as phosphorus and potassium can provide nutrients necessary for plant
growth and development, and maintain high crop yield.
Microorganism Development and production of beneficial microorganisms and
disease prevention microorganisms

(4) New Products Planned To Be Developed

The company focuses on the importance of soil and environmental protection, and actively develops multi-functional fertilizer products to replace the environmental damage caused by traditional chemical fertilizers. At present, the new products planned

by the company are as follows:

Research
Project
Main Technique Application Note
Phage
Biofertilizer
The phage which can control the R.
solanacearum is screened in the
wastewater, and the phage
It can be used for the control of
bacterial crop diseases caused by
R. solanacearum, and can be
  • 60 -
Research
Project
Main Technique Application Note
preparation is produced by using the
transgenic Escherichia coli as a host
for producing the phage, and then
added to the fertilizer.
applied to a variety of peppers,
tomatoes, ginger, potatoes and
bananas which are often attacked
byR. solanacearum.
Special
nitrogen-fixin
g biological
fertilizer for
rice and green
leafy
vegetables

Three high-efficiency
nitrogen-fixing bacteria were
transferred from MARDI. After
optimization of strain culture
conditions and yield amplification,
high-concentration bacterial liquid
was produced and added to fertilizer
to improve soil nitrogen fixation
performance.
High-efficiency nitrogen-fixing
bacteria promote the growth of
rice and short-term crops, reduce
the use of chemical nitrogen
fertilizer, and also use in the
early stage of oil palm seedling
emergence
Anti-white
root Disease
Endophytic Trichoderma was
screened from the roots of healthy
plants, and spores were optimized by
culture to control diseases.
Trichoderma viride combines
with other fertilizer ingredients to
biologically control the common
fungal disease of the rubber tree
(Rigidoporus lignosus) and
supplement its nutritional needs.
Oil palm
by-product
degradation
A variety of indigenous degrading
bacteria are mixed and processed for
various by-products of the palm oil
mill, and the finished product is
organic fertilizer.
The strain mixture is used to
catalyze the degradation of oil
palm empty fruit bunches and
other organic raw materials, and
to solve the excessive production
of waste oil in the palm oil
industryas organic fertilizer.
Value-added
agricultural
by-products
The addition of Trichoderma for
different agricultural by-products
produces a control agent for
manufacturers/farmers in a more
economical way, and also solves the
problem of excess by-products.
Different by-products and different
Trichoderma products are paired
with each other to debug a stable,
suitable concentration and
economical formula.
Excessive agricultural
by-products cost farmers/vendors
excessive waste disposal fees.
By-products that return to the
field without proper treatment
may cause pathogens to breed.
The value-added agricultural
by-products are designed to add
beneficial bacteria to different
raw materials, ensuring that the
product has the function of
controlling disease when
  • 61 -
Research
Project
Main Technique Application Note



recycled into the field. This
program can be used in oil mills,
vegetable orchards, flower beds,
foodprocessing plants, etc.
Disease
resistant
seedling
inoculation



Inoculate disease-resistant
Trichoderma for different crop
seedlings. The use of Trichoderma
species is adjusted according to the
crop and medium.











From the nursery stage to the
field, the seedlings are subjected
to multiple inoculation and root
sampling tests to ensure that the
roots are attached with
endophytic fungus, and that they
have sufficient disease resistance
to the disease when entering the
harsh field. Currently there are
palm (anti-ganoderma disease)
and rubber (anti-white root
disease).

5.1.2 Industry Overview

  • (1) Current Status And Development Of Industry

  • A. Industry Status

Among the agricultural materials, the use of fertilizers is the largest. According to the production process, the fertilizers can be roughly divided into chemical fertilizers, organic fertilizers and biological fertilizers. Each of the fertilizers has its advantages and disadvantages, and it needs to be integrated to exert the advantages of the fertilizers, so as to achieve uniform development of the industry and complement each other.

Chemical fertilizers generally have direct and rapid effects, and are more competitive in price than biological fertilizers and organic fertilizers, so they are easily accepted and adopted by users. However, chemical fertilizers often cause over-application per unit area due to ease of use, resulting in weak resistance of plant, high acidic and deterioration of soil fertility, and high concentrations of nitrate in agricultural products. It is more difficult to estimate the environmental pollution caused by long-term or improper application of chemical fertilizers. At present, agricultural production should reduce the method of relying on a large number of chemical fertilizers, which should replace some chemical fertilizers with organic fertilizers, microbial fertilizers and mineral fertilizers. The use of microbial fertilizers to promote the utilization efficiency of chemical fertilizers is a soil biotechnology that

  • 62 -

is currently worth of attention.

Organic fertilizers are made from the residues of animals, plants or microorganisms and their excreta. Although organic fertilizers often contain microorganisms in nature, they are naturally grown rather than artificially selected and cultured. It belongs to microbial fertilizer. If a specific artificially selected microorganism is added to the organic fertilizer, it may be referred to as an organic composite microbial fertilizer or a microbial composite organic fertilizer. The application advantage of organic fertilizer is that the effect is mild and less harmful tp the soil, and the application is helpful to the ecological maintenance of the soil. Due to the volume is large, the application cost is high, and the production of compost requires a large area of land and plant equipment, which is time-consuming and labor-intensive. The production process needs to solve the odor and wastewater problems, and it is still necessary to avoid large or improper application.

Biological fertilizer refers to a specific preparation for cultivating active microorganisms or dormant spores, such as bacteria (including actinomycetes), fungi, algae, etc., and their metabolites, and is used in crop production to provide plant nutrients or promote nutrient utilization. Microbial items. Biological fertilizer has the advantages of low pollution, not harmful, low application rate and ecological friendly, but it has a certain shelf life, and the effect is more susceptible to environmental influences. The fertilizer efficiency is slower, sometimes it was applied together with chemical fertilizers and organic fertilizers. Through an effective management model, biological fertilizers can improve the availability of nutrients in the soil, improve soil properties, antagonize pathogens in soils or implants, reduce or replace chemical fertilizer application, and improve problems caused by excessive fertilization.

In recent years, with the increasing demand for global crops, the erratic weather, changes in soil and ecological problems, and the rising awareness of environmental protection, the demand for bio-fertilizers has increased, making bio-fertilizers more and more concerned and valued by agricultural-related markets. As the demand for bio-fertilizers increase rapidly, the company continues to deepen research and development in the field of beneficial micro-organisms, by having a wealth of useful microbiological data, it is able to develop and compound multi-functional intelligent biochemical compound fertilizers according to different soil and pest problems faced by each customer. Optimize and quantify core technologies for beneficial microbes as a competitive advantage in the industry. Market research firm Grand View Research expects the global biofertilizer market to grow at a compound annual growth rate of 15.4% from 2013-2020. Nitrogen-fixing products are the main market, with a market share of approximately 77.4% in 2012. Another market research firm, Markets and

  • 63 -

Markets, points out that leading companies focus on local and overseas markets and are committed to build new plants to expand capacity and product lines.

According to the statistics released by FAO on Current world fertilizer trends and outlook to 2018, as of 2014, the global use of fertilizers was about 180 million tons, an increase of 2.0% over 2013. From 2014 to 2018, the average annual growth rate will continue to grow by 1.8%. The main fertilizer market is Asia which obtained 60% whereby Indonesia and Malaysia as the main fertilizer consumers. According to the "2017-2021 Fertilizer Outlook" published by IFA in June 2017, South East Asia is still the main source of increased demand for food in the next few years. In the next few years, the global fertilizer market is still deeply affected by global food demand. With the continuous population growth and limited arable land, the application of high-efficiency and low-cost fertilizers is the main trend, and the global fertilizer market should not undergo major changes.

Estimated Annual Growth Rate of Major Fertilizer Demand in the World and Regions from 2014 to 2018

==> picture [353 x 267] intentionally omitted <==

Source: Statistics of the Food and Agriculture Organization of the United Nations (FAO) 2018.

B. Industry Development

(A) Malaysia

According to the Malaysian Bureau of Statistics, the total planting area in Malaysia is about 7.3 million hectares. The fertilizer used in Malaysia in 2013-2016 is also stable. Malaysia's total production of 2.62 million tons of fertilizer in 2013 and will be increased to 3.4 million tons in 2016. Malaysia's overall fertilizer production

  • 64 -

has grown year by year with the total area planted in Malaysia, indicating that the use of fertilizer is still an indispensable investment in Malaysian agricultural planting.

In recent years, with the increase in global crop demand and weather changes, soil and ecological damage, global environmental awareness has risen, and the demand for bio-composite fertilizer market has increased. As farmers gradually understand and adopt the trend of bio-composite fertilizer, Global Market Insights estimated that the compound annual growth rate of biochemical compound fertilizer market in Malaysia will be 13.03% from 2015 to 2022, and it is estimated that the proportion of compound fertilizer market will increase in the future.

The fertilizer market in Malaysia can be divided into two major items: unit fertilizer and compound fertilizer. According to Universiti Putra Malaysia, Malaysia's unit fertilizer production accounted for 55.62% of the Malaysian fertilizer market in 2014, but with the strict rules of the Malaysian government's to hire foreign workers, labor costs have increased, and the use of unit fertilizers is facing the dilemma of labor shortage and labor costs. The use of compound fertilizer by large-scale planting groups has gradually increased. The company's share of the fertilizer market in Malaysia in 2014 was about 4.25%.

According to the Malaysian Bureau of Statistics, the total planting area in Malaysia is about 7.3 million hectares. The fertilizer use in Malaysia in 2013-2016 is also stable. Malaysia's total production of 2.62 million tons of fertilizer in 2013 will be produced in 2016. Increased to 3.4 million tons, overall, Malaysia's overall fertilizer production has grown year by year with the total area planted in Malaysia, indicating that the use of fertilizer is still an indispensable investment in Malaysian agricultural planting.

Malaysian fertilizer market structure in 2014

==> picture [327 x 191] intentionally omitted <==

Source Universiti Putra Malaysia

  • 65 -

(B) China

There are more than 300 bio-fertilizer producers with an annual output of over 500,000 tons and bio-fertilizer used areas reaching 167 million hectares. The development of microbial fertilizers in mainland China has been nearly 50 years old. From the earliest rhizobial preparations, many kinds of microbial fertilizers have been sold in the market. China has a vast territory and abundant microbial resources. The cases and experience of developing microbial materials for agricultural production are quite rich. However, the various microbial materials on the market are too varied, the actual effect of the field and the spread of publicity materials are very different, and because of the large number of products, farmers do not know how to choose and it affects the confidence of user towards the product. In order to manage the microbial materials in the market, the Ministry of Agriculture of China formulated the first microbial fertilizer standard in 1994, and in 1996, the microbial fertilizer was included in the national inspection and registration management, production, sales, application and publicity of microbial fertilizer for supervision were carried out. In 1999, we started to establish a microbial fertilizer standard system. It is expected to establish 18 standards in five levels, including general standards and technical regulations, from microbial fertilizer products, testing methods, strain safety and effectiveness of evaluation. At present, the Soil and Fertilizer Institute of the Chinese Academy of Agricultural Sciences and the Microbial Fertilizer Quality Inspection Center of the Ministry of Agriculture have established a catalogue of safe classification of strains established by the Microbial Fertilizer Standard System, and more than 90 species have been included.

(C) Taiwan

At present, there are 14 microbial fertilizer products registered in Taiwan. These fertilizers are all made in Taiwan. The registered fertilizer items are 13 kinds of phosphate solubilizing fertilizers. The microbial types involved include Bacillus safensis, B. licheniformis, B. subtillis and B. Amyloliquefaciens, and a arbuscular mycorrhizal fertilizer which microorganism involved is Glomus mosseae. As for the legume rhizobial fertilizer, the sputum nitrogen-fixing bacteria fertilizer, the lysate fertilizer, and even the compound microbial fertilizer, there are currently not registered commodities.

(2) Industrial Up stream, Middle And Downstream Relationship

The company is a professional fertilizer manufacturer, mainly producing compound fertilizers consisting of organic matter, microbes and chemical raw materials. The main raw materials of the products are nitrogen, phosphorus, potassium and other inorganic chemicals, organic raw materials and microbial strains. After the manufacturer processes, the finished products will deliver to downstream large-scale farms, dealers and farmers, the industrial relationship map is as follows:

  • 66 -

==> picture [417 x 262] intentionally omitted <==

A. Upstream Raw Materials

(A) Chemical Fertilizer

Also known as inorganic fertilizer, mainly urea, ammonia sulfate main production plant, phosphate mine processing plant, potassium mine developer, magnesium oxide processing plant and boron supplier. Since there is no large-scale production or mining of inorganic chemical minerals such as nitrogen, phosphorus and potassium in Malaysia, the main source still relies on imports. Due to the limited natural resources of nitrogen, phosphorus and potassium, as the world's population grows and the demand for food and crops increases, the use of fertilizers by farmers is increasing, and the demand and prices of raw materials such as nitrogen, phosphorus and potassium are stable. The trend of rising. According to the "2014~2018 Fertilizer Outlook" published by FAO in June 2015, the supply and demand of nitrogen, phosphorus and potassium raw materials changed slightly from 2014 to 2018, and the demand and price both showed a slight upward trend. The impact on the fertilizer industry will be relatively reduced.

On the whole, the main raw materials for chemical fertilizers are nitrogen, phosphorus and potassium. According to IFA, the main raw materials will be more than demand before 2016. Therefore, there is no supply shortage of the main raw material sources of the company, which will affects the operational risks of production.

  • 67 -

(B) Organic Fertilizer

The organic fertilizer raw materials are mainly waste residues of coffee processing plants, cocoa processing plants, palm oil processing plants or other organic raw materials. Malaysia is rich in agricultural resources, there are many organic raw material manufacturers, and organic raw materials can be replaced with each other, and there is no shortage of supply. In addition, Malaysia is a major palm oil exporter in the world. The large amount of waste residue after the refining of palm oil has caused the organic raw materials to fluctuate little over the years. Therefore, the organic fertilizer raw materials have no operational risks arising from insufficient supply or significant price changes.

(C) Microorganism

As microbial fertilizers are in the growth stage in Malaysia, although the main fertilizer market is still dominated by chemical fertilizers, more and more companies in Malaysia are beginning to invest in the microbial market. The main sources of microbial bacteria currently produced by the company are self-developed and cooperating with other academic or government organizations, such as the Malaysian University of Technology and the Malaysian Oil Palm Bureau (MPOB), the company has successfully developed and mass-produced microbial bacteria including nitrogen-fixing bacteria, nitrifying bacteria, phosphate-dissolving bacteria and yeast. Therefore, the microbiological sources required by the Company's products are not yet expose to the operational risks arising from insufficient supply or significant price changes.

B. Middlestream - Fertilizer Processing And Manufacturing

The Malaysian fertilizer manufacturing industry is a completely open market. In Malaysia, no biochemical compound fertilizer manufacturer is sufficient to monopolize the market. Therefore, the market price of biochemical compound fertilizer is determined by the market supply and demand mechanism. In recent years, with the increase in salary and the implementation of the Malaysian completion protection law, the manpower costs of fertilizer manufacturers have been rising, the gross profit has been compressed, and although the prices of inorganic chemicals such as nitrogen, phosphorus and potassium, which are the main raw materials, have continued to fall due to the global economic situation and further affecting the decline in fertilizer prices; the appreciation of the US dollar exchange rate as well as the fertilizer manufacturing industry.

In recent years, the values of environmental protection and eco green industry have been advocated in the society, the environmental protection concept of farmers has continued to increase. In addition, the application of chemical fertilizers has caused the problem of soil deterioration becoming more serious, and the acidification

  • 68 -

of soil is not suitable for farming or the rapid decline of plant resistance has reduced farmer’s income. As a result, farmers began to accept the concept of “developing sustainable agriculture” that decrease the use of chemical fertilizers, hoping to maintain ecological balance and minimise environmental pollution. The ultimate goal is to reduce production costs and energy consumption. Therefore, unlike the chemical fertilizers in the market, the level of acceptance of the farmer on biochemical compound fertilizers produced by the company, which is composed of organic matter, microorganisms and chemical raw materials, has gradually increased and revenue has continued to grow.

C. Downstream - Fertilizer User

The domestic fertilizer users in Malaysia are mainly government or privately owned landowners, farmers' associations and general farmers. The company has long-term cooperation with government-related investment companies, large private enterprises or professional oil palm plantation companies. According to the Malaysian Bureau of Statistics, 26% of Malaysia's population is engaged in agricultural-related activities in 2015, while Malaysia and Indonesia are the world's major palm oil producers, so the downstream fertilizer market should not be significantly changed.

(3) Various Development Trends Of Products

Traditional fertilizers are mainly made up of organic fertilizers, which are made from animal, plant or microbial residues and their excreta. For example, dead leaves, grass ash, rice bran, leftovers, leftovers, bean cakes and oilseeds are all sources of fertilizer. With the advancement of technology, chemical fertilizers made from chemical substances have become the main products in the market. Chemical fertilizers have the advantages of quick effect and low price, and are used by consumers for a long time. However, with the long-term use of chemical fertilizers, the plant resistance is weakened, the soil acidification is degraded, the agricultural products contain high concentrations of nitrates, and the environmental pollution is more serious. Therefore, consumers gradually replace the unit fertilizer with multifunctional fertilizers. . In the fertilizer market, biochemical compound fertilizers have gradually been accepted by consumers. In addition to providing nutrients, increasing production capacity and yield, biochemical compound fertilizers have fertilizers that prevent pests and diseases. For example, the company developed Anti-Ganoderma Lucidum product fertilizer as therapeutic for oil palm disease in 2012.

(4) Competitive Situation

Due to the low entry barriers for the production and sale of chemical fertilizers, the fertilizers used in the market are still dominated by chemical fertilizers. However, with the promotion of the company and the increase in customer use, the multi-functional

  • 69 -

compound fertilizer is gradually accepted by more consumers. The fertilizer produced by the company is mainly composed of organic, micro-organisms and chemical substances. Currently, there are only few manufacturers having the similar products in Malaysia, hence less competition; The Company ‘s direction is to strive for making more chemical fertilizer consumers to switch to multi-functional fertilizers.

5.1.3 Technology and R&D Overview

(1) Company Technology and R&D Overview

The company continues to focus on research and development and is one of the few companies that have successfully used beneficial microbiota (EM) in organic and bio-fertilizers. Besides her own research achievements, the company has also worked with other agencies such as the Malaysian Palm Oil Board and the Malaysian Rubber Board to develop effective microbial-based fertilizers. Follow by the MPOB F4 oil palm fertilizer being successfully produced, the GanoEF which specifically for prevention and treatment of Ganoderma Lucidum was developed.

The interaction between plants and microorganisms is an important issue in today's agricultural biotechnology. The company conducts research and product development for plant beneficial microorganisms, harmful microorganisms and nematodes on the basis of modern biology and the use of modern biotechnology. Beneficial microorganisms, such as the screening and application of growth-promoting bacteria, the improvement of the efficiency of phosphate-dissolving bacteria and nitrogen-fixing bacteria; the detection of harmful microorganisms, such as understanding the pathogenic mechanism of harmful microorganisms and increasing the resistance of plants themselves; Infection rules of important crops, screening and application of natural nematode resistance.

In order to enhance the understanding of the beneficial microbiota and to consider its potential and future development, the company established a research and development center in the Biotechnology Zone of the Malaysian University of Technology in Johor to develop and cultivate beneficial microorganisms. Microorganisms can be used in many advanced countries to promote green technology and play a very important role in human development in the future. Thus, the company will work with local and overseas companies to provide expertise and formulas to meet their demand. The company's research and development direction provides the development of microbial flora, biocontrol series, the production of single beneficial bacteria, the diversification of bacterial transport applications and field technical support.

The company has cooperated with the Malaysian University of Technology since 2009, and established the company's independent research and development team in 2011. The company now has mature facilities and skills, using the original ecological

  • 70 -

strain screening technology to separate, screen and preserve various bacteria. At present, more than 300 strains have been established. These strains can be accurately commercialized through identification tests and evaluation platforms for anti-antagonism, nutrient exchange, immune induction, and adversity protection for market positioning. In the fermentation production and cultivation of strains, we have developed quantification according to the growth characteristics and environmental requirements of each strain, optimized the fermentation production process, and cultivated a high concentration of bacterial liquid in a short time and cost savings.

The R&D team of the company often communicates with customers to understand the current needs of farmers and the problems to be solved in the field. For example, after the GanoEF product is launched into the market, the R&D team will go to different fields to collect sample the active substance of the roots and soil for laboratory quantitative tests. Test reports will be provided to the farmers, simultineusly increase the diversity of research samples in order to make the tests more accurate. Some customers required to do experiment in their own field before selecting a product. the R&D team will work with the customer to formulate the experimental design, present the performance of the product scientifically, and improve the customer’s trust and confidence towards to the product and company with perfect pre-sales and after-sales service.

The complete R&D and technical team can support the development of the company's products, from strain screening, preservation, optimization and quantification, productization, field trials, to customer after-sales service and other additional consulting services are the basis for the company's sustainable development. The R&D team established by the company can support the operation of microbial screening to production, and can also separate and purify the strains of soil, roots, fertilizers, etc. The company established a set of automated 5-50-500L fermentation tanks in 2015; this equipment platform can support more accurate quantitative production processes, develop culture parameters for the mass production needs of different strains, shorten fermentation time, reduce energy consumption and increase the concentration of bacteria, thus reducing production costs.

(2) Research Development Situation

The company always has great interest for research and development. Besides conducting new product research and development, it has also continuously improve the existing products and process adjustments to enhance the production efficiency and quality. The research results are as follows:

  • 71 -
Year Product Name Product Usage
2008 MPOB F4
(Biochemical
Compound
Fertilizer)

ACI was jointly developed with the Malaysian
Oil Palm Bureau (MPOB).

Specially used to increase the production of oil
palm trees.

Ingredients:

Chemical nutrients: chemical nutrients such as
nitrogen, phosphorus, potassium, magnesium,
boron and some trace elements.

Microorganisms: 8 microbial populations that
promote the absorption of chemical fertilizers
such as NPK and transform soil conditions.

Organic matter: Improve soil acidity and
alkalinity, increase chemical fertilizer utilization,
increase soil fertilityand water retention.
2012 GANO EF
Disease-resistant
biochemical
fertilizer


ACI and the Malaysian Oil Palm Bureau
(MPOB) jointly developed.

Ingredients:

Chemical nutrients: a variety of chemical
components and the addition of micronutrients to
provide efficient growth and optimum yield of
plants.

Organic substances: improve soil acidity and
alkalinity, increase chemical fertilizer utilization,
increase soil fertility and water retention.

Effective microbial population: Improve soil
biological microbial species, fix plant nitrogen
nutrition, and promote phosphate fertilizer
dissolution.

Composite active agents: Hendersonia
(endophytic fungi) and chitin, a Ganoderma
lucidum biocontrol agent and plant protection
inducer to help control and prevent the spread of
oilpalmGanoderma lucidum.
2013 Asacan
Water Soluble
Granular
Fertilizer

ACI's fertilizer products developed for the water
soluble fertilizer market.

Low-temperature compaction technology, which does
not require granular fertilizers made of adhesive
components, so it can be formulated with high NPK
ratio products.

Energy-saving production systems reduce costs, price
is popular, and farmers are more economical.

A variety of customized formulations (NPK + trace
elements or ASACAN NK + magnesiumoxide)
2014 MPB15-5-14
Pepper special
fertilizer


Pepper special fertilizer jointly developed by ACI and
Malaysian Pepper Bureau (MPB)

Three-in-one compound fertilizer provides the best
nutrients for pepper trees, combined with beneficial
bacteria and highqualityorganic matter. .
  • 72 -
Year Product Name Product Usage
2014 MPOB F4
Premium

ACI was jointly developed with the Malaysian Oil
Palm Bureau (MPOB).

Formulated specifically to increase the production of
oil palm trees, developed for palm planting in
Sarawak, East Malaysia

MPOB F4 formula is added to Azomite, a mineral
powder containing A~Z trace elements, which gives
the plant a perfect growth element.

Suitablefor high rainfallclimate use
2015 Tricho Acti Plus
Trichoderma

Life control products containing endophytic fungus

According to the bacteria selected by the customer, it
can be divided into wettable powder and organic
medium.

Effective control of fungal diseases

Suitable for palm, rubber, banana and other crops

Product content can be adjusted accordingtoprice
2017 K Neutralizer
Develop soil conditions using German technology to
effectively increase soil pH and supplement K2O and
TE nutrients

Suitable forpalm,rubber,banana and other crops

(3) Research And Development Personnel And Their Academic Experience

Unit Headcount %

Year
Education Qualification
2016 2017 2018
Master's Degree and above 4 4 4
College 3 3 5
High School And Below - - -
Total 7 7 9
Numbers of Company
Employee
360 425 460
Percentage of the Company
Employee(%)
1.94 1.65 1.96
  • (4) R&D Expenses Invested In The Past Five Years
Unit: NT$in Thousand Unit: NT$in Thousand
Year
Item
2014 2015 2016 2017 2018
Research
Development
Costs
7,908 6,090 5,855 4,456 6,587
Operating
Income
2,231,231 2,257,308 2,065,543 2,263,652 2,687,581
Proportion Of
Revenue(%)
0.35 0.27 0.28 0.20 0.25
  • 73 -

(5) Successfully Developed Technology Or Products In The Past Five Years

Year Product
Name
Product Usage
2014 MPB15-5-1
4
Pepper
special
fertilizer

Pepper special fertilizer jointly developed by ACI and
Malaysian Pepper Bureau (MPB)

Three-in-one compound fertilizer provides the best
nutrients for pepper trees, combined with beneficial
bacteria andhighquality organicmatter.
MPOB F4
Premium

ACI was jointly developed with the Malaysian Oil Palm
Bureau (MPOB).

Formulated specifically to increase the production of oil
palm trees, developed for palm planting in Sarawak, East
Malaysia

MPOB F4 formula is added to Azomite, a mineral
powder containing A~Z trace elements, which gives the
plant a perfect growth element.

Suitable for high rainfall climate use
2015 Tricho Acti
Plus

Life control products containing endophytic fungus

According to the bacteria selected by the customer, it can
be divided into wettable powder and organic medium.

Effective control of fungal diseases

Suitable for palm, rubber, banana and other crops

Product content can be adjusted accordingtoprice
2016 Value-added
agricultural
by-products
(palm oil
industry)


Development of value-added technology for by-products
of non-empty fruit bunches

Convertible pomace is a low-cost soil improver, fertilizer
and biocontrol agent

Better utilization of by-products of the farm and oil mills.

Customized addition of different functional bacteria, such
as nutrient supply or biological control

Add in Trichoderma to fight Ganoderma lucidum
2017 MARDI F1
ACI is jointly developed with the Malaysian Agricultural
Research and Development Agency (MARDI).

Special nitrogen-fixing biological fertilizer for rice and
green leafyvegetables
K-NEUTR
ALIZER
 Designed to improve and regulate acid soil problems
 Rapidly improve nutrient absorption rate effectively
 Increase soil activity and soil organic content

Improved soil also supplies nitrogen, potassium, sulfur
and other elements to improve the color, fragrance, taste,
and quality of crops.

K Compared with traditional regulators, K-Neutralizer is
more effective and lasting. The experimental results
maintain the soilpH at around 6 for 9 months to ayear.
  • 74 -

5.1.4 Long-Term And Short-Term Business Development Plans

  • (1) Short-Term Business Development Plans

A. Marketing Strategy

  • (A) Expanding The Mainstream Market

The company's main product is biochemical compound fertilizer. After nearly 20 years of continuous development, the expansion of the Malaysian market has achieved fruitful results in recent years. According to the Universiti Putra Malaysia report, the company's fertilizer sales in 2014 accounted for 4.25 %of the total fertilizer market in Malaysia, the company will continue to focus on expanding the Malaysian market to focus on Asia in Malaysia.

(B) Deep Market Strategy

Through briefing sessions, the company will continue to educate agricultural technicians and use advertising marketing to expand sales channels to open up local markets and attract medium and large-scale planting companies, state-owned agricultural companies and distributors.

  • (C) Increase Brand Awareness And Market Share In Overseas Markets

a. In the Indonesian market, the company will hold a product use briefing session in the first-line rural areas, and continue to educate the use of agricultural technicians and fertilizer knowledge.

b. In the Vietnamese market, the company will use advertising marketing to continue to expand sales channels.

B. Research direction

Through market research, the company is committed to developing functional, environmentally friendly customized products to provide better quality and cost saving to customers. It is also planned to continue to develop sophisticated market demand through efficient R&D management, and to enhance R&D technology and microbial bacteria libraries from marketing, R&D, production testing and other products to produce products that meet market needs.

C. Production Strategy

The company's current main operation is Malaysia. It plans to establish a cooperative distribution base in the ASEAN countries to expand the market quickly and effectively through the ASEAN national agent cooperation.

  • 75 -

D. Operation Scale

The company has now become a major producer of biochemical compound fertilizers, and has achieved initial gains from the development of Malaysia as the main market structure. In the future, we will continue to expand overseas channels and market Southeast Asia with unique products to increase market share and increase overall operating scale.

E. Financial planning

Strengthen the financial and operational management of the Company, enhance risk control, effectively avoid exchange rate, interest rate and market risk; and through public offering, enhance the company's visibility and obtain long-term and low-cost funds.

(2) Company Long-Term Plan

A. Marketing strategy

(A) Expanding overseas markets

The company will penetrate the Asian market with strong foundation in Malaysia (such as Indonesia, Vietnam, Thailand, Taiwan, Cambodia, Laos, Myanmar, Philippines, South Korea and Japan), and build factories in the region to save freight, and enter the Middle East and Europe. The market is the company's long-term goal.

  • (B) Developed as the No. 1 brand in Asia

At present, the company operates under the brand name “RealStrong” in Malaysia. It uses advertising marketing and customer reputation to continuously expand its sales channels to overseas. Through its active participation in public relations marketing strategies, it has shaped the company and its product image and popularity in order to develop into Asia. The No. 1 brand, a stable and sustainable business foundation

B. Research direction

The company continues to develop products for overseas market demand and cooperates with overseas universities to develop education. According to different regions and different climates, soils, plants and other specific products, products with functions such as pest resistance and environmental protection are introduced to increase customers' willingness to purchase and reduce Purchase cost. In addition, under the concept of sustainable agriculture, the company continued to develop projects for the use and recycling of agricultural by-products, and practiced

  • 76 -

environmental protection while reducing the cost of waste disposal for the agricultural industry. Microbial application platforms can develop different high-end cultivation materials, such as inoculation of disease-resistant strains for seedlings, which can reduce the disease resistance of plants, and then add company products to bring better disease resistance and yield increase.

In order to provide localized products and save transportation costs, the company will build factories in various sales regions to provide local consumers with nearby demand.

The company adheres to the concept of sustainable management, expands its human resources, expands its equipment, etc., and strives to expand its market share and become the No. 1 brand in Asia.

Enhance the company's financial management and operational capabilities, and use operational tools and flexible use of financial instruments to reduce operational risks and enhance competitiveness. Through the capital market, it will enrich working capital and support the needs of future development.

  • 77 -

5.2 Overview of Market, Production and Sales

5.2.1 Market Analysis

  • (1) Sales Area Of Major Commodities

Unit: NT$ in Thousand

Unit: NT$in Thousand Unit: NT$in Thousand
Year
Region
2016 2017 2018
Amount % Amount % Amount %
Domestic
Sales

1,876,480
90.85 2,065,892
91.26
2,495,239 92.84
Export 189,063 9.15 197,760
8.74
192,342 7.16
Total 2,065,543 100.00 2,263,652
100.00
2,687,581 100.00

Note: Domestic sales refer to sales in Malaysia and Indonesia, and the rest of the regions such as Vietnam, Taiwan and the Philippines are exported.

(2) Market share

According to the 2015 survey data of the Department of Ststistics Malayisa, the fertilizer market in Malaysia is still dominated by chemical fertilizers. Because Malaysian oil palm is mainly a large-scale planting company, the current unit fertilizer market is still higher than compound fertilizer. Refer to Universiti Putra Malaysia. According to the report, Malaysia's total fertilizer production in 2014 was 4.7 million tons, and the company's market share in 2014 was about 4.25%. At present, although the Malaysian market is still dominated by chemical unit fertilizers, the company's products can adjust the soil pH and organic content, so the application effect is better than chemical fertilizers in the land with low productivity or poor long-term application of chemical fertilizer pollution. With the increase in environmental awareness and the increase in long-term land pollution, the company's market share is expected to increase.

(3) Market Supply And Demand Situation And Growth In The Future

A. Global population growth pushes up overall demand

The global fertilizer market is closely related to food demand. As the global population continues to grow, it will push up global food demand and crop prices. With limited global arable land, increasing unit production has become the most urgent way for countries to solve food problems. In addition to the use of various fertilizers to increase unit yield and improve production efficiency, fertilizers with low cost and versatility are more acceptable to consumers.

  • 78 -

According to the information released by FAO on Current world fertilizer trends and outlook to 2015, as of 2011, the world's major fertilizer market accounted for 60% of the Asian region. According to the "2015-2019 Fertilizer Outlook" published by IFA in May 2015, Southeast Asia and North America are still the main areas for increased demand in the next few years. In the next few years, the global fertilizer market is still deeply affected by global food demand. With the continuous population growth and limited arable land, the application of high-efficiency and low-cost fertilizers is the main trend, and the global fertilizer market should not undergo major changes.

B. High-performance, low-application, low-toxic compound fertilizer trend

In the case of continuous population growth and limited arable land, the application of higher-efficiency and low-cost fertilizers is the main development trend. It is different from the large-scale application of general chemical fertilizers in the past. The current market demand is toward organic, micro-organisms with multifunctional and chemical compound fertilizer. Meaning, under the principle of reducing the use of chemical fertilizers and reducing the toxicity to the soil, appropriate compound fertilizer products are developed for the growth patterns and nutritional needs of different plants.

(4) Competitive Niche

A. Key Technology Threshold

Through the combination of chemical substances, organic fertilizers and microorganisms, the company has successfully developed biochemical compound fertilizers. By combining inorganic and organic to enhance soil pH and increase crop nutrient absorption, the company has improved its culture. Equipment and key patented technologies, the key beneficial microorganisms that are extracted and cultured from the soil, is to stabilize nitrogen in the air and soil, also contribute to the decomposition of phosphorus, acid, salt, potassium and organic matter, to allow plants to absorb directly, thereby increasing the fertilizers application, as well as the yield of crops compared with chemical fertilizers. The microbial flora can also enhance the immunity of crops against disease, make crops premature, antifreeze and increase water retention and drought resistance.

At present, the general compound fertilizers on the market are still dominated by chemical fertilizers. A few fertilizer manufacturers also produce chemical organic compound fertilizers. However, the production methods are organic fertilizers purchased separately from chemical fertilizers, and the loss rate is high, so even The product

  • 79 -

contains organic and microbial components. This method of production is easy to cause microbial death. Therefore, how to combine chemical fertilizers, organic fertilizers and microbial fertilizers into appropriate configurations has become the threshold for entry into the industry. The company has been researched for many years. Stabilization technology can effectively combine microorganisms with chemicals to successfully produce commercialized fertilizers.

Furthermore, even if the microbial death caused by chemical fertilizers is overcome, the oil palms have been planted for at least 2-3 years, and when new products are to be introduced into the market, they must be planted in two rounds, with at least 5- 6 years of product testing. If successful, there are opportunities to win customers' willingness to adopt. In contrast, the key technologies used by the company effectively combine chemical fertilizers, organic fertilizers and microbial fertilizers, but effectively prevent the contact of microorganisms and chemical fertilizers, so that microorganisms are not easily damaged, and the benefits of fertilizers are effectively maximized. In addition, this key technology has also successfully cooperated with the Malaysian Oil Palm Bureau to develop endophytic fungi that can inhibit ganoderma lucidum (stem-based rot). The company has successfully developed fertilizer products and has been certified by the Malaysian Oil Palm Bureau, so the key technology entry threshold is the company. An important competitive niche.

B. Product efficacy extends to pest control

Over the years, Malaysian oil palm tree has been seriously affected by ganoderma disease. Ganoderma lucidum is caused by Ganoderma fungus. The disease occurs at the base of the stem of the tree, so it is also called Basal Stem Rot. The infection rate of oil palm plantation About 20%, during the period of 10-12 years after planting the seedlings, it will lead to a significant reduction in production of more than 80%, which is a fatal disease of oil palm trees. In the early stage of Ganoderma lucidum, there are 1-3 pieces of Ganoderma lucidum fruit body in the stem base of the tree. The body shape is generally less than 3 cubic centimeters. The leaves are not drooping and dry, and the tree base condition is still hard. However, the plant vascular bundle is damaged and cannot be recovered. The Ganoderma lucidum fruiting body increased by 3-10 pieces, the leaves began to turn yellow and showed slight sagging, the tree body tissue began to soften, part of the Ganoderma lucidum body matured, the amount of the tree body became less and the fruit pieces became smaller; in the end stage, the Ganoderma lucidum fruiting body increased to more than 10 pieces, the body is hypertrophy, spread around the roots of the

  • 80 -

tree, the base of the stem can be easily excavated by sharp objects, the tree has no result, and the plant will be declared dead. According to statistics from the Federal Land Development Authority of Malaysia, ganoderma disease is happening in Malaysia annually. The damage is up to tens of billions of Taiwan dollars, which seriously jeopardizes the economic growth of the oil palm industry.

In order to effectively solve the harm of Ganoderma lucidum to oil palm trees, the company and the Malaysian Oil Palm Bureau have successfully developed Hendsonia, an endophytic fungus that controls Ganoderma lucidum in 2012, and launched a four-in-one biochemical compound fertilizer containing endophytic fungi. And can reduce the incidence of 70% of Ganoderma lucidum disease. By successfully developing the control effect of Ganoderma lucidum disease, the company has extended the fertilizer to the field of pest control, and is far ahead of other competitors. The company will continue to strive to prevent pests and diseases in the future. In order to be ahead from competitors, the company's products will partially replace the farmers' demand for pesticides and increase the added value of fertilizer use.

C. Safe and reliable brand reputation

The fertilizer product is directly used in the soil, and the crop system absorbs the nutrients and elements in the soil through the roots. However, the fertilizer is not completely absorbed by the crop, and there are still residual substances in the soil, so it can improve the soil pH value and improve the crop. In addition to the effects of yield and quality, the impact of residues of fertilizer products on crops and the environment cannot be ignored. In an industry that needs to strengthen product safety, technical support and goodwill, a safe and reliable brand image is very important. The company understands the cost and product efficiency of farmers, prefers fertilizers certified by government units or recommended by the government, and once farmers are accustomed to using a certain product, in order to ensure the stability of their crops, it is not easy to replace other brands. Due to the habits of use, the company has been striving to develop R&D for many years, continuously improving product quality, and has been certified by government agencies. With the brand name “Real Strong”, the company actively expands her product sales market and carefully tests the soil conditions of the area in line with local needs. The right formula has obtained high added value in every link of the industrial chain. After years of hard work, the company has established a good reputation in the industry, providing farmers with stable product quality, sincere after-sales service and good technical support. Reliable products to increase farmers' brand loyalty.

  • 81 -

D. Steady layout of production base and actively develop sales network

The company actively explores the sales market, based on Malaysia's stable layout, gradually sets up production bases, and actively establishes distribution networks in various places. The company plans to extend her products to the world. Her clients include government-to-investment companies and large private enterprises. Farmers' associations, regional distributors and end users-farmers. In the expansion of the market strategy, through the sales pipeline established after careful evaluation, the newly developed areas mainly through dealers, and hold public welfare briefings, to help and teach farmers in various areas to improve soil, and improve production and quality, to brand the concept enters the pipeline to enhance the local farmers' understanding and acceptance of the company's brand; for the infiltrated areas, through the group subsidiaries or local agents, directly to the terminal market, and actively participate in the promotion activities, regularly send people to teach, educate and assist farmers in various districts to improve soil yield and quality, and set up experimental manor in each district to provide fertilizer for farmers to test and compare, and strengthen farmers' loyalty to the company's brand products. In addition, the company also provides market and technical support services, and is committed to providing growers with the highest quality products and after-sales service, providing comprehensive solutions and technical consultation, in order to achieve product awareness and brand recognition.

The Company's Market Development Process

==> picture [355 x 190] intentionally omitted <==

E. Cost advantage

Since the traders import raw materials from abroad to Malaysia for sale, the raw material prices will be higher. In order to reduce the procurement cost of raw materials, the company actively seeks cooperation with raw material producers that can directly trade to reduce indirect purchases through traders. Successfully signed the 2014 annual

  • 82 -

purchase contract with the major potassium chloride producers in Belarus at the end of 2013. In addition, the company is directly trading with Chinese urea producers for another major raw material urea in 2016. The company directly and raw materials Producer transactions, to reduce the cost of raw materials, and make the company's product prices more competitive.

  • (5) Advantages, Disadvantages and Countermeasures of Developing Prospects

A. Favorable factors

  • (A) Increased demand for plant fertilizers in the global foraging crisis

The lack of food is the most direct factor affecting crop demand. Due to the rapid growth of the population, the global demand for food is increasing. Relatively, the arable land for producing crops is on the rise of environmental protection. Under the protection of forests and original forest land, not only can the current area be maintained, but some areas will also be affected by desertification, resulting in a reduction in cultivated area.

Therefore, under the trend of increasing demand for crops and reducing the area of arable land, the method of increasing crop yield is to adopt measures to strengthen crop resistance and increase crop yield. For example, increase the amount of biochemical compound fertilizer and prevent insects through root protection. Or the damage of crops such as germs, on the other hand, the bio-based compound fertilizer provides plant root nutrients, so that crops can obtain various nutrients and increase the output per unit area, in order to meet the current demand for crops. The aforementioned measures to increase crop yields will also drive the development of the overall crop biochemical compound fertilizer industry and expand the overall market size, which will be positive for the sales growth of All Cosmos's future business.

(B) Technical advantage

Various functional microorganisms can be mixed with each other, but when using mixed strains, it is necessary to consider the competition or the synergy between the strains, exert their positive effects, and reduce their negative effects. The company uses organic matter as a carrier of microorganisms. After the fermentation is completed, different organic matter must undergo microbial carrier compatibility test

  • 83 -

to understand the survival rate and stability of the carrier to ensure its survival rate and effectiveness.

In the fertilizer process, the biochemical compound fertilizer needs to be added to the stable carrier for anti-antagonism test, survival test, and integrate the affinity, timeliness and viability of the microbial flora, and the production cost of the bacteria must be considered at the same time. Mixed strains, carrier stability and other factors. The company has developed and applied for the patent of A Bio-stabilised Fertilizer and a Method for Producing, which can effectively combine microorganisms with chemical fertilizers and organic matter and effectively block microorganisms and chemical fertilizers. Direct contact with micro-organisms to ensure the efficacy of micro-organisms, thereby accumulating technical advantages, will help the company's development in the bio-composite fertilizer industry.

  • (C) Maintaining good relations with Malaysian government agencies and academic institutions

Over the years, the company has carried out many cooperation and exchanges with professional institutions such as the Malaysian Oil Palm Bureau, the Academy of Agricultural Sciences and the National University of Technology, and has maintained good cooperative relations for a long time. The company regularly sends people to academic units to discuss and share practical experience. Academics and students discuss, combine theory and practice, and exchange ideas and stimulate creativity. In addition, the company was appointed by the Ministry of Science, Technology and Innovation (MOSTI) of the Federal Government of Malaysia in 2011 as a consultant for high-tech green agriculture. The Prime Minister of Malaysia personally leads the research and development, innovation and environmental protection as its main purpose and implementation strategy. Its members are only 10 companies. The company is the only private company. It can be seen that the company's goodwill in the industry and its relationship with government agencies are very good. . As the fertilizer industry is an industry that attaches great importance to product safety, technical support and goodwill, the fertilizer products developed in cooperation with academic institutions or certified by government agencies are more trusted and favored by farmers, so they cooperate well with government agencies and academic institutions. Relationships have positive benefits for the company.

  • 84 -

B. Unfavorable factors

  • (A) The main raw materials depend on imports and are vulnerable to shortage of international raw materials or price increases.

The company's main chemical raw materials such as urea, phosphate fertilizer and potash fertilizer rely on imports. If there is a shortage of international raw materials or price increases, the company may be adversely affected.

Response measures:

The company keeps abreast of market information. In order to fully grasp the source of supply, there are more than two suppliers of main raw materials, and maintain a good and stable cooperative relationship. A reasonable safety stock is prepared for the raw materials, and the sales price of the downstream is moderately adjusted when the price fluctuates. Follow the market to reduce the impact.

(B) Risk of sales concentration

Oil palm is the main cash crop in Malaysia. Therefore, the government attaches great importance to the development of oil palm industry. It has a number of related institutions and investment companies. Oil palm enterprises need to have the processing capacity of palm oil processing, transportation and storage and sales. Therefore, Malaysian oil palm industry is mainly based on public and large-scale enterprises, which is the case where the company has sales of goods concentrated in large enterprises.

Response strategy:

In addition to its commitment to maintain relationships with her customers, the company regularly assigns technical personnel or sales personnel to the customer’s field to observe the use of fertilizers, and to produce research reports on its processes and achievements, to stabilize existing customers and actively expand new customers. The use of the company's products by well-known large enterprises, establish a brand image, and drive more farmers to buy and use, in order to reduce the risk of sales concentration.

5.2.2 Important use of the main products and production process

  • (1) Important uses of major products

Fertilizers can be roughly classified into chemical fertilizers, organic fertilizers and biological fertilizers according to the raw material categories. Various fertilizers have

  • 85 -

their own advantages and disadvantages. Chemical fertilizers have fast effects, but they are easy to cause environmental pollution and destroy soil structure. Organic fertilizers can change soil properties and increase nutrient, but large in volume and high in application cost; biological fertilizer is applied in small amount and low in cost, but it must be used in combination with other fertilizers. Here are the advantages and disadvantages listed below:

Fertilizer category Advantages Disadvantages
Biological fertilizer No pollution problem Non-fast-acting needs to be
combined with organic or
chemical fertilizers
Not harmful Haveacertain and shelf life
Less application Vulnerable to environmental
impact
Lower production costs Need to apply to the root
circle to be easyto express
Chemical fertilizer Rapidfertilizerefficiency Contaminated environment
Easy to adjust fertilizer ratio Improper use is easy to have
a fat injury
Supply sufficient nutrients Improper use of soil
degradation,acid
Less application Production consumes a lot of
energy
Organic fertilizer Good soil improvement Large volume and weight,
high application cost
Utility mitigation Composting production has
pollutionproblems
Less harmful Production of compost takes
time, labour, and land
consumption
Wide applicability Improper organic matter is
prone topests and diseases

Source: Taiwan Agricultural Biotechnology Industry Quarterly

Because fertilizer is a popular material, it is a relatively traditional industry, hence, it is very competitive especially with many large-scale chemical fertilizer plants in the market. Therefore, the company's main products are biochemical compound fertilizers that combine organic matter, beneficial micro-organisms and chemical raw materials. Its products mainly combine the advantages of each unit of fertilizer, improve the efficiency and effect of crop nutrient absorption, promote the growth of crop roots, enhance soil nutrients and improve water retention capacity, and clearly distinguish it from the chemical fertilizers that account for the majority of the market.

  • 86 -

(2) Production process of major products

The company's 3-in-1 biochemical compound fertilizer is mainly composed of chemical fertilizer, organic fertilizer and microbial fertilizer. According to the theory of nitrogen balance and soil health, it is compounded by techniques such as bio-high nitrogen source fermentation technology and comprehensive extrusion granulation. It can be mainly divided into beneficial microbial culture process and three-in-one biochemical fertilizer production process:

  • A. Beneficial microbial culture process

==> picture [431 x 291] intentionally omitted <==

B. Biochemical fertilizer production process

==> picture [444 x 169] intentionally omitted <==

  • 87 -

5.2.3 Supply status of major raw materials

The company's main raw materials are chemical raw materials such as urea, potassium chloride and phosphate rock. The company maintains a good and stable cooperative relationship with major raw material suppliers. In order to fully grasping the source of supply, it strictly controls quality and delivery. To ensure the supply of major raw materials is flawless. There was no supply shortage or interruption in the last three years and the application year, and the supply was stable.

  • 5.2.4 Explanation of major changes in gross profit margin of major products or sectors in the last two years
ast two years ast two years ast two years
Unit: NT$in Thousand
Year
Item
2017 2018
OperatingIncome 2,263,652 2,687,581
OperatingGross Profit 751,521 774,594
Gross Profit Margin 33.20% 28.82%
Gross Rate Of Change 4.63% 13.19%

The company's gross profit margin changes in the past two years have not reached more than 20%.

5.2.5 List of major customers and suppliers

  • (1) The name of the supplier who had accounted for more than 10% of the total purchase amount in any of the previous two years and the amount and proportion of the purchase amount
The name of the supplier who had accounted for more than 10% of the total purchase
amount in any of the previous two years and the amount and proportion of the purchase
amount
The name of the supplier who had accounted for more than 10% of the total purchase
amount in any of the previous two years and the amount and proportion of the purchase
amount
The name of the supplier who had accounted for more than 10% of the total purchase
amount in any of the previous two years and the amount and proportion of the purchase
amount
The name of the supplier who had accounted for more than 10% of the total purchase
amount in any of the previous two years and the amount and proportion of the purchase
amount
The name of the supplier who had accounted for more than 10% of the total purchase
amount in any of the previous two years and the amount and proportion of the purchase
amount
The name of the supplier who had accounted for more than 10% of the total purchase
amount in any of the previous two years and the amount and proportion of the purchase
amount
The name of the supplier who had accounted for more than 10% of the total purchase
amount in any of the previous two years and the amount and proportion of the purchase
amount
The name of the supplier who had accounted for more than 10% of the total purchase
amount in any of the previous two years and the amount and proportion of the purchase
amount
The name of the supplier who had accounted for more than 10% of the total purchase
amount in any of the previous two years and the amount and proportion of the purchase
amount
The name of the supplier who had accounted for more than 10% of the total purchase
amount in any of the previous two years and the amount and proportion of the purchase
amount
The name of the supplier who had accounted for more than 10% of the total purchase
amount in any of the previous two years and the amount and proportion of the purchase
amount
The name of the supplier who had accounted for more than 10% of the total purchase
amount in any of the previous two years and the amount and proportion of the purchase
amount
The name of the supplier who had accounted for more than 10% of the total purchase
amount in any of the previous two years and the amount and proportion of the purchase
amount
Unit: NT$in Thousand;%
2017 2018 March 31,2019
It
e
m

Name
Amount Net
annual
purchas
e of
goods
(%)
Re
lati
on
shi
p
Name Amount Net
annual
purchas
e of
goods
(%)
Re
lati
on
shi
p
Name Amount Net
annual
purchas
e of
goods
(%)

l

s
Re
ati
on
hi
p
1 JSC
BELARUSIAN
POTASH
COMPANY
(BPC)
486,949 36.38
No
ne
JSC
BELARUSIAN
POTASH
COMPANY
(BPC)
963,071
46.33
No
ne
JSC
BELARUSIA
N POTASH
COMPANY
(BPC)
181,718 59.84

n
No
e
2 BEHN MEYER
AGRICARE
(M) SDN BHD
( MEYER)

97,733
7.30
No
ne
BLUE DEEBAJ
FZCO (Deebaj)
69,224
3.33
No
ne
ETG AGRI
INPUTS FZE
(ETG)
30,639 10.09

n
No
e
3 GOLDEN
BARLEY
INTERNATIO
NAL
84,988 6.35
No
ne
YICHANG
NEW YANG
FENG
INTERNATION
62,909
3.03
No
ne
GOLDEN
BARLEY
INTERNATIO
NAL
21,820 7.19 No
ne
  • 88 -
2017 2017 2017 2017 2018 2018 2018 2018 March 31,2019 March 31,2019 March 31,2019 March 31,2019
( BARLEY) AL (BARLEY)
Others 668,772 49.97 No
ne
Others 983,718
47.31
No
ne
Others 69,494 22.88 No
ne
Net purchase 1,338,442 100.00 Net purchase 2,078,923 100.00 Net
purchase
303,671 100.00

The company is mainly engaged in the production and sales of biochemical composite fertilizers. The main raw materials of the products are urea, phosphate rock, potassium chloride, borax, ammonium phosphate, ammonium chloride, dolomite powder and organic matter (cocoa shell residue, coffee grounds or oil. Brown slag) and etc. Because raw materials such as urea, potassium chloride and phosphate rock are natural resources, only a few countries such as China, Arabia, Iran, Russia, Egypt and India have a large amount of reserves for mining, so the company avoids shortage of raw materials and reduces The impact of major changes in purchase prices, with supply contracts with major purchase suppliers for long-term cooperation to reduce risk.

Supplier changes are mainly affected by fluctuations in the performance of the company and are also affected by fluctuations in the unit price of raw materials. In the past two years and the first quarter of this year, BPC is mainly supplying the company's chemical raw material potassium chloride. BPC is located in the Belarusian potassium chloride manufacturer, and the supply and price are relatively stable. In addition, the company started to contact New Yang Feng in 2017. As the demand for monoammonium increases year by year, it is directly supplied with the producer to ensure price, quality and delivery time. Others such as BARLEY, MEYER, DEEBAJ and ETG are mainly engaged in the trading and marketing of chemical fertilizers, chemical raw materials and pesticides. The company will also purchase goods from local competitive pricing unit suppliers.

  • (2)The name of the customer who had accounted for more than 10% of the total sales in any of the previous two years and the amount and proportion of the sales

Unit: NT$ in Thousand;%

Unit: NT$in Thousand;% Unit: NT$in Thousand;% Unit: NT$in Thousand;% Unit: NT$in Thousand;%
2017 2018 March 31, 2019
Ite
m

Name
Amount Net
annual
sales
of
goods
(%)

Re
lati
on
shi
p
Name Amount Net
annual
sales
of
goods
(%)


Re
lati
on
shi
p
Name Amount Net
annual
sales
of
goods
(%)

Re
lat
on
shi
p
1
NARSCO
BERHAD
(NARSCO)
248,512 10.98 No
ne


FELDA
TECHNOPLANT
SDN BHD
399,365 14.86 No
ne
SABAH
SOFTWOODS
BERHAD(SSB)
66,466 18.75 No
te1
2
BORNEO
SAMUDERA
SDN
BHD
(BORNEO)

242,947
10.73 No
ne


RISDA
VENTURES SD N
BHD (RVSB)

260,279

9.68
No
ne
BORNEO
SAMUDERA
SDN BHD
25,452 7.18 No
te2
  • 89 -
3



SABAH
SOFTWOODS
BERHAD
(SSB)
238,431 10.53
No
te1
SABAH
SOFTWOODS
BERHAD (SSB)
235,165
8.75
No
te1
KUALA
LUMPUR
KEPONG
BERHAD(KLK)
23,936 6.75 No
ne
4



FELDA
TECHNOPLAN
T
SDN
BHD(FTPSB)

198,029

8.75
No
ne
BORNEO
SAMUDERA SDN
BHD ( BORNEO)

186,773

6.95
No
te2
DEL
MONTE
FRESH
PRODUCE
(DEL)

20,689
5.84 No
ne
Others 1,335,733 59.01 Others 1,605,999 59.76 Others 217,830 61.48
Net Sales 2,263,652 100.00 Net Sales 2,687,581 100.00 Net Sales 354,353 100.00

Note 1: SSB holds a 45% stake in SSHF and is a substantial shareholder of the subsidiary. Note 2: BORNEO is an affiliate of Sawit Kinabalu Ecotech Sdn. Bhd.

The Company is principally engaged in the production and sales of biochemical composite fertilizers. The current sales area is South East Asia and Mainland China, and the main sales market is Malaysia. Sales customers are mainly state-owned enterprises, companies or individuals in oil palm planting and crop planting, including large enterprises, local distributors and grassroots farmers. The changes in sales volume of major customers of the Company are affected by global food demand.

FELDA is a Malaysian Federal Land Development Agency transfer company, one of the largest companies in the world, BORNEO is Sawit Kinabalu Sdn. Bhd. (Kota Kinabalu Oil Palm Co., Ltd., SWSB) 2nd tier subsidiary company with 100% shareholding. In order to optimize and promote economy of Sabah, SWSB is the investment company of the Sabah State Government. BORNEO mainly develops oil palm plantation and produces and sells palm oil products. SSB also invested by Sabah State Government and her main business activity is to operate oil palm plantations. NARSCO is the Malaysian National Rubber Small Owner Cooperative Company established by RISDA in 2000. It is mainly responsible for the procurement and supply of agricultural tools, pesticides and fertilizers of the RISDA Group. RVSB is a 100% shareholding company of Rubber Industry Smallholders Develoment Authority (RISDA). Its parent company RISDA is the Ministry of Rural and Regional Development of the Federal Government of Malaysia in 1973 to assist local rubber in Malaysia. The small garden owners were established by using cultivating and new agricultural technologies to enhance the diversity and quality of crops, while RVSB was mainly responsible for sourcing and supplying compound fertilizers to various oil palm and rubber planting companies.

KLK is principally engaged in palm and rubber plantation, real estate development, retail and chemical manufacturing. Currently, it has approximately 270,000 hectares of plantations in Malaysia and Indonesia, and its own refinery refines palm oil and downstream. The product is one of the world's largest producers of palm oil chemicals. KLK has been

  • 90 -

trading with the company since 2012 and is purchasing compound fertilizers two to three times a year.

Founded in 2000 in Florida, DEL is a 100% owned investment company of Fresh Del Monte Produce Inc. (NYSE:FDP), a company listed on the New York Stock Exchange. The group has 36 distribution centers and 40,000 worldwide. A number of employees, mainly providing fresh fruits and vegetables, cut food manufacturing, distribution wholesale and logistics services, including Wal Mart, Costco, McDonalds and 7-11 retail and catering companies, since May 2015 through the Philippines local business agent introduction, the business has started, mainly selling fertilizers for fruits such as bananas and pineapples.

5.2.6 Production Value Of The Last Two Years

Unit Ton NT$ in Thousand

UnitTonNT$ in Thousand UnitTonNT$ in Thousand UnitTonNT$ in Thousand
Annual year
Production
value
Major
Products

2017
2018
Production
Capacity
Production
Amount
Production
Value
Production
Capacity
Production
Amount
Production
Value
Biochemical
Compound
Fertilizer

327,260
188,371 1,366,435 327,26 0
186,301
57,911
1,755,588
Chemical
Fertilizer
23,339
Total 327,260 211,710 1,366,435 327,26 0
244,212
1,755,588

Note 1: Capacity only lists the capacity of subsidiaries ACI and SSHF machines. Note 2: The output does not include product packaging such as unit fertilizer packaging, manual mixing and small packaging.

5.2.7 Sales Volume In The Last Two Years

Unit: Tons: NT$ in Thousand

5.2.7 Sales Volume In The Last Two Years Volume In The Last Two Years Volume In The Last Two Years Volume In The Last Two Years Unit: Tons: NT$in Thousand Unit: Tons: NT$in Thousand Unit: Tons: NT$in Thousand Unit: Tons: NT$in Thousand
Year
Product
2017 2018
Domestic sales Export Domestic sales Export
Amount Value Amount Value Amount Value Amount Value
Biochemical
Compound
Fertilizer

170,261
1,638,120 16,452 197,654
172,313
1,749,323 17,220 192,342
Chemical
Fertilizer
64,324 410,942 - - 96,828 708,234 - -
Others 3,947 16,830 15 106
6,178
37,682 - -
合計Total 238,532 2,065,892 16,467 197,760
275,319
2,495,239 17,220 192,342

Note 1: The sales volume does not include other items such as bags and coffee grounds. Note 2: Chemical fertilizers contain raw materials for sale.

Note 3: Domestic sales are sold in Malaysia and Indonesia, and exported to the Philippines, Taiwan and Vietnam.

  • 91 -

5.3 The number of employees, average service years, average age and academic distribution ratio of employees in the last two years and the year ended

UnitHeadcount UnitHeadcount UnitHeadcount
Year 2017 2018 End of March, 2019
Number of
Staff
Direct employee 254 290 285
Indirect employee
171
170 156
Total 425 460 441
Average age 31.44 33.23 33.33
Average Service Years 3.51 4.12 4.29
Academic
Distribution
Master's Degree
and above
5 11 12
College 58 90 87

High school and
below
362 359 342
Total 425 460 441

5.4. Environmental Expenditure Information

  1. According to the law, the applicant shall apply for a permit or a pollutant discharge permit or a pollution prevention and control fee or a person who should set up an environmental protection special unit. The claim, payment or establishment status: None.

  2. The company's investment in the main facility for the prevention and control of environmental pollution and its use and possible benefits:

December 31, 2018 Unit RM

December 31,2018 UnitRM
Device name Quant
ity
Date Of
Acquisition

Cost Of
Investment
Unreduced
Balance
Use and anticipation may
result in benefits
Dust pipe 1 2011.06.16 18,000.00 - Dust generated during the
production of fertilizer
Dust collection
chamber
(14mx3mx2.8m)
1 2011.05.18 40,260.00 15,434 Collect dust from the
production of fertilizer
Dust collection
chamber
(8mx3mx2.8m)
1 2011.05.18 12,110.00 4,642 Collect dust from the
production of fertilizer
  • 92 -
Dust recycling
equipment
system
1 2017.07.30 474,300.00
454,538

Collect dust from the
production of fertilizer
  1. The company has improved the environmental pollution in the last two years as per annual report, and the company has a pollution dispute, and should explain its treatment: None.

  2. The total amount of damages (including compensation), the total amount of the company's losses (including compensation) and the future response measures (including improvement measures) and possible expenses (including possible counter measures may not be taken) due to environmental pollution losses (including compensation) in the last two years and the end of the annual report. The estimated amount of loss, disposition and compensation, if it cannot be reasonably estimated, should state the fact that it cannot be reasonably estimated): None.

  3. The current pollution situation and its impact on the company's earnings, competitive position and capital expenditure and its estimated major environmental capital expenditures in the next two years: None.

5.5. The Relationship of Employers and Employees

  1. The company's various employee welfare measures, training, retirement system and its implementation status, as well as the agreement between labor and management and the maintenance measures of various employee rights and interests

    • (1) Employee welfare measures

      1. Give annual salary increases and pay year-end bonuses based on employee performance

      2. Promotion and salary increase according to the performance of the administrative staff

      3. Employee overtime allowance

      4. Employee annual leave system

      5. Employee medical assistance and health check

      6. Employee flexible work system

      7. Employee travel allowance

      8. Employee leisure and club activity benefits

  2. (2) Employee training and training situation

In line with the company's operating policies, departmental goals, personal work or tasks, and in-house training or external training, sponsor employees to participate in relevant knowledge, technology, attitude and other related courses.

In addition, the company allocates an additional 1% of the salary cost (1% of the statutory requirement) to the Development Human Resources Development Fund

  • 93 -

(HRDF) for employee training. Training courses such as leadership, project management, intensive technical training, interpersonal communication skills, work attitudes and safety knowledge.

(3) Retirement system

The Company has a retirement scheme and allocates a provident fund to a certain percentage of the total amount of wages paid in accordance with the local “Labor Law”, namely the EPF (locally referred to as EPF) rules and regulations on EPF contributions ratio.

The basis of the Malaysian Provident Fund Board (EPF) is as follows:

  • A. Non-employed employees: Can not be listed.

  • B. Non-Malaysian citizens: You may choose to option out from the scheme

  • C. Malaysian citizens: 11% for employees and 12% for companies.

  • (4) Agreement between labor and management

At present, employees of the company can express their opinions to the human resources department or department heads through e-mail, or meetings and meetings with employees. The communication channel is smooth and the labor relations are harmonious. The only case happened between company and employee was the mistake in dismissal of employee in 2017 which was settled out of court.

  • (5) Protection measures for various employee rights

  • The highest arbitration unit of the company's personnel evaluation committee for employees' problems and disputes

  • Company personnel regulations, national labor and employment regulations as a model for solving personnel problems

  • The company's personnel regulations electronic manual is widely distributed to each new employee, and explanation and guidance are given.

  • The company's personnel department gives immediate assistance and corrections to the employees on their problems and rights on daily basis.

  • . 2. In the past two years and up to the date of publication of the annual report, the company suffered losses due to labor disputes, and disclosed the estimated amount and corresponding measures that may occur in the current and future. If it cannot be reasonably estimated, which fact should be stated.

  • 94 -

The company has a smooth communication channel and harmonious relationship with employees. The only case happened between company and employee was the mistake in dismissal of employee in 2017 which was settled out of court.

5.6 Important Contracts

Contract
No Contract Holder Contract Validity Contains and Term & Conditions
Title
1 Fertilizer
Formula
Licensing
Agreement
1. MALAYSIAN PALM
OIL BOARD, MPOB
2. All Cosmos Industries
Sept 1, 2012 till
Aug 31, 2017
(Note)
The licensed product is a compound fertilizer
for use in oil palm, and its production is based
on the information, expertise or improvement
provided by MPOB in accordance with this
contract. The technical fee is RM15,000 and the
total sales tonnage is RM15per ton.
2 Trademark
Licensing
Agreement
1. Malaysia
Biotechnology
Corporation Sdn Bhd
2. All Cosmos Industries
Jun 13, 2012 till
Feb 1, 2019
The Licensor (Malaysia Biotechnology
Corporation Sdn Bhd) agrees to grant All
Cosmos Industries a non-exclusive license to
use its own "BiotechCorp" trademark in
Malaysia under the trademark registration
number 09003881. All Cosmos Industries uses
the trademark in strict accordance with the
BioNexus Status trademark design manual used
bythe authorizer.
3 Joint
Venture
Agreement
1.
Sabah Softwoods
Berhad (SSB)
2.
All Cosmos Industries
Jan 12, 2011 Established a joint venture company (Sabah
Softwoods Hybrid Fertiliser Sdn Bhd) in Sabah
to operate a fertilizer manufacturing plant that
markets, trades and sells fertilizers.
4 Land Sales
& Purchase
Agreement
1. Real Strong (M) Sdn
Bhd
2. All Cosmos Industries
Dec 31, 2009
(Valid till Jan 29,
2026)
Purchase of leased land at PLO 539, Jalan Kelui,
Pasir Gudang Industrial Estate, Johor Bahru,
Johor from Real Strong (M) Sdn Bhd until
January 29, 2026, including 1.2141 hectares of
land and buildings One factory. The bid-ask
price is RM 2,800,000
5 Land Sales
& Purchase
Agreement
1. Johor Corporation
2. All Cosmos Industries
July 18, 2011
(effective from
January 30, 2026,
until January 29,
2056)
Johor Corporation (Perbadanan Johor) agreed to
extend the lease of land at PLO 539, Jalan
Kelui, Pasir Gudang Industrial Estate, Johor
Bahru, Johor, number HS(D) 266016
PTD128164, with a new lease term of 30 years
from January 30, 2026 Effective, until January
29,2056,the totalprice of RM 914,760.
6 Land Sales
& Purchase
Agreement
1. Johor aluminum
2. All Cosmos Industries
Oct 30, 2000 Johor Alumium (Perbadanan Johor) agreed to
lease the land at PLO 442 Jalan Suasa, Pasir
Gugang Industrial Estate, Johor Bahru, Johor,
number HS(D) 215592 PTD111510 for a total
price of RM3,750,000.
7 Land Sales
& Purchase
Agreement
Appendix
1. Johor Corporation
2. All Cosmos Industries
July 20, 2011
(effective from
September 24,
2023, until
September 23,
2053)
Johor Corporation (Perbadanan Johor) agreed to
extend the lease of the land at PLO 442 Jalan
Suasa, Pasir Gugang Industrial Estate, Johor
Bahru, Johor, number HS(D) 215592
PTD111510, with a new lease term of 30 years,
effective September 24, 2023 By September 23,
2053,the totalprice was RM 1,471,894.
8 Land Sales
& Purchase
Agreement
1. Johor Corporation
2. All Cosmos Industries
March 28, 2012
(The period of use
until December 26,
2072)
Johor Corporation (Perbadanan Johor) agrees to
lease the land at PLO 650, Zone 12, Pasir Gudan
Industrial Estate, Johor Bahru, Johor, number
HS(D) 516678 PTD216257 for a total of 6.453
  • 95 -
Contract
No Contract Holder Contract Validity Contains and Term & Conditions
Title
acres with a lease term of 60 years from March
28, 2012 The date of entry into force will expire
on December 26, 2072, with a total price of RM
4,513,880.
9 Purchase
Contract
1. BPC(Belarus)
2. All Cosmos Industries
Jan 6, 2016 till
March 31, 2018
For the purchase of potassium chloride
framework contract in 2017, 240 US dollars per
ton of US dollars, a total of 60,000 tons, the
total amount of US dollars 14,400,000 yuan, the
transaction model is LC payment. The
restriction is forbidden to resell to a third party
and will be subject to a 25% penalty for breach
of contract. The actual purchase price and
quantity will be finalized according to the
attached contract.
10 Sales
Agency
Contract
1. A&M Agrisolution, Inc.
2. Enlasa Philippines, Inc.
3. All Cosmos Industries

Sept 15, 2015
(Valid for 3 years)
Authorize the two factories to be All Cosmos's
exclusive agent contract in the Philippines.
According to the contract, the purchase price
should not be less than 2,000 tons in 2015. The
demand for purchase in 2016 should not be less
than 4,000 tons. The purchase price after 2017
should not be less than 7,000 tons. The contract
is valid for 3years
11 Bank Loan
Agreement
AmIslamic Bank Signing date:
May 28, 2012
Modified credit
date:
July 30, 2015
Date of
modification clause:
June 20, 2018

Comprehensive credit contract:
1. Unless the company or bank changes, the
amount is not clearly valid.
2. The amount of quota and the number of days
that can be used:
(1) Cashline (working capital requirement): RM
2,000; 5 years and regular review.
(2) Term Financing (long-term loan): RM 5,000
(original contract number) / RM 4,232
( (modified number); 7 years from the date of
the start of the loan.
(3) Revolving Credit: RM 3,500 ;; 5 years.
(4) Multi Trade Finance: RM3,000; the
maximum number of days is 150 days.
3. Guarantor: All Cosmos Bio-Tech Holding
Corporation
4. Collateral: Property Land PLO 539 & PLO
650, with a deposit of RM3,900.
5. Restriction: This amount can only be used for
goods and purposes that meet the "Halal"
(MuslimCode).
12 Fertilizer
Formulatio
n Licensing
Agreement

1. MALAYSIAN PALM
OIL BOARD, MPOB
2. SABAH SOFTWOODS
Effective from
October 24, 2014,
within five years
from the date of
signing the contract
(Note)
The licensed product is a compound fertilizer
for use in oil palm, and its production is based
on the information, expertise or improvement
provided by MPOB in accordance with this
contract. The technical fee is RM15,000 and the
total sales tonnage is RM15per ton.
13 Land Sales
& Purchase
Agreement

1. POIC Sabah Sdn Bhd
2. SABAH SOFTWOODS
March 31, 2011
(Validity till Dec 31,
2104)

POIC Sabah Sdn Bhd agreed to lease the land at
No. 50 (392,040 square feet) of Phase 2, Jalan
Tengah Nipah, POIC. Lahad Datu, Sabah, No.
115435642, for a total amount of RM
4,638,617.28.
14 Land Sales
& Purchase
Agreement

1. POIC Sabah Sdn Bhd
2. SABAH SOFTWOODS
March 31, 2011
(Validity till Dec 31,
2104)

POIC Sabah Sdn Bhd agreed to lease the land at
No. 51 (217,800 square feet) of Phase 2, Jalan
Tengah Nipah, POIC. Lahad Datu, Sabah, No.
115435642, for a total amount of MYR
2,518,464.96.
  • 96 -
Contract
No Contract Holder Contract Validity Contains and Term & Conditions
Title
15 Bank Loan
Agreement
AmIslamic Bank Signing date:
August 29, 2012
Modified credit
date:
April 9, 2014
Date of
modification clause:
October 5, 2016

Comprehensive credit contract:
1. Unless the company or bank changes, the
amount is not clearly valid.
2. The amount of quota and the number of days
that can be used:
(1) Cashline (working capital requirement): RM
5,000; 5 years and regular review.
(2) Term Financing-1 (long-term loan): RM
15,080 ( (original contract number) / RM
14,374 ( (modified number); 7 years from the
date of commencement of borrowing.
(3) Term Financing-2 (long-term loan):
RM3,000 ;; three years from the date of the
start of the loan.
3. Guarantor: Peng Sheng Ching and Peng Shih
Hao.
4. Collateral: Property No. 50 and No. 51 of
Property POIC Datu Sabah.
5. Restrictions: This amount can only be used
for goods and purposes that meet the "Halal"
(Muslim Code).
16 Joint
Venture
Agreement
1. Sawit Kinabalu Ecotech
Sdn Bhd (SKESB)
2. All Cosmos Industries
Feb 23, 2018 Established a joint venture company in Kinabalu
(Kinabalu Life Sciences Sdn Bhd), which is
mainly responsible for the research and
production of bacterial cells for oil palm waste
disposal.
17 Joint
Venture
Agreement
1. Sawit Kinabalu Ecotech
Sdn Bhd (SKESB)
2. All Cosmos Industries
Feb 23, 2018 Established a joint venture company in Sabah
(Sawit Ecoshield Sdn Bhd) to provide
industrialized services for agricultural waste
recycling. The company assists agricultural
processing plants to convert waste, which would
otherwise require expensive processing fees,
into a multi-functional and economically
valuable agricultural product such as organic
fertilizer with disease resistance.
18 Joint
Venture
Agreement
1. YPJ Plantations Sdn
Bhd
2. All Cosmos Bio-Tech
Holding Corporation
March 12, 2018 Established a joint venture company (PT All
Cosmos Biotek) in Indonesia to operate a
fertilizer manufacturing plant, which will
market, trade and sell fertilizers
19 Technical
Sales
Agreement
1. Malaysian Agricultural
Research And
Development Institute
(MARDI)
2. Arif Efektif Sdn Bhd
Oct 9, 2018 AESB signed a technical sales contract with
MARDI to obtain a liquid gun for the use of
induced system resistant papaya seedlings to
control papaya bacterial wilt, and adjustable
capacity.
- Contract is a technical buyout contract
- contract price RM 375,000
20 Distribution
Agreement
1. Arif Efektif Sdn Bhd
2. Exotic Star (M) Sdn Bhd
Nov 23, 2018
(Valid for 2 years)
AESB signed exclusive sales rights with Exotic
for a period of two years.
- Price ordering is subject to the contract and
any changes must be made at least 60 days
prior;
- For earlyterminate of contract,notification is
  • 97 -
Contract
No Contract Holder Contract Validity Contains and Term & Conditions
Title
required 12 months in advance;
21 Joint
Venture
Agreement
1. Grape King Bio. Ltd
2. Chiu, Hsien Chih
3. All Cosmos Bio-Tech
HoldingCorporation
Jan 9, 2019 Established a joint venture company (GK Bio
International Sdn Bhd) in Malaysia to promote
and sell healthy foods, food suppliments and
raw materials in member countries such as
Malaysian Association of Southeast Asian
Nations.
22 Land Sales
& Purchase
Agreement

1. PT Perkebunan
Nusantara III (Persero)
2. PT All Cosmos Biotek
Sept 17, 2018
(Validity till Sept
16, 2048)
PT Perkebunan Nusantara III agreed to lease the
land (40,000 square meters) at Sei Mangkei
Village, Bosar Malings Sub-District,
Simalungun Recency, North Sumatera Province
Plot B-9 (total amount of Indonesian rupiah
26,000,000,000yuan).
23 Purchase
Contract
1. JSC BPC (Belarus)
2. All Cosmos Industries
Jan 1, 2019 till
March 31, 2020
For the framework contract for purchasing
potassium chloride in 2019, the total amount of
US$ 310 per ton is 100,000 tons, and the total
amount is US$31,000,000. The transaction
mode is LC payment. The restriction is to
prohibit resale in other countries and a 25%
liquidated damages will be payable for default.
The actual purchase price and quantity will be
finalized in accordance with the attached
contract.

Note: The contract is extended with the written consent of both parties.

  • 98 -

6.0 Financial Overview

6.1 Brief financial statements and comprehensive profit and loss statements for the recent five years

6.1.1 Information on brief financial statement and comprehensive profit and loss statements

1. Concise Balance Sheet

Unit : NT$ In Thousand

Year
Item
Year
Item
(Financial information for recent five years) (Financial information for recent five years) (Financial information for recent five years) (Financial information for recent five years) (Financial information for recent five years) As at March 31,
2019
Financial Report
2014 2015 2016 2017 2018(note1)
Current assets 1,435,417
1,517,225

1,369,721

1,942,817

2,133,931

2,265,946
Real estate, plant
and equipment
640,301
545,565

468,990

475,961

482,291

484,411
Intangible assets 2,947
1,736

2,717

2,079

8,580

8,660
Other assets 284,230
285,442

271,722

266,653

356,068

368,213
Total assets 2,362,895
2,349,968

2,113,150

2,687,510

2,974,870

3,127,230
Current
liabilities
Before
Distributi
on
791,480
806,005

458,041

263,052

390,855

479,977

After
Distributi
on
876,230
862,505

579,516

432,742

390,855

479,977
Non-current
liabilities
166,154
118,094

97,509

79,132

47,949

45,772
Total
liabilities
Before
Distributi
on
957,634
924,099

555,550

342,184

438,804

525,749

After
Distributi
on
1,042,384
980,599

677,025

511,874

438,804

525,749
Attributable to the
owners of the parent
company

1,286,421

1,234,646

1,332,857

2,038,955

2,172,389

2,219,616
Share capital 550,000
565,000

565,000

640,340

640,340

640,340
Capital re serve 380,589
411,187

411,187

781,838

781,838

781,886
Retainin
g surplus
Before
Distributi
on
426,782
539,096

725,813

927,211

1,062,310

1,062,836
After
Distributi
on
342,032
482,596

604,338

757,521

1,062,310

1,062,836
Other rights (70,950) (280,637) (369,143) (310,434) (312,099) (265,446)
Treasurystock -
-

-

-

-

-
Non-control interest 118,840
191,223

224,743

306,371

363,677

381,865
Total
equity
Before
Distributi
on
1,405,261
1,425,869

1,557,600

2,345,326

2,536,066

2,601,481
Before
Distributi
on
1,320,511
1,369,369

1,436,125

2,345,326

2,536,066

2,601,481

Note 1: The 2018 surplus distribution case was approved by the board of directors of the company on March 26, 2019, but as of the date of publication of the annual report, it has not yet been resolved by the shareholders' meeting.

  • 99 -

2. Brief Comprehensive Profit and Loss Statement

Unit : NT$ in Thousand

Year
Items
(Financial information for recent five years) (Financial information for recent five years) (Financial information for recent five years) (Financial information for recent five years) (Financial information for recent five years) As at March 31,
2019
Financial
Report
2014 2015 2016 2017 2018
Operatingincome 2,231,231
2,257,308

2,065,543

2,263,652

2,687,581

354,353
Operating gross
profit
568,347
622,887

655,420

751,521

774,594

68,627
Operating profit and
loss
176,780
283,911

324,598

406,721

356,769

6,246
Non-operating
income
And expenditure
5,612
(60,694)

5,956

214

42,246

(1,884)
Netprofit before tax 182,392
223,217

330,554

406,935

399,015

4,362
Continuing business
unit
Current netprofit
175,209
216,150

292,264

396,423

348,687

1,815
Loss of business unit -
-

-

-

-
Current net profit
(loss)
175,209
216,150

292,264

396,423

348,687

1,815
Other
comprehensive
profit and loss of the
period(net after tax)
(6,791)
(225,461)

(104,033)

66,787

(1,577)

54,537
Current consolidated
profit and loss
lumpsum
168,418
(9,311)

188,231

463,210

347,110

56,352
Net profit belongs to
Parent company
owner
195,639
197,064

243,217

322,873

305,058

526
Net profit belongs to
Non-control interest
(20,430)
19,086

49,047

73,550

43,629

1,289
The total profit and
loss is attributable to
the parent company
owner
188,730
(10,979)

154,711

381,582

303,393

47,179
Total consolidated
profit and loss is
attributable to
non-controlling
interests
(20,312)
1,668

33,520

81,628

43,717

9,173
Earningsper share 3.78
3.52

4.30

5.31

4.76

0.01
  • 6.1.2 Significant events affecting the above-mentioned concised financial statements for consistency comparison, such as accounting changes, company mergers or suspension of business departments, etc. and their impact on the current year's financial statements: None.

  • 6.1.3 Names and audit opinions of auditor in the past five years

  • Names and audit opinions of auditor in the past five years

Year Name of Audit Firm Auditors Audit opinions
2014 Deloitte & Touche Yu Cheng Chuan and
ZhangGen Xi
Unqualified Opinion
  • 100 -
2015 Deloitte & Touche Yu Cheng Chuan and
ZhangGen Xi
Rectified with
Unqualified Opinion
2016 Deloitte & Touche Yu Cheng Chuan and
ZhangGen Xi
Unqualified Opinion
2017 Deloitte & Touche Chen Chiang Hsun
and Yu ChengChuan
Unqualified Opinion
2018 Deloitte & Touche Chen Chiang Hsun
and Yu ChengChuan
Unqualified Opinion
  1. If there is any changes of auditor in the last five years, the reason of replacement of the company, the predecessor and the successor auditor must be stated. The company passed the board of directors in March 2014 and appointed the auditor of Deloitte & Touche to conduct the audition. In the past four years, the two auditors of Deloitte & Touche, Yu Cheng Chuan and Zhang Gen Xi have conducted the audition. Due to the internal rotation mechanism of the accounting firm, in the third quarter of 2017, two auditors, Chen Chiang Hsun and Yu Cheng Chuan, were required to conduct the audit.

  2. The local public listed company has been in last seven consecutive years since the public issuance, or the foreign public listed company are being audit by the same auditor for recent seven consecutive years. It should explain the reasons for not changing the auditor. The independency of current appointed auditor or the company has implemented any countermeasure to strengthen the independency of auditor: not applicable.

6.2 Financial Analysis over the Recent Five Years

Unit : NT$ in Thousand

Year
Analysis Items (Note 1)
Year
Analysis Items (Note 1)
Financial Analysis over the Recent Five Years Financial Analysis over the Recent Five Years Financial Analysis over the Recent Five Years Financial Analysis over the Recent Five Years Financial Analysis over the Recent Five Years As at
March 31,
2019
Financial
Report
2014 2015 2016 2017 2018
Financial
structure
(%)
Liabilities to assets ratio 40.53
39.32
26.29
12.73

14.75

16.81
Long-term capital fixed
assets ratio
245.42
283.00
352.91
444.78

460.25

466.89
Debt
paying
ability
(%)
Current ratio 181.36
188.24
299.04
738.57

545.97

472.09
Quick ratio 134.43
149.66
240.31
592.35

368.88

307.69
Interest coverage ratio 895.85
973.10
1,460.25
3,110.54

2,237.66

233.67
Operation
capability
Receivables turnover
rate(times)
5.08
4.06
4.22
4.86

3.96

0.50
Average number of days
of cash receipt
72
90
86
75

92

729

Inventory turnover rate
(times)
5.51
6.32
6.04
6.26

4.45

0.43

Payable turnover rate
(times)
11.37
17.89
23.88
35.82

43.30

6.47
Average number of days
ofgoods sale
66
58
60
58

82

849
Total assets turnover rate
(times)

3.57

3.81
4.07
4.79

5.61

0.73
  • 101 -
Year
Analysis Items (Note 1)
Total asset turnover rate
(times)
Year
Analysis Items (Note 1)
Total asset turnover rate
(times)
Year
Analysis Items (Note 1)
Total asset turnover rate
(times)
Financial Analysis over the Recent Five Years Financial Analysis over the Recent Five Years Financial Analysis over the Recent Five Years Financial Analysis over the Recent Five Years Financial Analysis over the Recent Five Years As at
March 31,
2019
Financial
Report
2014 2015 2016 2017 2018
Total asset turnover rate
(times)
1.03
0.96

0.93

0.94

0.95

0.12
Profitability Asset return rate(%) 8.92
9.99

13.92

13.88

11.28

0.10
Shareholders’ equity
return rate(%)
16.81
15.63

18.95

19.15

14.49

0.02
Percentage
of paid-up
capital (%)
Operating
profit
32.14
50.25

57.45

63.52

55.72

0.98
Net income
before tax

33.16

39.51

58.53

63.55

62.31

0.68
Net income rate(%) 7.85
9.58

14.15

14.26

11.35

0.15
Earnings per share
(NT$)
3.78
3.52

4.30

5.31

4.76

0.01
Cash
flow
Cash flow ratio (%) 12.26
18.08

110.77

66.95

(55.86)

24.64
Cash flow fair ratio (%) 43.24
45.44

83.60

107.87

58.22

66.94
Cash re-investment ratio
(%)
(1.57)
3.46

23.93

3.23

(21.95)

6.54
Leverage Operation leverage 12.63
7.95

6.36

5.57

7.53

56.72
Financial leverage 1.15
1.10

1.08

1.03

1.06

2.09
Please indicate the reasons for the changes in the financial ratios in the last two years. (If the increase or
decrease is less than 20%, it can be exempted from analysis)
1. Reduction of current ratio and quick ratio: due to the outstanding repayment from customers, increase in
inventory, and increase in short-term purchase loans and increase in lease hold land payable.
2. Reduction of interest coverage ratio: The increase in short-term purchases of loans has resulted the reduce of
the interest coverage ratio.
3. Decrease in inventory turnover rate: due to the contract signed with the supplier, which fixed volume of the
purchase is required. As the price of palm oil fell below RM2,000 in the fourth quarter of 2018, most farmers
began to slow down the fertilization. Therefore, it affected the company's fourth quarter revenue, and also
increased the inventory at the end of 2018.
4. The increase in payables turnover rate is due to the fact that the purchase of materials mainly requires
prepayments, in order to reduce the accounts payable.
5. Decrease in return on equity: due to the decrease in orders in the fourth quarter and the expiration of the
subsidiary ACI tax exemption period, resulting in a decrease in profit.
6. Reduction of net profit margin: due to the decrease in orders in the fourth quarter and the expiration of the
subsidiary ACI tax exemption period, resulting in a decrease in profit.
7. Cash flow ratio; the ratio of cash flow compared with cash reinvestment should be lesser: due to the overdue
outstanding payment of customers and the increase in inventory, resulting in the outflow of operating cash
flow.

Note 1. Calculation formula for analysis items:

  1. Financial structure

  2. (1) Liabilities to assets ratio = total liabilities / total assets.

  3. (2) Long-term capital to property, plant & equipment ratio = (total equity + non-current liabilities) / net property, plant and equipment.

  4. Debt paying ability

  5. (1) Current ratio = current assets / current liabilities.

  6. (2) Quick ratio = (current assets - inventory – prepaid expenses) / current liabilities.

  7. (3) Interest coverage ratio = net income before tax and interest expense / interest expense for the current period.

  8. Operation capability

  9. (1) Receivables (including accounts receivable and bills receivable arising from business operation) turnover rate = net sales / average receivables for each period (including balance of accounts receivable and bills receivable arising from business operation).

  10. (2) Average number of days cash receipt = 365 / receivables turnover rate.

  11. (3) Inventory turnover rate = cost of goods sold / average inventory amount.

  12. 102 -

  13. (4) Payables (including accounts payable and bills payable arising from business operation) turnover rate = cost of goods sold / average payables for each period (including accounts payable and notes payable arising from business operation).

  14. (5) Average number of days of goods sale= 365 / inventory turnover rate.

  15. (6) Fixed assets turnover rate = net sales of goods / net fixed assets.

  16. (7) Total asset turnover rate = net sales of goods / total assets.

  17. Profitability

  18. (1) Assets return rate = [Profit and loss after tax + interest expense × (1 - tax rate)] / average total assets.

  19. (2) Shareholders’ equity return rate = Profit and loss after tax attributable to owners of the parent company / average attributable to owners of the parent company.

  20. (3) Net income rate = profit and loss after tax/ net sales of goods.

  21. (4) Earning per share = (profits and losses attributable to owners of the parent company - special dividends) / weighted average number of issued shares. (Note 3)

  22. Cash flow

  23. (1) Cash flow ratio = net cash flow from operating activities / current liabilities.

  24. (2) Net cash flow fair ratio = net cash flow from operating activities over the current five years / increase in (capital expenditure + inventory + cash dividend) for the current five years.

  25. (3) Cash re-investment ratio = (net cash flow from operating activities - cash dividends) / (gross fixed assets + long-term investment + other non-current assets + working capital). (Note 4)

  26. Leverage:

  27. (1) Operation leverage = (net operating income - variable operating costs and expenses) / operating profit (Note 5).

  28. (2) Financial leverage = operating profit / (operating profit - interest expense).

  29. Note 2: The calculation formula of the earnings per share of the preceeding paragraph should pay special attention to the following matters when measuring:

  30. Based on the weighted average number of common shares, not based on the number of shares issued at the end of the year.

  31. Anyone who has a cash increase or a treasury stock trader should consider the circulation period and calculate the weighted average number of shares.

  32. Anyone who has transferred surplus or capital increase will be retrospectively adjusted according to the proportion of capital increase when calculating the earnings per share of the previous year and the semi-annual, and no consideration on period of issuance is needed for the capital increase.

  33. If the special stock is a non-convertible accumulative of special stock, its annual dividend (whether or not it is paid) shall be the net profit reduction after tax or increase the net loss after tax. If the special stock is non-cumulative, in the event of net profit after tax, the special stock dividend shall be deducted from the net profit after tax; if it is a loss, it shall not be adjusted.

  34. Note 3: The cash flow analysis should pay special attention to the following items when measuring:

    1. Net cash flow from operating activities refers to the cash inflow as per operating activities
  35. statement.

    1. Capital expenditure refers to the number of cash outflows per year of capital investment.

    2. The increase in inventory is only included when the ending balance is greater than the opening balance. If the inventory is reduced at the end of the year, it is calculated as zero.

    3. Cash dividends include common shares and special shares cash dividends.

    4. Gross property, plant and facility are the total amount of real estate, plant and facility before deducting accumulated depreciation.

  36. Note 4: The Issuer should classify various operating costs and operating expenses into fixed and variable properties. If there is an estimate or subjective judgment, attention should be paid to its rationality and consistency.

  37. Note 5: If the company's stock is not denominated or the denomination is not NT$10, the calculation of the proportion of the paid-up capital in the former opening is calculated by the equity ratio of the balance sheet attributable to the owner of the parent company.

  38. 103 -

6.3 Audit Committee Review Report of the Latest Annual Financial Report

All Cosmos Bio-Tech Holding Corporation.

Audit Committee Review Report

The Board of Directors has prepared the 2018 Business Report, Financial Statement and Retained Earning Distribution Proposal, of which the financial statements have been audited by Cheng Chiang Hsun and Yu Cheng Chuan, auditors of Deloitte & Touche, and unqualified opinion auditing report is issued. The above-mentioned business report, financial statement and earnings distribution proposal have been checked by the Audit Committee and it is considered that there is no discrepancy. A report will be issued in accordance with the Securities Exchange Law for reference.

All Cosmos Bio-Tech Holding Corporation

Audit committee convener

Yang Yung Cheng

March 26, 2019

  • 104 -

6.4 The consolidated financial statements of the parent company of the recent year by the accountant :

Please refer to pages 132 to 203 of this report.

6.5 If the company and its affiliate companies have encounter any financial turnover difficulty, the impact on the company financial condition should be listed in the latest annual report: None.

  • 105 -

7.0 Review and analysis of financial status and financial performance and risk issues

  • 7.1 Financial status: The main reasons for the significant changes in assets, liabilities and shareholders' equity in the last two years and their impacts. If the impact is significant, the future countermeasure plan should be stated.

Unit : NT$ in Thousand

Unit : NT$in Thousand Unit : NT$in Thousand Unit : NT$in Thousand
Year/
Analysis Item
2017 2018 Difference
Amount
Ratio(%)
Current assets 1,942,817 2,133,931
191,114
9.84
Property, plant and
equipment
475,961 482,291
6,330
1.33
Intangible assets 2,079 8,580
6,501
312.70
Other assets 266,653 350,068
83,415
31.28
Total assets 2,687,510 2,974,870
287,360
10.69
Current liabilities 263,052 390,855
127,803
48.58
Long-term liabilities 44,969 21,217
(23,752)
(52.82)
Other Liabilities 34,163 26,732
(7,431)
(21.75)
Total liabilities 342,184 438,804
96,620
28.24
Share capital 640,340 640,340
-
-
Capital surplus 781,838 781,838
-
-
Retained earnings 927,211 1,062,310
135,099
14.57
Other equity (310,434) (312,099) (1,665) 0.54
Total equity 2,345,326 2,536,066
190,740
8.13

The main reasons for the increase and decrease of the two phases are more than 20%, and the change amount is NT$10,000,000.

  1. Other assets: mainly due to the purchase of lease hold land for a period of 30 years by PT All Cosmos Biotek, the Indonesian subsidiary of the company. The increase of investment in equity method in East Malaysia. Leasehold land are purchased by the company’s Indonesian subsidiary PT All Cosmos Biotek for the expansion in Indonesian market. The incremental of investment in equity method in East Malaysia is to develop industrial service of oil palm waste treatment as well as agricultural waste recycling, which is required for business expansion. Therefore, it is reasonable and will not cause any significant impact.

  2. Current liabilities: mainly due to the increase in bank loans and other payables such as leasehold land. The increase in bank loans is mainly for the purchase of raw materials, and the procurement of raw materials is based on the demand for sales orders. The coefficient is required as per operational demand, which will not have any significant impact. Leasehold land are purchased by the company’s Indonesian subsidiary PT All Cosmos Biotek for the expansion in Indonesian market. It is reasonable and will not have any significant impact.

  3. Long-term liabilities: mainly the repayment of long-term loans and the reduction of the amount of liabilities, which it is reasonable and will not cause any significant impact.

  4. 106 -

7.2 Financial Performance:

  • (1) Financial performance analysis table

Unit : NT$ in Thousand



Unit : NT$ in Thousand Unit : NT$ in Thousand
Year
Analysis Item
2017 2018 Difference
Amount
Ratio(%)
Operatingrevenue 2,263,652 2,687,581
423,929
18.73%
Operatingcosts 1,512,131 1,912,987
400,856
26.51%
Grossprofit 751,521
774,594

23,073
3.07%
Operatingexpenses 344,800 417,825
73,025
21.18%
Profit from 406,721
356,769
operations (49,952) (12.28%)
Non-operating
income and 214 42,246
expenses 42,032 19,641.12%
Net profit before 406,935
399,015
tax (7,920) (1.95%)
Income tax expense
10,512
50,328
39,816
378.77%
Netprofit after tax 396,423 348,687
(47,736)
(12.04%)

The main reasons for the increase or decrease of the two phases are more than 20%, and the change amount is NT$10,000.

  1. Operating costs: operating income increased by 18.73%, operating costs increased by 26.51%, the difference ratio is higher than the business revenue mainly due to the increase in fertilizer sales, the customer is a group company and has a large-scale oil palm plantation, their orders are gone through tender bidding and are produced according to the formula and product type required. In order to penetrate into these groups market, it is necessary for the company to obtain some orders and contacts of the customers through supplychain network. The company gradually promotes the 3-in-1 compound fertilizer to customers, or provides suggestions for field trials. Due to fierce competition in fertilizer bidding prices, gross profit margins are low and raw material costs are high. In addition, due to the decline in palm oil prices, customers have chosen the chemical fertilizer which is less effective andcheaper in price compared to the 3-in-1 compound fertilizer products, resulting in an increase of chemical fertilizers sales.

  2. Operating expenses: The increase in sales expenses was due to the increase in sales. In addition, the storage management fee was increased in 2018 compared with the same period of previous year, mainly because the subsidiary company set up a warehouse at the Philippine agency in order to supply to the shipment demand of the customer Sumifru, resulted warehousing cost increased. The administrative fee is $35 per ton and this year it increased by about NT$11.29 millions.

In anticipation of credit impairment losses, the interest of the bad debts increased by NT$29.72 millions in 2018, mainly due to the incremental of accounts receivable. The price of palm oil began to weaken in 2018 and fell below RM2000 in the fourth quarter, which greatly affected the customer's revenue and caused customers began to extend the payment term to the company;

In addition, Malaysia experienced the first change of government in 60 years in

  • 107 -

May 2018, and most of the internal executives of the public enterprise were replaced, which also affected internal operations such as payment arrangements and decision-making process. The outstanding payment aging became longer in the third quarter;

  1. Non-operating income and expenses: mainly due to the increase in other interests such as foreign currency exchange benefits and the increase in financial assets.

  2. Income tax expenses: All Cosmos Industries Sdn. Bhd., a subsidiary of the Company, is eligible for Income Tax (Exemption) (No. 17) and has been approved by the Ministry of Finance of Malaysia for a 10-year tax credit of 100%. The credit period is from March 27, 2008 to March 26, 2018. 10 years after the expiration of the credit period, it is necessary to start paying income tax in 2018.

  3. (2) Expected sales volume and its basis, possible impact on the company's future business financial and countermeasure plan

As the fertilizer market in Malaysia is still dominated by chemical fertilizers, the Company continues to expand its market. It is expected that the sales volume will continue to grow compared to last year, which will further enhanced the business financial of the Company.

  • 108 -

7.3 The analysis of cash flow changes

  • (1) Latest Analysis of changes in cash flow (2018)

Unit : NT$ in Thousand





Unit : NT$in Thousand Unit : NT$in Thousand

Analysis Item
Year
2017
2018 Difference
Amount
Ratio(%)
Cash flow from
operatingactivities
176,120 (218,333)
(394,453)
(223.97%)
Cash flow from
investingactivities
13,383 (93,249)
(106,632)
(796.77%)
Cash flow from
financingactivities
82,874 (93,991)
(176,865)
(213.41%)

Changes analysis:

  1. Cash flow from operating activities:

  2. The 2018 cash flow ratio decreased by 183.44% or 394.45 millions compared to previous period, and was negative, mainly due to the following factors:

  3. i. The net change in accounts receivable was (268.46) millions, an increase of (123.94) millions or -85.76% compared to previous period.

  4. ii. The net change in inventory was (372.08) millions, an increase of (362.44) millions or -3759% compared to previous period.

  5. iii. The net change in prepayment was 59.04 millions, an increase of 137.27 millions or 175.48% compared to previous period.

  6. iv. The income tax paid in 2018 was 70.87 millions, an increase of 43.31 millions compared to previous period.

In 2018, the average number of days of receivables of the Company's accounts receivable is longer than year 2017. It is mainly affected by two factors:

  1. The price of palm oil began to weaken in 2018, and it fell below RM2000 in the fourth quarter, which greatly affected the customer's revenue and caused customers began to extend the payment term to the company;

  2. In addition, in May 2018, Malaysia experienced the first change of government in 60 years. Most of the internal management of the public enterprises were replaced, which also affected internal operations such as payment arrangements and decision-making process. The outstanding payment aging became longer in the third quarter;

  3. The payment has been gradually recovered in 2019

The company's inventory at the end of 2018 was mainly due to the increase in raw materials, of which potassium chloride was a large amount, which was about NT$337.96 millions. Potassium chloride is used as a raw material for the supply of phosphorus in fertilizers. The supply of this raw material is monopolized by several major mine owners. In order to stabilize the supply and price, the company started to directly contact one of the mine owners- JSC Belarusian in 2013. The company has clinched the deal with JSC Belarusian to supply the raw material with the condition that fixed order/quantity of 6 months supply should be made on each purchase. In Q4 of 2018, the price of palm oil has dropped below RM2,000 . As a result, most farmers began to reduce fertilization, thus affecting the company's fourth quarter revenue as well as incremental of inventory at the end of 2018. Currently, the company has started to receiving orders and utilised raw material inventory.

  • 109 -

In the 2018 prepayments, mainly to reduce advance payment. Reduction of 56.95 millions compared with the previous period. The purchase plan was to purchase according to the order requirements, and the payment terms were repaid according to the terms agreed by the supplier.

All Cosmos Industries Sdn. Bhd., a subsidiary of the Company, is eligible for Income Tax (Exemption) (No. 17) and has been approved by the Ministry of Finance of Malaysia to receive 100% of its taxable income for 10 years. From March 27, 2008 to March 26, 2018. 10 years after the expiration of the exemption period, it is necessary to start paying income tax in 2018.

  1. Cash flow from investing activities: mainly due to capital expenditures - increased investment in real estate.

  2. Cash flow from financing activities: due to the inflow of capital increase in 2017.In 2018, mainly repayment of bank loans, distribution of cash dividends

  3. (2) Improvement plan for insufficient liquidity

Although the company continues to have operational capital turnover requirements in the coming year, it is expected that the company's revenue will be stable and the funds will be invested, so that the business activities will show a net cash inflow, and the cash flow of investment and financing activities should be available. Moreover,the company and the bank establish long-term good credit conditions, so there is no shortage of liquidity.

(3) Analysis of cash flow in the coming year (2019)

Unit : NT$ in Thousand




Unit : NT$ in Thousand Unit : NT$ in Thousand
Cash At The
Beginning
Balance
Estimated annual
cash flow
(output)

Expected to
remain today
(insufficient)
amount
Estimated Insufficient Cash
Remedy
Investment plan Financial plan
591,505 92,995
684,500
- -
Analysis of changes in cash flow in the coming year:
1. Business activities: Continue to expand the company's business, and strengthen
cost control, to estimate incoming cash flow amount.
2. Investment activities: Having two new joint ventures in East Malaysia's Sabah
state, to do research and produce industrialized services for oil palm waste
treatment and agricultural waste recycling services;
Indonesia's new joint venture company set up a factory to expand the Indonesian
market.
3. Financing activities: It is expected to process cash capital increase or issue
convertible bonds and cash dividends.
  • 110 -

7.4 The significant impact of annual capital expenditures on financial operations in the most recent year:

Due to the good operating conditions of the company, the cash inflow from operating activities is stable and there is no significant capital expenditure in recent years, thus, there is no significant impact on the company's finances.

7.5 The most recent annual investment policy, the main reason for its profit or loss, the improvement plan and the investment plan for the following year

  • 7.5.1 The company's investment policy:

The Company's main investment target is on the same industry and has not been engaged in non-related industries investment. In addition to the investment cycle regulation of the internal control system, the Company's Management enforced a standard of managing transfer investment business, such as “Relationship on Corporate Transaction Management Measures” and “ The Measures for the Supervision and Management of Subsidiaries” are regulated for the investment in control. In addition, consider the various investment companies in the local laws and regulations and the actual operating conditions, and assist the transfer companies to establish appropriate internal control systems.

  • 7.5.2 The main reasons for the profit or loss of investment in recent years and the improvement plan:

Unit: NT$ in Thousand



Unit: NT$in Thousand
Re-invested
Entities
Principal Business
Activities
2018
Gain/(Loss)
on
Investment
Main Reason for Gain/(Loss)
ACI Manufacturing and sales of
biochemical organic
high-performance
compound fertilizer
281,740 Malaysia districts achieved good
volume of sales
SSHF Manufacturing and sales of
biochemical organic
high-performance
compound fertilizer
51,876 Malaysia districts achieved good
volume of sales
PT ACB Manufacturing and sales of
biochemical organic
high-performance
compound fertilizer
443
Other operating profit
PT ACI Sales of biochemical
compound fertilizer
products
(1,632)
Other operating loss
AESB Research and production of
bacterial biochemical
organic high-performance
compound fertilizer

1,029
Malaysia districts achieved good
volume of sales
  • 111 -
Re-invested
Entities
Principal Business
Activities
2018
Gain/(Loss)
on
Investment
Main Reason for Gain/(Loss)
KLS Research and production of
bacterial cells into oil palm
waste treatment

_
Only registration without capital
injection
CB Forest planting and
research
(728) No business income yet
GKB Probiotics for sale (25) No business incomeyet
SE Research and production of
bacterial cells into oil palm
waste treatment

(20)
No business income yet

The loss of PTACI is mainly due to the fact that PTACI is 100% domestically sold to the Indonesian market, the revenue is Indonesian rupiah, but the payment to ACI is US dollar, which resulting in exchange losses.

  • 7.5.3 Investment plan for the coming year

The company expects two new joint ventures in East Malaysia's Sabah state to do research and produce industrialized services for oil palm waste treatment and agricultural waste recycling in the coming year; Indonesia's new joint venture company setting up a factory to expand the Indonesian market. The Company will continue to cooperate with the overall operation and development, observe the market sentiment trend and the Group's business strategy and other factors to invest in the appropriate time.

7.6 Analysis and assessment of recent year and till the publication date of annual report :

  • 7.6.1 The impact of interest rate, exchange rate changes and inflation on the company's profit and loss and future countermeasures

  • (1) Interest rate changes

The Company's interest expenses for 2017 and 2018 were 13.52 millions and 18.67 millions respectively, accounting for 0.60% and 0.69% of the net operating income ratio. The interest expense of the Company is mainly due to bank loans, and the ratio of operating income is not significant, so the interest rate changes have little impact on the Company. However, if there is a large fluctuation in the interest rate trend and the Company continues to have the demand for loans, the company will observe the interest rate trend and choose the fixed interest rate in addition to the other capital market financing tools. Loans by means of floating interest rates to reduce the risk of interest rate fluctuations.

  • 112 -

(2) Exchange rate changes

Since the company's main sales locations are mainly in Southeast Asia such as Malaysia, basically most of the sales are denominated in Malaysian currency, while the purchases are mainly denominated in US dollars. Therefore, most of the exchange differences are pre-purchased in foreign currency, but there may still be insufficient of pre-purchased foreign exchange will may cause the appreciation of the RM position to the US dollar incurred risk of the foreign currency exchange loss to the Company.

The Company's foreign currency exchange (loss) gains in 2017 and 2018 were (8.37) millions and 30.08 millions respectively, accounting for the net operating income ratio (0.37%) and 1.12%, and there was no significant exchange rate fluctuation loss. The company has taken below countermeasures:

A. Continue to strengthen the concept of financial personnel's hedging, evaluate the pre-purchased foreign currency according to the company's purchase of raw material order amount and the exchange rate set by the sales order, and through the online exchange rate real-time system and strengthen the relationship with financial institutions and monitor international political status, etc. In order to judge the trend of exchange rate changes, it is used as a basis for pre-purchasing foreign currency.

B. Increasing the proportion of export sales against the expenses of the sales under the same currency of the cost of purchase and related expenses, in order to achieve natural hedging effect.

(3) Inflation

In recent years, due to the global crute oil and commodity prices dropping and the implementation of loose monetary policy in the world, the uncertainties of global economic growth, the market prices of the company's main raw materials such as chlorine, phosphorus and potassium have also fluctuated, with some slight production costs influences. Since the European debt and China's economic growth have stagnated, global economic activity has slowed down, and short-term inflationary pressures have increased. However, the company has become a strategic partner with suppliers in recent years. During the period of inflation, suppliers are supplying raw material at the lower cost than the market price. In addition, the expansion of production capacity to achieve economical scale, continuous improvement of process capability to reduce production costs, and simultaneously to develop of high value-added products, etc., have achieved concrete results in improving gross profit and reducing inflation, while the dropping of raw material cost, the result is remarkable.

  • 7.6.2 Engagement in high-risk, high-leverage investment, capital loan and others, endorsement guarantee and derivative commodity trading, profit or loss and future countermeasures

  • 113 -

The Company has always focused on the industry and operated its business on a pragmatic basis. Apart from focusing on the company's business areas, the Company has not engaged in high-risk, highly leveraged investments. The Company is engaged in the main business of derivative products in response to the risk of exchange rate fluctuations, and the company's fund loan and endorsement guarantees are all inter-group companies, and the company has “derivative commodity operating procedures”, “finance loan and endorsement guarantee operations”. Measures and "Acquisition or Disposition of Asset Processing Procedures" for compliance.

7.6.3 Research and development extimation expenses for future R&D projects

R&D Projects Projects Contents
4-in-1 phage
biofertilizer
Screening of phage that can control R. solanacearum in
wastewater, using transgenic E. coli as a host for mass
production of phage, production of phage preparations and
application tofertilizerproducts
4-in-1 anti-white root
disease control
fertilizer
Screening endophytic Trichoderma from roots of healthy
plants, optimizing the production of spores through culture,
and combiningfertilizers to control diseases
Oil palm by-product
degradation
A variety of Malaysian native degrading bacteria are mixed
and degraded for by-products such as oil slag from palm oil
mills to decompose the finished product into organic
fertilizer.
Value-added
agricultural
by-products
The addition of Trichoderma for different agricultural
by-products produces a control agent for farmers in a more
economical way, and also solves the problem of excess
by-products.
Different
by-products
and
different
Trichoderma products are paired with each other, and the
formula is stable, suitable concentration and economical
formula
Disease resistant
seedling inoculation
Inoculate disease-resistant Trichoderma for different crop
seedlings. The use of Trichoderma species is adjusted
accordingto the cropand medium.
Special nitrogen-fixing
biological fertilizer for
rice and green leafy
vegetables
Develop high-efficiency nitrogen-fixing bacteria, optimize
the breeding conditions and breed the strain, produce
high-concentration bacterial liquid, and apply it to fertilizer
products to improve soil nitrogen fixationperformance.

The company is expected to consider the actual needs of the future to upgrade the experimental equipment, to expand the development of functional strains and to have a backup microbial production line and increase the production speed, continue to commercialize the bacterial strain and to invest in research and development resources according to individual product development plans in the future. Currently, target to invest approximately RM5 million into the research and development.

  • 114 -

  • 7.6.4 The impact of important policies and legal changes at home and abroad on the company's financial business and the countermeasures

The country of registration of the company is at Cayman Islands. The Cayman Islands is mainly engaged in financial services. The economy is open and there is no exchange control, and the political and economic environment is stable. The main operating country is Malaysia. The main product produced and sold by the company is biochemical compound fertilizer, which required for the growth of oil palm tree, the most important economic crop in Malaysia. The company's biochemical compound fertilizer MPOB F4 is approved and licensed by the Malaysian Oil Palm Board (MPOB) and continues to introduce biochemical compound fertilizers that can treat and prevent diseases, such as Gano EF, which prevents oil palm tree ganoderma disease. The company has been long in cooperating with professional organizations and is always aware of the impact of important domestic and international policies and legal changes on the company's financial operations in order to take appropriate countermeasures. In recent year and till the date of publication of annual report, the company has not had any significant events affecting the company's financial business due to changes in important policies and laws in the above regions.

  • 7.6.5 The impact of technological changes and industrial changes on the company's financial business and the countermeasures

The company's main products are biochemical compound fertilizers necessary for the growth of crops. With the increasing global population, the reduction of arable land and environmental awareness. The ratio of farmers using general chemical fertilizers has been declining year by year, and compound fertilizers mixed with various unit fertilizers have gradually replaced traditional fertilizers. With the advancement of science and technology, the multifunctional biochemical compound fertilizer is the main development trend. Demand in the fertilizer market is affected by crop production and food supply. According to the "Fertilizer Outlook for 2018~2019" published by the International Fertilizer Industry Association in November 2018, with the decline in crop prices and dramatic changes in the global climate, slowing the growth of the agricultural market, the stock consumption of the world's major agricultural products in the next five years. The ratio will not change drastically.

The company continues to develop various types of fertilizers, using innovative technology to add biological species, green technology, pest control and other elements to the fertilizer manufacturing, not only can provide soil nutrients can change the soil's pH, viscosity, pest diseases, weeds and other issues. Therefore, technological changes and industrial changes have not had a major impact on the company's financial business.

  • 7.6.6 The impact of corporate image change on corporate crisis management and countermeasures

  • 115 -

The company is committed to be sustainable with business integrity, focusing on the development and production of various types of fertilizers, in order to meet the needs of various regions of climate, soil, crops, etc., The company has very good reputation and is well known among the industry in Malaysia. In the recent year, there has been no corporate crisis management due to changes in corporate image.

7.6.7 Expected benefits, possible risks and countermeasures for M&A

There have been no plans to acquire other companies in recent year of the company and till the publication date of the annual report.

7.6.8 Expected benefits, possible risks and countermeasures for the expansion of the plant

The company has no intention of expanding its plant in recent year and till the publication date of the annual report.

  • 7.6.9 Risks and countermeasures in the concentration of purchase or sales

(1) Purchase

The purchase amount of the top ten Supplier Company in 2017 and 2018 accounted for 74.08% and 71.98% of the total annual net purchases, respectively, with a slight increase or decrease in the proportion. The procurement projects are mainly potassium chloride, urea and phosphate rock powder, of which potassium chloride is the main raw material exceeding 40% of the net purchase. Because JSC BELARUSIAN POTASH COMPANY (hereinafter referred to as BPC) is the main direct manufacturer of potassium chloride, the company has a higher ratio of potassium chloride purchase from BPC. The Company's good business relationship with BPC and its products are substitutable. Therefore, the situation of concentrated purchases should not have a material adverse impact on the financial business of the Company.

The above-mentioned company's purchase concentration is caused by the industrial characteristics. In addition, the company continues to search for suitable urea, potassium chloride and phosphate rock suppliers around the world based on the diversification of sources to minimise the risk of concentrated purchases. Therefore, the company should not have encounter risk of major concentrated purchases.

(2) Sales

The sales of the top ten customers of the Company in 2017 and 2018 accounted for 61.15% and 63.59% of the annual operating income, mainly due to the fact that global oil palm production is mainly concentrated in Malaysia and Indonesia, as oil palm is an important cash crop, hence, Malaysian government value the importance of the development of oil palm industry, and numbers of related institutions and investment companies have been set up. Moreover, oil palm enterprises need to be facilitated with palm oil processing, transportation, storage and sales operations, thus the oil palm industry is owned by Malaysia government and large enterprises,

  • 116 -

whom owned more than 80% of the total plantation space in Malaysia. Only approximately 10% of the oil palm plantation is owned by the small owner. As a result, the sales ratio of the top ten customers of the company is relatively high. However, the Company continues to strive to develop new customers in each region, and the sales ratio of each period to a single customer has not exceeded 20%. The company's operation has also shown stable profit for many years, so the risk of sales concentration should not be significant.

  • 7.6.10 Directors, supervisors or major shareholders holding more than 10% of the shares, the impact of a large number of shares transferred or replaced on the company, risks and countermeasures

The Company's recent year and till the annual report published date, there is no operational risk to the company due to the substantial transfer or replacement of the directors or major shareholder equity.

  • 7.6.11 The impact of changes in management rights on the company, risks and countermeasures

There has been no change in the Company's management rights in the recent year and till the date of publication of the annual report.

  • 7.6.12 Litigation or non-litigation incidents, the company and the company's directors, supervisors, general managers, substantive personels, major shareholders holding more than 10% of the shares and subordinate companies have A major lawsuit that the subordinate company has decided to determine or is still in the system of litigation, non-litigation or administrative litigation, the result may have a significant impact on shareholders' equity or securities prices. The facts of the dispute, the amount of the subject matter, the commencement date of the litigation, the main litigant and the annual report shall be disclosed.

  • (1) The company's recent two-year and up-to-date annual report stated cases of the litigation, non-litigation or administrative litigation that has been determined or currently in the system, and the results may have a significant impact on shareholders' equity or securities prices. The fact of the dispute, the amount of the subject matter, the commencement date of the lawsuit, the parties involved in the proceedings and the current situation should be disclosed:

The company itself has not litigated or a non-litigation situation in the last two years and up to the date of publication of the annual report. However, as far as the subsidiary company is concerned, only the case of the labor dispute of the subsidiary SSHF has been resolved on May 19, 2017 out of court. The external settlement was approved by the Industrial Arbitration Tribunal and therefore had no significant impact on the shareholders' equity of the Company.

  • (2)The company's directors, supervisors, general managers, substantive principals, major shareholders and subordinate companies with a shareholding ratio of more

  • 117 -

than 10% have been determined or currently in the company's last two years and up to the date of publication. In the event of litigation, non-litigation or administrative litigation, the outcome may have a significant impact on the company's shareholders' equity or securities price:

Peng Sheng Ching, a director of the company, was accused of committing a forgery in the Republic of China in 1992. However, the case has been filed by the Taiwan Taipei District Prosecutor’s Office No. 16236 for the non-prosecution of the case. Although Mr. Lin Qichun has raised an appeal later, but was dismissed by the Taiwan High Court Procuratorate's 104th Annual Speech No. 8590. Despite Lin Qichun’s 2nd appeals was being dismissed by the Taipei District Court’s 104 No.265. The plaintiff also filed a civil lawsuit against the director Peng Sheng Ching in the same incident. The case was judged by the Taiwan Taipei District Court's 101 No. 945 and the plaintiff was found to have lost the first instance appeal. The plaintiff then filed a second-instance appeal. The judgment (Case No.: No. 323, No. 323) was dismissed, and Lin Qichun was defeated. The plaintiff again submitted the third trial, which was already numbered by the Supreme Court in the 106th year of Taiwan Anti-Japanese No. 1028, No. 1029, No. 1030 and Taihang. No. 2319 ruled that the plaintiff’s protest was dismissed. However, in the case of the plaintiff Lin Qichun’s additional lawsuit in the second instance, (the case number: Taiwan High Court No. 103 No. 323), the High Court also ruled that the plaintiff’s additional lawsuit was dismissed by the judgment of March 27, 2007. The plaintiff Lin Qichun’s second-instance appeal was resubmitted to the third trial, which is currently under review.

As per the lawyer's opinion, since the plaintiff, Mr. Lin Qichun, did not fully explain it, it should be difficult to obtain a favorable judgment in the case of civil litigation. The civil litigation incident is only intended to confirm that the director, Peng Sheng Ching, served as a director of his company more than ten years ago. Whether the appointment relationship exists or not, the results should not have any impact on the shareholders' equity or the securities price of the company.

  • (3) The company's directors, supervisors, managers and major shareholders with a shareholding ratio of more than 10% have stipulated in Article 157 of the Securities Exchange Law in the last two years and up to the date of publication of the annual report and the company's current handling Situation: None.

  • 7.6.13 Other important risks and countermeasures:

    • (1) Risk of research and development of new products

The company continues to improve its research and development capabilities to maintain its market competitiveness. However, biotechnology and technology are rapidly developing, and new products still need to be certified by government agencies and field experiments. Therefore, can the company timely research results? There is still a risk of uncertainty in commercial production and acceptance in the market.

  • 118 -

  • (2) Main chemical fertilizer raw materials depend on import risks

Because Malaysia produces only a small amount of nitrogen, phosphorus and potassium, which are the main raw materials for chemical fertilizers, the raw materials are subject to imports. The import prices fluctuate due to the global economy. However, most of the orders of the company are obtained through competitive bidding. Therefore, before bidding, the company will refer to the quotation of the raw materials provided by the supplier to determine the bid price, in order to minimise the impact of the change of raw material price on the profit margin, also to control the import of raw material cost fluctuation risk effectively.

  • (3) Risk of horizontal competition

Due to the high technical threshold for the production of biochemical compound fertilizer, the microbial extraction, culture, quantification and compounding technology required for biochemical compounding are not easy to obtain. The company aimed to be ahead of the same industry competitors, thus, continuously invest in research and development of microbial related technologies, simultaneously apply for related patent rights to prevent peers from entering biochemistry compound fertilizer market. On the other hand, the company continues to develop new products to maintain competitive advantage and market share.

  • (4) Ten-year tax exemption does not meet the risk of recourse and maturity Subsidiary ACI obtained the ten-year tax exemption for Malaysian Biotechnology Corporation Sdn. Bhd. (hereinafter referred to as BNX) in March 2008. However, due to insufficient number of knowledge workers in 2008, it was inconsistent with the regulations of the competent authorities. Nevertheless, after the company applied to BNX in 2009 and obtained the consent to adjust the conditions of the knowledge workers, the company has been reviewed by the competent authorities every year so far, except for the case of non-conformity in 2008.

After consulting the lawyers and taking the relevant authorities' correspondence, BNX has issued a evaluation letter to the company in 2009 to inform that despite the company is not eligible due to case of non-conformity in 2008, however, considering the business model of the company, it agreed to reduce the proportion, and the company has been awarded with 10 years tax exemption. Since 2009 to 2013, the company has passed the BNX tax exemption qualification evaluation. In addition, due to the company's good compliance record, BNX advised that the company only required to report online in 2014 and 2015. In summary, despite the company was disqualified from the 10-year tax exemption previously. The risk of recourse to unqualified taxes is still low and should not have a material adverse effect on the Company.

The tax-free offer is expected to expire in March 2018. It is calculated based on

  • 119 -

the 2017 profit and loss amount and the 20% tax rate. After the expiration of the offer, the company needs to increase the annual income tax of approximately RM6 million to make 2017 earnings per share. The earning per share was reduced by 0.99 and the dilution rate was about 20%. The company that had obtained the 10-year tax-free concession had a tax rate of 20% in the ten years after the tax-free offer expired, which is lower than the general tax rate of 24% to the applicable Malaysian companies.

7.7 Other important matters : None

  • 120 -

8.0: Special Records

8.1 Information about the affiliate companies:

  • 8.1.1 Overview of affiliate companies

  • (1) Organization chart

==> picture [474 x 271] intentionally omitted <==

  • (2) Name of each company, date of establishment, address, amount of paid-in capital, main business items

Unit : in Thousand

Company Name Date of
establishment
Address Paid-up capital Main business
activities or
Production items
All Cosmos Industries
Sdn. Bhd.
Jul, 1999 PLO 539, Jalan Keluli, Pasir
Gudang Industrial Estate,81700
Pasir Gudang, Johor, Malaysia.
RM 30,000 Research and
development,
manufacturing and
sales of biochemical
compound fertilizer
products
Sabah Softwoods
Hybrid Fertiliser Sdn
Bhd
Nov, 2010 TB 11828, Block C Taman El-
nysa, Jalan Kabota Camp, Off
Jalan Apas Batu 3, 91000,
Tawau,Sabah.
RM 60,000 Manufacturing and
sales of biochemical
compound fertilizer
products
PT All Cosmos
Indonesia
Aug, 2011 Ira Building Jl. Cactus Raya Blok
J No.1 Komp. Perumahan Taman
Setia Budi Indah Medan - 20131,
Sumatera Utara - Indonesia
RP 4,000,000 Sales of biochemical
compound fertilizer
products
Arif Efektif Sdn. Bhd Apr, 2012 PLO 539, Jalan Keluli, Pasir
Gudang Industrial Estate,81700
Pasir Gudang,Johor,Malaysia.
RM 500 Study on
disease-resistant phage
Cosmos Biowood Sdn. Oct,2015 12A,Jalan Dedap17,Taman RM 500 Forestplantingand
  • 121 -
Bhd. Johor Jaya, 81100 Johor Bahru,
Johor,Malaysia.
research
Kinabalu Life Sciences
Sdn. Bhd.
Dec, 2017 MPT 4604, 3rd Floor, Lot 15-16,
Block B, Bandaran Baru, Jalan
Baru, 91000 Tawau, Sabah.
RM 0.01 Research and
production of bacterial
cells into oil palm
waste treatment
Sawit Ecoshield Sdn.
Bhd.
Nov, 2017 Jalan Kelapa Sawit, Off KM 4,
Jalan Tuaran, 88300 Kota
Kinabalu, Sabah, Malaysia.
RM 5,000 Research and
production of bacterial
cells into oil palm
waste treatment
PT All Cosmos Biotek Aug, 2018 Jalan Kelapa Sawit – Nomor 1,
KEK Sei Mangkei, Kecamatan
Bosar Maligas, Kabupaten
Simalungun, Sumatera Utara,
Indonesia.
RP 14,000,000 Manufacturing and
sales of biochemical
compound fertilizer
products
GK Bio International
Sdn. Bhd.
Oct, 2018 42-2, Jalan PJU 5/11, Dataran
Sunway, Kota Damansara, 47810
Petaling Jaya, Selangor,
Malaysia.
RM 3,000 Probiotics for sale
  • (3) Presumed to be the same shareholder information for those with control and affiliation: None

  • (4) Relationship between the company and the related company, mutual shareholding ratio, share and actual investment amount

March 31, 2019

March 31,2019 March 31,2019 March 31,2019
Name Relationship The companyholds at the end of theperiod Holdingthe company
Shares Holding
proportion

Shares
Holding
Investment
Amount
Ratio Unit
Share
Investment
Amount
All Cosmos Industries
Sdn. Bhd.
Subsidiary
company
100% 30,000,000 RM
30,000,000
Sabah Softwoods
Hybrid Fertilizer Sdn.
Bhd.
Subsidiary
company
55% 33,000,000 RM
33,000,000
PT All Cosmos
Indonesia
Subsidiary
company
100% 80,000 Rp.
4,000,000,000
PT All Cosmos Biotek Subsidiary
company
60% 8,400 Rp.
8,400,000,000
Arif Efektif Sdn. Bhd. 2nd Tier
Subsidiary
company
49% 245,000 RM 245,000
Kinabalu Life Sciences
Sdn. Bhd.
2nd Tier
Subsidiary
company
60% 6 RM 6
Cosmos Biowood Sdn.
Bhd.
2nd Tier
Subsidiary
company
80% 400,000 RM 400,000
GK Bio International
Sdn. Bhd.
2nd Tier
Subsidiary
company
60% 1,800,000 RM 1,800,000
Sawit Ecoshield Sdn.
Bhd.
Related
company
40% 2,000,000 RM 2,000,000
  • 122 -

8.1.2 Operation overview

Overview of the operations of various related companies

As at March 31,2018. Unit : in Thousand As at March 31,2018. Unit : in Thousand As at March 31,2018. Unit : in Thousand As at March 31,2018. Unit : in Thousand As at March 31,2018. Unit : in Thousand As at March 31,2018. Unit : in Thousand As at March 31,2018. Unit : in Thousand
Company Name Paid-up
capital
Total assets
Total debt
Net worth Current
operating
income
Current
business
profit
Current
profit and
loss (after
tax)
Earnings per
share (yuan)
(after tax)
All Cosmos Industries
Sdn. Bhd.
RM 30,000 RM
257,627
RM 34,445 RM
223,182
RM
255,387
RM 37,506 RM 38,314 RM 1.28
Sabah Softwoods
Hybrid Fertiliser Sdn
Bhd
RM 60,000 RM
119,261
RM 16,220 RM
103,041
RM
105,409
RM 13,845 RM 12,619 RM 0.21
PT All Cosmos Biotek RP
14,000,000
RP
32,719,627
RP
18,371,293
RP
14,348,334
- RP
(388,481)
RP
348,335
RP 24,881
PT All Cosmos
Indonesia
RP
4,000,000
RP
13,079,133
RP
11,907,094
RP
1,172,039
RP
21,926,711
RP
688,151
RP
(768,967)
RP (9,612)
Arif Efektif Sdn. Bhd RM 500 RM 3,082 RM 1,037 RM 2,045 RM 2,148 RM 344 RM281 RM 0.56
Kinabalu Life Sciences
Sdn. Bhd.
RM 0.01 - - - - - - -
Cosmos Biowood Sdn.
Bhd.
RM 500 RM 9 RM (345) RM (336) - RM (122) RM (122) RM (0.24)
GK Bio International
Sdn. Bhd.
RM 0.01 RM 0.01 RM (3) RM (3) - RM (3) RM (3) RM (300)
Sawit Ecoshield Sdn.
Bhd.
RM 5,000 RM 6,910 RM 1,917 RM 4,993 - RM (11) RM (7) -

8.2 The most recent year and the end of the annual report, the date of published, private

equity securities processing : None.

  • 8.3 The latest annual report, the date of publication, the company holds or disposes of the company's stock : None.

8.4 Other necessary supplementary notes : None.

  • 123 -

8.5 The occurrence of significant impact on shareholders' equity or securities price as stipulated in Article 36-2-2 of the Securities Exchange Law : None.

8.6 A statement of significant differences with the provisions of the shareholders' rights and interests of the Republic of China :

Due to the slight inconsistency between the British Cayman Islands Act and the Republic of China Act, the Taiwan Stock Exchange Co., Ltd. announced the “Registration Form for the Protection of Shareholders’ Rights of Foreign Issuer Registration Countries” (hereinafter referred to as “Shareholders’ Rights Protection Matters”). ) The following list shows the differences between the Company's current Articles of Association (the “Articles of Association”) and the protection of shareholders' interests due to the provisions of the British Cayman Islands Act, and the Articles of Association of the Company provisions.

Differences with the
Articles of Association and
provisions on matters of British Cayman Islands Act
Description
protection of shareholders' and Description
rights and interests
If a company buys its own
shares and transfers it to
employees, it may limit the
employees from
transferring within a
certain period of time.
However, the period may
not exceed two years.

The treasury shares are
subject to the terms and
conditions of the company
directors; the Cayman
Company Law does not
have provisions for
employee reward programs.
According to Article 1 of the Articles
of Association, Treasury Shares are
shares issued in accordance with the
Articles of Association, the Cayman
Companies Act and the Listing Rules
Act, which are bought back,
redeemed or otherwise obtained by
the company and have not been
cancelled; This provision is set out in
section 40D of the company's
articles of association; however,
according to Cayman's lawyers, the
restrictions on the transfer are
between the company and the
employee's contractual relationship
(the restrictions agreed between the
company and the employee is a
contractual matter between
themselves. )
5. The following matters
shall be listed and
explained in the
convening of the
shareholders' meeting,
and shall not be
proposed by a
provisional motion:
(1) Appointing or
dismissing directors or
supervisors;
(2) Changethe charter;
Regarding 5. The Cayman
Company Law has no
special provisions for the
provisional motion.
According to Cayman's
lawyers, regarding the
provisional motion, the
notice of the shareholders'
meeting must clearly stated
the content of the meeting
and provide relevant
information for the
The Cayman Company Law has no
special provisions for the provisional
motion; therefore, the item 5 is
stipulated in Article 50 of the
Articles of Association. According to
Cayman's lawyers, regarding the
provisional motion, the notice of the
shareholders' meeting must clearly
state the agenda of the meeting and
provide relevant information for the
shareholders; however, in the notice
of the shareholders' meeting,the
  • 124 -
Differences with the
Articles of Association and
provisions on matters of British Cayman Islands Act
Description
protection of shareholders' and Description
rightsandinterests
(3) Dissolution, merger,
share conversion, and
division of the
company;
(4) conclude, change or
terminate a contract for
the lease of all
business, entrusted
operations or joint
operations with others;
(5) to transfer all or a
major part of the
business or property;
(6) Transferring all
business or property to
others, which has a
significant impact on
the operation of the
company;
(7) Private placement of
securities of an equity
nature;
(8) The director is engaged
in the licensing of
non-competition
activities;
(9) Distribution of one or
all dividends by way of
issuing new shares;
(10) The statutory surplus
reserve and the capital
reserve due to the
issuance of shares or
the incentive of the
shares, and the
distribution of new
shares to the original
shareholder
shareholders; however, in
the notice of the
shareholders' meeting, the
"any other subject" agenda
is usually added. Usually
have an informal or
insignificant nature, the
chairman should not add
any important events into
this agenda; if there are any
important matters, the
meeting should be convened
to discuss the resolution
according to the procedure;
if the matter is urgent, it
must be discussed in the
next shareholders meeting,
which agenda will be
proposed and ratified in the
next meeting. Although
Cayman’s law does not
expressly prohibit an
interim motion, Cayman’s
lawyers advise that it is not
appropriate to have a
provisional motion at the
shareholders’ meeting.

"any other subject" agenda is usually
added. Usually have an informal or
insignificant nature, the chairman
should not add any important events
into this agenda; if there are any
important matters, the meeting
should be convened to discuss the
resolution according to the
procedure; if the matter is urgent, it
must be discussed in the next
shareholders meeting, which agenda
will be proposed and ratified in the
next meeting.
3. When the company
exercises its voting
rights in writing or
electronically, its
method of exercise
shall be stated in the
notice convened by the
shareholders' meeting.
Shareholders who
According to the opinion of
the British Cayman Islands
lawyers, the chairman of the
shareholders' meeting will
be entrusted to vote on
behalf of the shareholders
whom voted in the form of
writing.

The Cayman Company Law does not
specifically stipulate the content of
the preceding paragraph of Article 3.
Therefore, the first paragraph of
Article 3 is stipulated in Article 68 of
the Articles of Association.
According to the opinion of Cayman
Lawyers, Shareholders who exercise
their votingrights are deemed to
  • 125 -
Differences with the
Articles of Association and
provisions on matters of British Cayman Islands Act
Description
protection of shareholders' and Description
rightsandinterests
exercise their voting
rights in writing or
electronically are
deemed to be present in
person at the
shareholders' meeting.
However, the
provisional motion of
the shareholders
meeting and the
amendment of the
original motion are
deemed to be waived.
have entrusted the chairman of the
shareholders' meeting to vote on
behalf on the basis of the
instructions in the written or
electronic . In consideration of
Cayman's lawyer's opinion, the third
paragraph shall be stipulated in
Article 68 of the Articles of
Association (that is, the shareholders
who exercise the voting rights in
writing or electronically shall be
deemed to have entrusted the
chairman of the shareholders'
meeting to act on behalf in the
shareholders' meeting in accordance
with the instructions in the written or
electronic documents. Its voting
rights, but the temporary motion of
the shareholders meeting and the
amendment of the original motion
are deemed to be waived, but the
above-mentioned entrustment shall
be deemed not to constitute the
principalof thelisting cabinet law.
5. After the shareholder
has exercised the voting
right in writing or
electronically, if he
wishes to attend the
shareholders' meeting in
person, he shall revoke
the initial exercise of
voting rights in the
preceding paragraph two
days before the the
shareholders' meeting;
the overdue revocation
shall be in writing or
electronically. The voting
right of the mode of
exercise shall prevail
According to the opinion of
the British Cayman Islands
lawyers, the chairman of the
shareholders' meeting will
be entrusted to vote on
behalf of the shareholders
whom voted in the form of
writing.

The Cayman Company Law does not
specifically stipulate the content of
item 5; therefore, the item 5 is
stipulated in Article 70 of the
Articles of Association. According to
Cayman's lawyer, under the
Common Law, the principal can
revoke its proxy by attending the
meeting in person, due to written or
electronic Shareholders who exercise
their voting rights are deemed to
have entrusted the chairman of the
shareholders' meeting to vote on
behalf on the basis of the
instructions in the written or
electronic documents. Therefore, the
item 5 may not be enforceable (not
enforceable).
4. After the power of
attorney has been served
on the company, the
shareholder who wishes
to attend the
The Cayman Company Law
has no special provisions for
the power of attorney or
collection of powers.

The Cayman Company Law has no
special provisions for the power of
attorney or the collection of powers
of attorney; therefore, the fourth
item is specified in Article 62B of
  • 126 -
Differences with the
Articles of Association and
provisions on matters of British Cayman Islands Act
Description
protection of shareholders' and Description
rightsandinterests
shareholders' meeting in
person or wishes to
exercise his or her
voting rights in writing
or electronically; shall
notify the company in
writing of the
cancellation of the
entrustment two days
before the shareholders'
meeting; Any delay in
cancellation of
entrustment is subject to
Proxy votingrights.
the Articles of Association.
According to Cayman's lawyer,
under the Common Law, the
principal can revoke its proxy by
attending the meeting in person,
thus, the item 4 may not be
enforceable.
The following resolutions
relating to the interests of
shareholders shall be
attended by more than
two-thirds of the total
number of shareholders
who have issued shares,
and more than half of them
shall agree to the voting
rights of the shareholders.
If the total number of
shares of the attending
shareholders is less than
the above-mentioned
quota, it is allowed to
attend by proxy as long as
the attendance are more
than half of the total
number of shareholders
who have issued shares
and to attend more than
two-thirds of the voting
rights of the shareholders:
1. The company concludes,
alters or terminates the
contract for the lease of
all business, entrusted
operations or
co-operation with
others, the transfer of all
or a major part of the
business or property, the
transfer of all business

Regarding 1., 4., and 5.
(Segmentation), there are no
special requirements or
prohibitions in the Cayman
Company Law.
With regard to 2. and 3.,
Article 24 of the Cayman
Companies Act stipulates
that any changes to the
Bylaws shall be subject to a
special resolution.
Regarding 5 (dissolved
part). Article 116 of the
Cayman Company Law
stipulates that the company
shall voluntarily dissolve by
special resolution, and if it
is unable to pay off the debt
and voluntarily dissolve it,
it shall be passed by the
shareholders' meeting (the
company In general meeting
resolves...), Cayman’s
lawyers believe that the
aforementioned resolutions
of the shareholders’ meeting
can be resolved by ordinary
resolutions, special
resolutions or higher
resolutions as stipulated in
the company’s articles of
association. Ordinary
Resolution can bepassed.



(1) The Cayman Company Law
does not specifically require or
prohibit the division of
paragraphs 1, 4 and 5; therefore,
the divisions of paragraphs 1, 4
and 5 are separately specified in
the company. Article
32(a)(b)(c)(d)(g) of the Bylaws
must be adopted by a special
resolution of the shareholders'
meeting (ie “Supermajority
Resolution Type A” or “Type B
Special Resolution”
( Supermajority Resolution Type
B) (as defined above)
(2) According to Article 24 of the
Cayman Company Law, any
change in the company's articles
of association must be subject to
a special resolution of the
shareholders' meeting; therefore,
paragraph 2 is stipulated in
Article 157 of the Articles of
Association, that is, the company
may have a special resolution at
any time ( Special Resolution)
Change Memorandum and/or
Bylaws. The shareholders'
meeting will be in accordance
with Article 51 of the Articles of
Association (that is, the voting
shareholders who represent more
than half of the total number of
  • 127 -
Differences with the
Articles of Association and
provisions on matters of British Cayman Islands Act
Description
protection of shareholders' and Description
rightsandinterests
or property of others,
which has a significant
impact on the company's
operations.
2. Change charter
3. If the change of the
articles of association
will caused damage to
the special shareholders,
a special shareholder
resolution meeting is
required.
4. Distribution of one or all
dividends by way of
issuing new shares
5. Resolution of
dissolution, merger or
division


In addition, regarding 5
(merger), according to
Cayman's lawyer, Section
233(6) of the Cayman
Company Law is subject to
special resolution. If there
are other resolutions in the
company's articles of
association, it shall be
handled in accordance with
the company's articles of
association.
issued shares will be present in
person or by proxy)
(3) According to Article 24 of the
Cayman Company Law, any
change in the company's articles
of association must be subject to
a special resolution of the
shareholders' meeting approval;
therefore, paragraph 3 shall be
stipulated in Article 18 of the
Articles of Association, that is, if
the company's articles of
association are changed. The
matters of the rights of the
special shareholders shall be
subject to the Special Resolution
by the Special Shareholders'
Meeting, in addition to the
Special Resolution. The
shareholders' meeting will be in
accordance with Article 51 of the
Articles of Association (that is,
the voting shareholders who
represent more than half of the
total number of issued shares will
be present in person or by proxy)
(4) Regarding the dissolution of
paragraph 5, according to Article
116 of the Cayman Company
Law, the company shall
voluntarily dissolve by special
resolution, and if it is unsolvable,
it should be passed through
resolution of the shareholders'
meeting (the Company in general
meeting resolves...), Cayman's
lawyers believe that the
aforementioned resolution of the
shareholders' meeting can be
resolved by an Ordinary
Resolution, a Special Resolution
or a higher resolution as
stipulated in the company's
articles of association; Partially
stipulated in Article 33 of the
Articles of Association, in which
if the companyvoluntarily
  • 128 -
Differences with the
Articles of Association and
provisions on matters of British Cayman Islands Act
Description
protection of shareholders' and Description
rightsandinterests
disbands due to the inability to
pay off the debts as scheduled, it
should be approved by the
shareholders meeting with a
special resolution (ie
“Supermajority Resolution Type
A” or “Type B Special
Resolution”. (Supermajority
Resolution Type B) (as defined
above) (Article 33(a)), if the
company voluntarily disbands for
other reasons, it shall be subject
to a Special Resolution approval
(Article 33(b) article). The
shareholders' meeting will be in
accordance with Article 51 of the
Articles of Association (that is,
the voting shareholders who
represent more than half of the
total number of issued shares will
be present in person or by proxy).
(5) Regarding the merger of
paragraph 5, Cayman's lawyer
stated that the merger part is
subject to the special resolution
approval (Special Resolution) in
accordance with the provisions of
Article 233(6) of the Cayman
Company Law. If the company's
articles of association have other
resolutions, It is handled in
accordance with the provisions of
the company's articles of
association; therefore, the merger
of the fifth paragraph is stipulated
in Article 31(c) of the Articles of
Association. The shareholders'
meeting will be in accordance
with Article 51 of the Articles of
Association (that is, the voting
shareholders who represent more
than half of the total number of
issued shares will be present in
personorby proxy)
Supervisor regulations The Cayman Company Act
has no special rules for
supervisors.
As the company did not set up a
supervisor, the charter was not
amended.
  • 129 -
Differences with the
Articles of Association and
provisions on matters of British Cayman Islands Act
Description
protection of shareholders' and Description
rightsandinterests
1. Shareholders who hold
more than three percent
of the total number of
issued shares of the
company for more than
one year may request the
supervisor to file a
lawsuit against the
company through the
Taipei District Court of
Taiwan as first administer
court.
2. Within 30 days after the
shareholder made the
request, when the
supervisor did not file a
lawsuit, the shareholder
may file a lawsuit against
the company and the
Taipei District Court of
Taiwan shall be the first
administer court .

There are no special
requirements or prohibitions
in the charter of the Cayman
company.
According to Cayman law,
in the event of a shareholder
filed a lawsuit on behalf of a
company is: (A) the act is
illegal or exceeds the scope
of the company's
jurisdiction and cannot be
ratified by the shareholders;
or (B) the act constitutes a
fraud against the minority
shareholder (ie The personel
of seeking relief in the
lawsuit is the major
shareholder, and the major
shareholder will not allow
the company to let the
plaintiff seek relief in the
lawsuit. If the lawsuit is
filed on the grounds of this
paragraph, it is necessary to
prove the case of fraud and
the person engaged in the
wrongful act. The company
has authority).
Cayman's courts tend to not
interfere with the company's
internal behavior when the
conduct within the
company's jurisdiction, or
beyond the scope of
authority, which can be
ratified by shareholders and
in accordance with the will
of themajority shareholder.






There are no special requirements or
prohibitions in the charter of the
Cayman company, and the company
does not set up the supervisor, but
the audit committees are set up; refer
to the letter of the Board of Directors
on July 27, 101, Taiwan letter No.
1011702189 The independent
directors replaced the supervisors, so
the contents of items 1 and 2
regarding the supervisors were
replaced by independent board
members of the audit committee,
which was stipulated in Article 123
under the Articles of Association,
that is, courts with jurisdiction
(including Taipei, Taiwan) The
District Court, if applicable, is the
court of jurisdiction; another
Cayman lawyer stated that Article
123 under the Articles of Association
must comply with Cayman law.
According to Cayman law, if the
director believes that the lawsuit is
not of interest to the company, the
director is not liable for those
shareholders who hold more than 3%
of the shares to file a lawsuit against
other directors.
1. The directors of the
company shall manage
the business with honesty
and integrity. If there is
any violation of the
company interest, whom
should be liable for the
damage. If the act is
committed byitself or by
According to the Cayman
Company Law, directors
have fiduciary duties on the
company. If there is any
breach of such obligations,
the court shall hold the
director’s liability for
compensation; if it is a
breach of trust obligations
As per Cayman's lawyers opinion
(see the left column), the contents of
items 1., 2. and 3. are stated in
Article 97B of the Articles of
Association; However, Cayman's
lawyers stated that although the
company's articles of association
stipulate directors and companies
Joint and several liability,from the
  • 130 -
Differences with the
Articles of Association and
provisions on matters of British Cayman Islands Act
Description
protection of shareholders' and Description
rightsandinterests
others, the shareholder
reserved the rights to
decide on the proceeds of
the act as the company's
income.
2. The director of the
company acts on the
execution of the
company's operation, if
there is any violation of
the law and causes
damage to others, the
company shall be liable
for compensation.
3. The manager and
supervisor of the
company shall be
responsible for the same
liability as the directors
of the company within
the scope of their duties.
for himself or others on self
beneficial, the court shall
decide to return such
benefits.
According to Cayman law,
the director causes damage
to a third party during the
company's execution of the
business operation. The
third party may claim
damages from the company,
despite the company may
request the director for the
same liability of
compensation to the third
party under the joint and
several liability term. From
the perspective of Cayman
law, the third party is unable
to make direct claim to the
director.

Cayman legal point of view, the third
party still unable to claim directly
from the director.
  • 131 -

All Cosmos Bio-Tech Holding Corporation and Subsidiaries

Consolidated Financial Statements for the Years Ended December 31, 2018 and 2017 and Independent Auditors’ Report

  • 132 -

INDEPENDENT AUDITORS’ REPORT

The Board of Directors and Shareholders All Cosmos Bio-Tech Holding Corporation

Opinion

We have audited the accompanying consolidated financial statements of All Cosmos Bio-Tech Holding Corporation (the “Company”) and its subsidiaries (collectively referred to as the “Group”), which comprise the consolidated balance sheets as of December 31, 2018 and 2017 and the consolidated statements of comprehensive income, changes in equity and cash flows for the years then ended, and the notes to the consolidated financial statements, including a summary of significant accounting policies (collectively referred to as the “consolidated financial statements”).

In our opinion, the accompanying consolidated financial statements present fairly, in all material respects, the consolidated financial position of the Group as of December 31, 2018 and 2017, and its consolidated financial performance and its consolidated cash flows for the years then ended in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers, and International Financial Reporting Standards (IFRS), International Accounting Standards (IAS), IFRIC Interpretations (IFRIC), and SIC Interpretations (SIC) endorsed and issued into effect by the Financial Supervisory Commission of the Republic of China.

Basis for Opinion

We conducted our audits in accordance with the Regulations Governing Auditing and Attestation of Financial Statements by Certified Public Accountants and auditing standards generally accepted in the Republic of China. Our responsibilities under those standards are further described in the Auditors’ Responsibilities for the Audit of the Consolidated Financial Statements section of our report. We are independent of the Group in accordance with The Norm of Professional Ethics for Certified Public Accountant of the Republic of China, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Key Audit Matters

Key audit matters are those matters that, in our professional judgment, were of most significance in our audit of the consolidated financial statements for the year ended December 31, 2018. These matters were addressed in the context of our audit of the consolidated financial statements as a whole, and in forming our opinion thereon, and we do not provide a separate opinion on these matters.

  • 133 -

Key audit matters for the Group’s consolidated financial statements for the year ended December 31, 2018 are stated as follows:

Impairment of Trade Receivables

At the end of the reporting period, the balance of net trade receivables (including related parties) of the Group was $808,203 thousand, which amounted to 27% of the Group’s total assets. When assessing the allowance for impairment losses on trade receivables, management took into consideration past default experience of the debtor and an analysis of the debtor’s current financial position. Refer to Notes 4(m), 5(a), and 8 in the consolidated financial statements for the details on the accounting policy, accounting estimation and assumption uncertainty and relevant disclosures of the impairment of accounts receivables. Since the assessment of the expected credit loss rate on trade receivables is subject to management’s judgment, we identified such assessment as a key audit matter.

Our key audit procedures performed in respect of the above mentioned assessment included the following:

  1. We understood management’s assumptions used in assessing the expected credit loss rate and ascertaining the reasonableness of the assumptions;

  2. We sampled the documentation of the aging of trade receivables provided by management to test the accuracy;

  3. We performed our own calculation of the expected credit loss on trade receivables based on the expected credit loss rate provided by management in order to assess the reasonableness of the recognition of the allowance for impairment loss on trade receivables; and

  4. We reviewed the subsequent collections of overdue trade receivables to evaluate the adequacy of the allowance for impairment losses on trade receivables.

Responsibilities of Management and Those Charged with Governance for the Consolidated Financial Statements

Management is responsible for the preparation and fair presentation of the consolidated financial statements in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers, and IFRS, IAS, IFRIC, and SIC endorsed and issued into effect by the Financial Supervisory Commission of the Republic of China, and for such internal control as management determines is necessary to enable the preparation of consolidated financial statements that are free from material misstatement, whether due to fraud or error.

In preparing the consolidated financial statements, management is responsible for assessing the Group’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless management either intends to liquidate the Group or to cease operations, or has no realistic alternative but to do so.

Those charged with governance, including the audit committee, are responsible for overseeing the Group’s financial reporting process.

  • 134 -

Auditors’ Responsibilities for the Audit of the Consolidated Financial Statements

Our objectives are to obtain reasonable assurance about whether the consolidated financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditors’ report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with the auditing standards generally accepted in the Republic of China will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these consolidated financial statements.

As part of an audit in accordance with the auditing standards generally accepted in the Republic of China, we exercise professional judgment and maintain professional skepticism throughout the audit. We also:

  1. Identify and assess the risks of material misstatement of the consolidated financial statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error, as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

  2. Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Group’s internal control.

  3. Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by management.

  4. Conclude on the appropriateness of management’s use of the going concern basis of accounting and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Group’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditors’ report to the related disclosures in the consolidated financial statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditors’ report. However, future events or conditions may cause the Group to cease to continue as a going concern.

  5. Evaluate the overall presentation, structure and content of the consolidated financial statements, including the disclosures, and whether the consolidated financial statements represent the underlying transactions and events in a manner that achieves fair presentation.

  6. Obtain sufficient and appropriate audit evidence regarding the financial information of entities or business activities within the Group to express an opinion on the consolidated financial statements. We are responsible for the direction, supervision, and performance of the group audit. We remain solely responsible for our audit opinion.

We communicate with those charged with governance regarding, among other matters, the planned scope and timing of the audit and significant audit findings, including any significant deficiencies in internal control that we identify during our audit.

  • 135 -

We also provide those charged with governance with a statement that we have complied with relevant ethical requirements regarding independence, and to communicate with them all relationships and other matters that may reasonably be thought to bear on our independence, and where applicable, related safeguards.

From the matters communicated with those charged with governance, we determine those matters that were of most significance in the audit of the consolidated financial statements for the year ended December 31, 2018 and are therefore the key audit matters. We describe these matters in our auditors’ report unless law or regulation precludes public disclosure about the matter or when, in extremely rare circumstances, we determine that a matter should not be communicated in our report because the adverse consequences of doing so would reasonably be expected to outweigh the public interest benefits of such communication.

The engagement partners on the audit resulting in this independent auditors’ report are Chiang Hsun Chen and Cheng Chuan Yu.

Deloitte & Touche Taipei, Taiwan Republic of China March 26, 2019

Notice to Readers

The accompanying consolidated financial statements are intended only to present the consolidated financial position, financial performance and cash flows in accordance with accounting principles and practices generally accepted in the Republic of China and not those of any other jurisdictions. The standards, procedures and practices to audit such consolidated financial statements are those generally applied in the Republic of China.

For the convenience of readers, the independent auditors’ report and the accompanying consolidated financial statements have been translated into English from the original Chinese version prepared and used in the Republic of China. If there is any conflict between the English version and the original Chinese version or any difference in the interpretation of the two versions, the Chinese-language independent auditors’ report and consolidated financial statements shall prevail.

  • 136 -

  • 137 -

ALL COSMOS BIO-TECH HOLDING CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017 (In Thousands of New Taiwan Dollars, Except Earnings Per Share)

OPERATING REVENUE (Notes 3, 4, 23 and 34)
Sales

OPERATING COSTS (Notes 9 and 24)
Cost of goods sold

GROSS PROFIT

OPERATING EXPENSES (Notes 24 and 34)
Selling and marketing expenses
General and administrative expenses
Research and development expenses
Expected credit loss

Total operating expenses

PROFIT FROM OPERATIONS

NON-OPERATING INCOME AND EXPENSES
(Notes 4 and 24)
Other income
Other gains and losses
Finance costs
Share of loss of associates (Note 11)

Total non-operating income and expenses

PROFIT BEFORE INCOME TAX FROM
CONTINUING OPERATIONS
INCOME TAX EXPENSE (Notes 4 and 25)

NET PROFIT FOR THE YEAR

OTHER COMPREHENSIVE (LOSS) INCOME
(Notes 4, 22 and 25)
Items that will not be reclassified subsequently to
profit or loss:
Exchange differences on translation to the
presentation currency
2018
Amount
%
$ 2,687,581
100
(1,912,987)
(71)

774,594
29

(197,888) (8)
(187,302) (7)
(6,587)
-
(26,048)
(1)

(417,825)
(16)

356,769
13

20,976
1
39,956
2
(18,666) (1)
(20)

-

42,246

2

399,015
15
(50,328)
(2)

348,687
13

(431)
-
2017


























Amount
%
$ 2,263,652
100
(1,512,131)
(67)
751,521
33

(155,994) (7)

(184,350) (8)

(4,456)
-
-

-
(344,800)
(15)
406,721
18

14,204
1

(473)
-

(13,517) (1)
-

-
214

-

406,935
18
(10,512)
(1)
396,423
17

67,059
3
(Continued)
  • 138 -

ALL COSMOS BIO-TECH HOLDING CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017 (In Thousands of New Taiwan Dollars, Except Earnings Per Share)

Items that may be reclassified subsequently to profit
or loss:
Exchange differences on translating the financial
statements of foreign operations

Income tax relating to items that may be
reclassified subsequently to profit

Other comprehensive (loss) income for the year, net of
income tax

TOTAL COMPREHENSIVE INCOME FOR THE
YEAR

NET PROFIT ATTRIBUTABLE TO:
Owners of the Company

Non-controlling interests


TOTAL COMPREHENSIVE INCOME
ATTRIBUTABLE TO:
Owners of the Company

Non-controlling interests


EARNINGS PER SHARE (Note 26)
From continuing operations
Basic
Diluted
2018
Amount
%
$ (1,508)
-
362

-

(1,577)

-

$ 347,110
13

$ 305,058
11
43,629

2

$ 348,687
13

$ 303,393
11
43,717

2

$ 347,110
13

$ 4.76
$ 4.75
2017


















Amount
%
$ (358)
-
86

-
66,787

3
$ 463,210
20
$ 322,873
15
73,550

3
$ 396,423
18
$ 381,582
17
81,628

3
$ 463,210
20
$ 5.31
$ 5.30
$ $
$ $
$ $
$ $
$ $


The accompanying notes are an integral part of the consolidated financial statements.

(Concluded)

  • 139 -

ALL COSMOS BIO-TECH HOLDING CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017 (In Thousands of New Taiwan Dollars)

CASH FLOWS FROM OPERATING ACTIVITIES
Income before income tax

Adjustments for:
Excepted credit loss recognized on trade receivables
Impairment loss reversed on trade receivables
Depreciation expenses
Amortization expenses
Amortization of prepayments for leases
Net gain on fair value change of financial assets at fair value through
profit or loss
Finance costs
Interest income
Compensation costs of employee share options
Share of loss of associates by equity method
Gain on disposal of property, plant and equipment
Write-downs of inventories
Reversal of write-downs of inventories
Net unrealized gain on foreign currency exchange
Changes in operating assets and liabilities
Financial assets at held for trading
Trade receivables

Trade receivables from related parties
Other receivables
Inventories

Prepayments
Trade payables
Other payables
Contract liabilities
Receipts in advance
Other current liabilities

Cash (used in) generated from operations

Interest received
Interest paid
Income tax paid

Net cash (used in) generated from operating activities

CASH FLOWS FROM INVESTING ACTIVITIES
Purchase of financial assets at fair value through profit or loss
Acquisition of investments accounted for using the equity method
Net cash outflow on acquisition of subsidiaries (Note 28)
Payments for property, plant and equipment
Proceeds from property, plant and equipment
Decrease in refundable deposits
Payments for intangible assets
2018
$ 399,015

26,048
-
45,307
908
2,760
(10,020)
18,666
(12,614)
-
20
(73)
-
(189)
(263)
-
(268,462)

(14,161)
(14,123)
(372,085)
59,045
9,004
(12,354)
3,075
-

(1,250)

(141,746)
12,871
(18,587)

(70,871)

(218,333)

575
(14,788)
(2,100)
(57,391)
177
3,119
(2,133)
2017
$ 406,935
-
(3,671)
39,962
876
2,177
(7,964)
13,517
(11,970)
5,537
-
(661)
1,826
-
(9,911)
(13,265)
(144,518)
(6,549)
(4,362)
(9,642)
(78,222)
(4,634)
23,215
-
4,822

2,199
205,697
11,797
(13,815)

(27,559)

176,120
-
-
-
(24,686)
1,327
677
(202)
(Continued)

141

ALL COSMOS BIO-TECH HOLDING CORPORATION AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017 (In Thousands of New Taiwan Dollars)

Increase in other receivables from related parties

Decrease in other receivables from related parties
Increase in other financial assets
Decrease in other financial assets
Increase in prepayments for equipment
Increase in prepayments for leases

Net cash (used in) generated from investing activities

CASH FLOWS FROM FINANCING ACTIVITIES
Proceeds from short-term borrowings
Repayments of short-term borrowings
Repayments of long-term borrowings
Refund of guarantee deposits received
Increase in other payables to related parties
Decrease in other payables to related parties
Decrease in finance lease payables
Cash dividends paid

Changes in non-controlling interests
Issuance of ordinary shares for cash

Net cash (used in) generated from financing activities

EFFECTS OF EXCHANGE RATE CHANGES ON THE BALANCE
OF CASH HELD IN FOREIGN CURRENCIES

NET (DECREASE) INCREASE IN CASH AND CASH
EQUIVALENTS

CASH AND CASH EQUIVALENTS AT THE BEGINNING OF THE
YEAR

CASH AND CASH EQUIVALENTS AT THE END OF THE YEAR
2018
$ (15)

-
(3,769)
-
-

(16,924)


(93,249)

87,255
-

(23,002)
(8)
5
-
(1,117)
(169,690)

12,566

-


(93,991)


3,249

(402,324)

993,829

$ 591,505
2017
$ -
15
-
41,551
(5,299)

-

13,383
-
(208,032)
(26,413)
(14)
-
(2)
(1,644)
(121,475)
-

440,454

82,874

28,745
301,122

692,707
$ 993,829

The accompanying notes are an integral part of the consolidated financial statements.

(Concluded)

142

NOTES TO CONSOLIDATED FINANCIAL STATEMENTS FOR THE YEARS ENDED DECEMBER 31, 2018 AND 2017 (In Thousands of New Taiwan Dollars, Unless Stated Otherwise)

ALL COSMOS BIO-TECH HOLDING CORPORATION AND SUBSIDIARIES

1. GENERAL INFORMATION

All Cosmos Bio-Tech Holding Corporation (the “Company”) is a limited company incorporated in the Cayman Islands on March 26, 2010. The Company and its subsidiaries (collectively, referred to as the “Group”) have reorganized in order to list the Company’s shares on the Taiwan Stock Exchange. On June 1, 2010, the Company issued new shares for 100% equity interest in All Cosmos Industries Sdn. Bhd. and completed the Group’s investment process. The major operation activities of the Group are production and sales of Bio-organic and Bio-chemical fertilizers.

The Company’s shares have been listed on the Taiwan Stock Exchange since June 2017.

The functional currency of the Company is Malaysian Ringgit. For greater comparability and consistency of financial reporting, the consolidated financial statements of the Group are presented in New Taiwan dollars since the Company’s shares are listed on the Taiwan Stock Exchange.

2. APPROVAL OF FINANCIAL STATEMENTS

The consolidated financial statements were approved by the Company’s board of directors and authorized for issue on March 26, 2019.

3. APPLICATION OF NEW, AMENDED AND REVISED STANDARDS AND INTERPRETATIONS

  • a. Initial application of the amendments to the Regulations Governing the Preparation of Financial Reports by Securities Issuers of Republic of China and the International Financial Reporting Standards (IFRS), International Accounting Standards (IAS), Interpretations of IFRS (IFRIC), and Interpretations of IAS (SIC) (collectively, the “IFRSs”) endorsed and issued into effect by the Financial Supervisory Commission (FSC)

Except for the following, whenever applied, the initial application of the amendments to the Regulations Governing the Preparation of Financial Reports by Securities Issuers and the IFRSs endorsed and issued into effect by the FSC would not have any material impact on the Group’s accounting policies:

  • 1) IFRS 9 “Financial Instruments” and related amendments

IFRS 9 supersedes IAS 39 “Financial Instruments: Recognition and Measurement”, with consequential amendments to IFRS 7 “Financial Instruments: Disclosures” and other standards. IFRS 9 sets out the requirements for classification, measurement and impairment of financial assets and hedge accounting. Refer to Note 4 for information relating to the relevant accounting policies.

Classification, measurement and impairment of financial assets

On the basis of the facts and circumstances that existed as of January 1, 2018, the Group has performed an assessment of the classification of recognized financial assets and has elected not to restate prior reporting periods.

  • 143 -

The following table shows the original measurement categories and carrying amount under IAS 39 and the new measurement categories and carrying amount under IFRS 9 for each class of the Group’s financial assets as of January 1, 2018.

Financial Assets
Cash and cash equivalents

Mutual funds

Trade receivable (included
related parties) and other
receivables (excluded GST
refund receivables)

Other financial assets and
refundable deposits

Financial Assets

FVTPL
Financial assets at FVTPL

Amortized cost
Add: Reclassification from loans
and receivables (IAS 39)

Measurement Category
Carrying Amount
IAS 39
IFRS 9
IAS 39
IFRS 9
Remark
Loans and receivables
Amortized cost
$ 993,829 $ 993,829
Note
Held-for-trading
Mandatorily at fair value
through profit or loss
(FVTPL)
22,152
22,152
-
Loans and receivables
Amortized cost
552,429
552,429
Note
Loans and receivables
Amortized cost
134,537
134,537
Note
IAS 39
Carrying
Amount as of
January 1,
2018
Reclassifi-
cations
Remea-
surements
IFRS 9
Carrying
Amount as of
January 1,
2018
Retained
Earnings
Effect on
January 1,
2018
Other
Equity
Effect on
January 1,
2018
Remark
$ 22,152
$ -
$ -
$ 22,152
$ -
$ -

-
1,680,795

-
1,680,795

-

-
Note
$ 22,152
$ 1,680,795
$ -
$ 1,702,947
$ -
$ -

Note: Cash and cash equivalents, trade receivables (included related parties), other receivables (excluded GST refund receivable), other financial assets and refundable deposits that were previously classified as loans and receivables under IAS 39 are reclassified as at amortized cost with an assessment of expected credit losses under IFRS 9.

  • 2) IFRS 15 “Revenue from Contracts with Customers” and related amendments

IFRS 15 establishes principles for recognizing revenue that apply to all contracts with customers and supersedes IAS 18 “Revenue”, IAS 11 “Construction Contracts” and a number of revenue-related interpretations. Refer to Note 4 for related accounting policies.

Under IFRS 15, the net effect of revenue recognized and consideration received and receivable is recognized as a contract asset or a contract liability. Prior to the application of IFRS 15, receivables were recognized or deferred revenue was reduced when revenue was recognized for the relevant contract under IAS 18.

The Group elected only to retrospectively apply IFRS 15 to contracts that were not complete as of January 1, 2018 and recognize the cumulative effect of the change in retained earnings on January 1, 2018.

  • 144 -

The impact on assets, liabilities and equity as of January 1, 2018 from the initial application of IFRS 15 is set out below:


15 is set out below:
Originally Adjustments
Amount stated Arising from Restated
as of January 1, Initial Amount as of
2018 Application January 1, 2018
Contract liabilities- current $
-
$ 6,796 $ 6,796
Other current liabilities 12,049
(6,796)

5,253
Total effect on liabilities $ 12,049 $ - $ 12,049

Had the Group applied IAS 18 in the current year, the following adjustments should be made to reflect the line items and balances under IAS 18.


reflect the line items and balances under IAS 18.
December 31,
2018
Decrease in contract liability - current $ (9,867)
Increase in other current liabilities
9,867
$ -
  • b. Amendments to the Regulations Governing the Preparation of Financial Reports by Securities Issuers and IFRSs endorsed by the FSC for application starting from 2019.
New, Amended or Revised Standards and Interpretations
(the “New IFRSs”)
Annual Improvements to IFRSs 2015-2017 Cycle

Amendments to IFRS 9 “Prepayment Features with Negative
Compensation”

IFRS 16 “Leases”

Amendments to IAS 19 “Plan Amendment, Curtailment or
Settlement”

Amendments to IAS 28 “Long-term Interests in Associates and Joint
Ventures”

IFRIC 23 “Uncertainty over Income Tax Treatments”
Effective Date
Announced by IASB (Note 1)
January 1, 2019
January 1, 2019 (Note 2)
January 1, 2019
January 1, 2019 (Note 3)
January 1, 2019
January 1, 2019
  • Note 1: Unless stated otherwise, the above New IFRSs are effective for annual periods beginning on or after their respective effective dates.

  • Note 2: The FSC permits the election for early adoption of the amendments starting from 2018.

  • Note 3: The Group shall apply these amendments to plan amendments, curtailments or settlements occurring on or after January 1, 2019.

  • IFRS 16 “Leases”

IFRS 16 sets out the accounting standards for leases that will supersede IAS 17 “Leases”, IFRIC 4 “Determining Whether an Arrangement Contains a Leases” and a number of related interpretations.

  • 145 -

Definition of a lease

Upon initial application of IFRS 16, the Group will elect to apply the guidance of IFRS 16 in determining a lease only to contracts after January 1, 2019. Contracts identified as containing a lease under IAS 17 and IFRIC 4 will not be reassessed and will be accounted for in accordance with the transitional provisions under IFRS 16.

The Group as lessee

Upon initial application of IFRS 16, the Group will recognize right-of-use assets and lease liabilities for all leases on the consolidated balance sheets except for those whose payments under low-value asset and short-term leases will be recognized as expenses on a straight-line basis. On the consolidated statements of comprehensive income, the Group will present the depreciation expense charged on right-of-use assets separately from the interest expense accrued on lease liabilities; interest is computed using the effective interest method. On the consolidated statements of cash flows, cash payments for the principal portion of lease liabilities will be classified within financing activities; cash payments for the interest portion will be classified within operating activities. Currently, payments under operating lease contracts are recognized as expenses on a straight-line basis. Prepaid lease payments for land use rights of land located in Malaysia and Indonesia are recognized as prepayments for leases. The difference between the actual payments and the expenses, as adjusted for lease incentives, is recognized as prepayments for leases. Cash flows for operating leases are classified within operating activities on the consolidated statements of cash flows. Leased assets and finance lease payables are recognized for contracts classified as finance leases.

The Group anticipates applying IFRS 16 retrospectively with the cumulative effect of the initial application of this standard recognized on January 1, 2019. Comparative information will not be restated.

Lease liabilities will be recognized on January 1, 2019 for leases currently classified as operating leases with the application of IAS 17. Lease liabilities will be measured at the present value of the remaining lease payments, discounted using the lessee’s incremental borrowing rate on January 1, 2019. Right-of-use assets will be measured at amount equal to the lease liabilities. The Group will apply IAS 36 to all right-of-use assets.

The Group expects to apply the following practical expedients:

  • a) The Group will apply a single discount rate to a portfolio of leases with reasonably similar characteristics to measure lease liabilities.

  • b) The Group will account for those leases for which the lease term ends on or before December 31, 2019 as short-term leases.

  • c) The Group will exclude initial direct costs from the measurement of right-of-use assets on January 1, 2019.

  • d) The Group will use hindsight, such as in determining lease terms, to measure lease liabilities.

For leases currently classified as finance leases under IAS 17, the carrying amounts of right-of-use assets and lease liabilities on January 1, 2019 will be determined as at the carrying amounts of the respective leased assets and finance lease payables as of December 31, 2018.

  • 146 -

Anticipated impact on assets, liabilities and equity

Carrying Carrying Adjustments Adjustments Adjusted Adjusted
Amount as of Arising from Carrying
December 31, Initial Amount as of
2018 Application January 1, 2019
Right-of-use assets $ -
$ 179,883 $ 179,883
Prepayments for leases - current 4,103 (4,103) -
Prepayments for leases - non-current 171,888
(171,888) -
Lease assets 2,751
(2,751) -
Total effect on assets $ 178,742
$
1,141
$ 179,883
Lease liabilities - current $ -
$
1,584
$ 1,584
Finance lease payables - current 964 (964) -
Lease liabilities - non-current - 1,088 1,088
Finance lease payables - non-current 567
(567) -
Total effect on liabilities $ 1,531
$
1,141
$ 2,672

Except for the above impacts, as of the date the consolidated financial statements were authorized for issue, the Group continues assessing other possible impacts that the application of the aforementioned amendments and the related amendments to the Regulations Governing the Preparation of Financial Reports by Securities Issuers will have on the Group’s financial position and financial performance and will disclose these other impacts when the assessment is completed.

c. New IFRSs in issue but not yet endorsed and issued into effect by the FSC

New IFRSs
Amendments to IFRS 3 “Definition of a Business”

Amendments to IFRS 10 and IAS 28 “Sale or Contribution of Assets
between An Investor and Its Associate or Joint Venture”

IFRS 17 “Insurance Contracts”

Amendments to IAS 1 and IAS 8 “Definition of Material”
Effective Date
Announced by IASB (Note 1)
January 1, 2020 (Note 2)
To be determined by IASB
January 1, 2021
January 1, 2020 (Note 3)
  • Note 1: Unless stated otherwise, the above New IFRSs are effective for annual periods beginning on or after their respective effective dates.

  • Note 2: The Group shall apply these amendments to business combinations for which the acquisition date is on or after the beginning of the first annual reporting period beginning on or after January 1, 2020 and to asset acquisitions that occur on or after the beginning of that period.

  • Note 3: The Group shall apply these amendments prospectively for annual reporting periods beginning on or after January 1, 2020.

As of the date the consolidated financial statements were authorized for issue, the Group is continuously assessing the possible impact that the application of other standards and interpretations will have on the Group’s financial position and financial performance, and will disclose the relevant impact when the assessment is completed.

  • 147 -

4. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

For the convenience of readers, the accompanying consolidated financial statements have been translated into English from the original Chinese version prepared and used in the Republic of China. If there is any conflict between the English version and the original Chinese version or any difference in the interpretation of the two versions, the Chinese-language consolidated financial statements shall prevail.

  • a. Statement of compliance

The consolidated financial statements have been prepared in accordance with the Regulations Governing the Preparation of Financial Reports by Securities Issuers of Republic of China, and the IFRSs as endorsed and issued into effect by the FSC.

  • b. Basis of preparation

The consolidated financial statements have been prepared on the historical cost basis except for financial instruments which are measured at fair value.

The fair value measurements, which are grouped into Levels 1 to 3 based on the degree to which the fair value measurement inputs are observable and based on the significance of the inputs to the fair value measurement in its entirety, are described as follows:

  • 1) Level 1 inputs are quoted prices (unadjusted) in active markets for identical assets or liabilities;

  • 2) Level 2 inputs are inputs other than quoted prices included within Level 1 that are observable for an asset or liability, either directly (i.e. as prices) or indirectly (i.e. derived from prices); and

  • 3) Level 3 inputs are unobservable inputs for an asset or liability.

  • c. Classification of current and non-current assets and liabilities

Current assets include:

  • 1) Assets held primarily for the purpose of trading;

  • 2) Assets expected to be realized within 12 months after the reporting period; and

  • 3) Cash and cash equivalents unless the asset is restricted from being exchanged or used to settle a liability for at least 12 months after the reporting period.

Current liabilities include:

  • 1) Liabilities held primarily for the purpose of trading;

  • 2) Liabilities due to be settled within 12 months after the reporting period, even if an agreement to refinance, or to reschedule payments, on a long-term basis is completed after the reporting period and before the consolidated financial statements are authorized for issue; and

  • 3) Liabilities for which the Group does not have an unconditional right to defer settlement for at least 12 months after the reporting period. Terms of a liability that could, at the option of the counterparty, result in its settlement by the issue of equity instruments do not affect its classification.

Assets and liabilities that are not classified as current are classified as non-current.

  • 148 -

d. Basis of consolidation

The consolidated financial statements incorporate the financial statements of the Company and the entities controlled by the Company (i.e. its subsidiaries).

Income and expenses of subsidiaries acquired or disposed of during the period are included in the consolidated statement of profit or loss and other comprehensive income from the effective dates of acquisitions up to the effective dates of disposals, as appropriate.

When necessary, adjustments are made to the financial statements of subsidiaries to bring their accounting policies into line with those used by the Group.

All intra-group transactions, balances, income and expenses are eliminated in full upon consolidation. Total comprehensive income of subsidiaries is attributed to the owners of the Company and to the non-controlling interests even if this results in the non-controlling interests having a deficit balance.

Refer to Note 10 and Table 6 for detailed information on subsidiaries (including percentages of ownership and main businesses).

e. Business combinations

Acquisitions of businesses are accounted for using the acquisition method. Acquisition-related costs are generally recognized in profit or loss as they are incurred.

Goodwill is measured as the excess of the sum of the consideration transferred and the fair value of the acquirer’s previously held equity interests in the acquiree over the net of the acquisition-date amounts of the identifiable assets acquired and the liabilities assumed.

Where the consideration the Group transfers in a business combination includes assets or liabilities resulting from a contingent consideration arrangement, the contingent consideration is measured at its acquisition-date fair value and considered as part of the consideration transferred in a business combination. Changes in the fair value of the contingent consideration that qualify as measurement period adjustments are adjusted retrospectively, with the corresponding adjustments being made against goodwill or gains on bargain purchases. Measurement period adjustments are adjustments that arise from additional information obtained during the measurement period about facts and circumstances that existed as of the acquisition date. The measurement period does not exceed 1 year from the acquisition date.

f. Foreign currencies

In preparing the financial statements of each individual group entity, transactions in currencies other than the entity’s functional currency (i.e. foreign currencies) are recognized at the rates of exchange prevailing at the dates of the transactions.

At the end of each reporting period, monetary items denominated in foreign currencies are retranslated at the rates prevailing at that date. Exchange differences on monetary items arising from settlement or translation are recognized in profit or loss in the period in which they arise.

For the purpose of presenting consolidated financial statements, the functional currencies of the Company and the group entities (including subsidiaries in other countries that use currencies which are different from the currency of the Company) are translated into the New Taiwan dollars, as follows: Assets and liabilities are translated at the exchange rates prevailing at the end of the reporting period; and income and expense items are translated at the average exchange rates for the period. The resulting currency translation differences are recognized in other comprehensive income attributed to the owners of the Company and non-controlling interests as appropriate.

  • 149 -

g. Inventories

Inventories consist of raw materials, merchandise, finished goods and work in progress and are stated at the lower of cost or net realizable value. Inventory write-downs are made by item, except where it may be appropriate to group similar or related items. The net realizable value is the estimated selling price of inventories less all estimated costs of completion and costs necessary to make the sale. Inventories are recorded at the standard cost, then adjusted to weighted-average cost on the balance sheet date.

h. Investments in associates

An associate is an entity over which the Group has significant influence and which is neither a subsidiary nor an interest in a joint venture.

The Group uses the equity method to account for its investments in associates.

Under the equity method, investments in an associate are initially recognized at cost and adjusted thereafter to recognize the Group’s share of the profit or loss and other comprehensive income of the associate.

When the Group’s share of losses of an associate equals or exceeds its interest in that associate (which includes any carrying amount of the investment accounted for using the equity method and long-term interests that, in substance, form part of the Group’s net investment in the associate), the Group discontinues recognizing its share of further losses. Additional losses and liabilities are recognized only to the extent that the Group has incurred legal obligations, or constructive obligations, or made payments on behalf of that associate.

The entire carrying amount of an investment (including goodwill) is tested for impairment as a single asset by comparing its recoverable amount with its carrying amount. Any impairment loss recognized is not allocated to any asset, including goodwill, that forms part of the carrying amount of the investment. Any reversal of that impairment loss is recognized to the extent that the recoverable amount of the investment subsequently increases.

i. Property, plant and equipment

Property, plant and equipment are measured at cost, less accumulated depreciation and accumulated impairment loss.

Property, plant and equipment in the course of construction are measured at cost less any recognized impairment loss. Cost includes professional fees and borrowing costs eligible for capitalization. Such assets are depreciated and classified to the appropriate categories of property, plant and equipment when completed and ready for intended use.

Depreciation of property, plant and equipment is recognized using the straight-line method. Each significant part is depreciated separately. If the lease term is shorter than the assets’ useful lives, such assets are depreciated over the lease term. The estimated useful lives, residual values and depreciation method are reviewed at the end of each reporting period, with the effect of any changes in estimate accounted for on a prospective basis.

On derecognition of an item of property, plant and equipment, the difference between the sales proceeds and the carrying amount of the asset is recognized in profit or loss.

j. Goodwill

Goodwill arising from the acquisition of a business is measured at cost as established at the date of acquisition of the business less accumulated impairment loss.

  • 150 -

For the purposes of impairment testing, goodwill is allocated to each of the Group’s cash-generating units or groups of cash-generating units (referred to as “cash-generating units”) that is expected to benefit from the synergies of the combination.

A cash-generating unit to which goodwill has been allocated is tested for impairment annually or more frequently when there is an indication that the unit may be impaired, by comparing its carrying amount, including the attributed goodwill, with its recoverable amount. However, if the goodwill allocated to a cash-generating unit was acquired in a business combination during the current annual period, that unit shall be tested for impairment before the end of the current annual period. If the recoverable amount of the cash-generating unit is less than its carrying amount, the impairment loss is allocated first to reduce the carrying amount of any goodwill allocated to the unit and then pro rata to the other assets of the unit based on the carrying amount of each asset in the unit. Any impairment loss is recognized directly in profit or loss. Any impairment loss recognized on goodwill is not reversed in subsequent periods.

  • k. Intangible assets

  • 1) Intangible assets acquired separately

Intangible assets with finite useful lives that are acquired separately are initially measured at cost and subsequently measured at cost less accumulated amortization and accumulated impairment loss. Amortization is recognized on a straight-line basis. The estimated useful life, residual value, and amortization method are reviewed at the end of each reporting period, with the effect of any changes in estimate accounted for on a prospective basis. Intangible assets with indefinite useful lives that are acquired separately are measured at cost less accumulated impairment loss.

  • 2) Derecognition of intangible assets

On derecognition of an intangible asset, the difference between the net disposal proceeds and the carrying amount of the asset is recognized in profit or loss.

  • l. Impairment of tangible and intangible assets other than goodwill

At the end of each reporting period, the Group reviews the carrying amounts of its tangible and intangible assets, excluding goodwill, to determine whether there is any indication that those assets have suffered any impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss. When it is not possible to estimate the recoverable amount of an individual asset, the Group estimates the recoverable amount of the cash-generating unit to which the asset belongs.

Intangible assets with indefinite useful lives and intangible assets not yet available for use are tested for impairment at least annually and whenever there is an indication that the assets may be impaired.

The recoverable amount is the higher of fair value less costs to sell and value in use. If the recoverable amount of an asset or cash-generating unit is estimated to be less than its carrying amount, the carrying amount of the asset or cash-generating unit is reduced to its recoverable amount, with the resulting impairment loss recognized in profit or loss.

When an impairment loss is subsequently reversed, the carrying amount of the corresponding asset or cash-generating unit is increased to the revised estimate of its recoverable amount, but only to the extent of the carrying amount that would have been determined had no impairment loss been recognized for the asset or cash-generating unit in prior years. A reversal of an impairment loss is recognized in profit or loss.

  • 151 -

m. Financial instruments

Financial assets and financial liabilities are recognized when a group entity becomes a party to the contractual provisions of the instruments.

Financial assets and financial liabilities are initially measured at fair value. Transaction costs that are directly attributable to the acquisition or issuance of financial assets and financial liabilities (other than financial assets and financial liabilities at FVTPL) are added to or deducted from the fair value of the financial assets or financial liabilities, as appropriate, on initial recognition. Transaction costs directly attributable to the acquisition of financial assets or financial liabilities at FVTPL are recognized immediately in profit or loss.

1) Financial assets

All regular way purchases or sales of financial assets are recognized and derecognized on a trade date basis.

  • a) Measurement categories

2018

Financial assets are classified into the following categories: Financial assets at FVTPL and financial assets at amortized cost.

  • i. Financial assets at FVTPL

Financial assets are classified as at FVTPL when such a financial asset is mandatorily classified as at FVTPL. Financial assets mandatorily classified as at FVTPL include investments in equity instruments which are not designated as at FVTOCI and debt instruments that do not meet the amortized cost criteria or the FVTOCI criteria.

Financial assets at FVTPL are subsequently measured at fair value, with any gains or losses arising on remeasurement recognized in profit or loss. The net gain or loss recognized in profit or loss does not incorporate any dividends or interest earned on such a financial asset. Fair value is determined in the manner described in Note 33.

  • ii. Financial assets at amortized cost

Financial assets that meet the following conditions are subsequently measured at amortized cost:

  • i) The financial asset is held within a business model whose objective is to hold financial assets in order to collect contractual cash flows; and

  • ii) The contractual terms of the financial asset give rise on specified dates to cash flows that are solely payments of principal and interest on the principal amount outstanding.

Subsequent to initial recognition, financial assets at amortized cost, including cash and cash equivalents, trade receivables at amortized cost and other financial assets, are measured at amortized cost, which equals the gross carrying amount determined using the effective interest method less any impairment loss. Exchange differences are recognized in profit or loss.

  • 152 -

Interest income is calculated by applying the effective interest rate to the gross carrying amount of such a financial asset, except for:

  • i) Purchased or originated credit impaired financial assets, for which interest income is calculated by applying the credit-adjusted effective interest rate to the amortized cost of such financial assets; and

  • ii) Financial assets that are not credit impaired on purchase or origination but have subsequently become credit impaired, for which interest income is calculated by applying the effective interest rate to the amortized cost of such financial assets in subsequent reporting periods.

Cash equivalents include time deposits with original maturities within 3 months from the date of acquisition, which are highly liquid, readily convertible to a known amount of cash and are subject to an insignificant risk of changes in value. These cash equivalents are held for the purpose of meeting short-term cash commitments.

2017

Financial assets are classified into the following categories: Financial assets at FVTPL and loans and receivables.

  • i. Financial assets at FVTPL

Financial assets are classified as at FVTPL when such financial assets are held for trading as at FVTPL.

Financial assets at FVTPL are stated at fair value, with any gains or losses arising on remeasurement recognized in profit or loss. The net gain or loss recognized in profit or loss incorporates any dividends or interest earned on such a financial asset. Fair value is determined in the manner described in Note 33.

  • ii. Loans and receivables

Loans and receivables (including trade receivables, cash and cash equivalents and other financial assets) are measured at amortized cost using the effective interest method less any impairment, except for short-term receivables when the effect of discounting is immaterial.

Cash equivalents include time deposits with original maturities within 3 months from the date of acquisition, which are highly liquid, readily convertible to a known amount of cash and are subject to an insignificant risk of changes in value. These cash equivalents are held for the purpose of meeting short-term cash commitments.

  • b) Impairment of financial assets

2018

The Group recognizes a loss allowance for expected credit losses on financial assets at amortized cost (including trade receivables).

The Group always recognizes lifetime expected credit losses (ECLs) for trade receivables. For all other financial instruments, the Group recognizes lifetime ECLs when there has been a significant increase in credit risk since initial recognition. If, on the other hand, the credit risk on a financial instrument has not increased significantly since initial recognition, the Group measures the loss allowance for that financial instrument at an amount equal to 12-month ECLs.

  • 153 -

Expected credit losses reflect the weighted average of credit losses with the respective risks of default occurring as the weights. Lifetime ECLs represent the expected credit losses that will result from all possible default events over the expected life of a financial instrument. In contrast, 12-month ECLs represent the portion of lifetime ECLs that is expected to result from default events on a financial instrument that are possible within 12 months after the reporting date.

The Group recognizes an impairment gain or loss in profit or loss for all financial instruments with a corresponding adjustment to their carrying amount through a loss allowance account, except for investments in debt instruments that are measured at FVTOCI, for which the loss allowance is recognized in other comprehensive income and does not reduce the carrying amount of such a financial asset.

2017

Financial assets, other than those at FVTPL, are assessed for indicators of impairment at the end of each reporting period. Financial assets are considered to be impaired when there is objective evidence, as a result of one or more events that occurred after the initial recognition of the financial assets, that the estimated future cash flows of the investment have been affected.

For financial assets measured at amortized cost, such as trade receivables are assessed for impairment on a collective basis even if they were assessed not to be impaired individually. Objective evidence of impairment for a portfolio of receivables could include the Group’s past experience of collecting payments, an increase of delayed payments in the portfolio past the average credit period, as well as observable changes in national or local economic conditions that correlate with defaults on receivables, and other situations.

For financial assets measured at amortized cost, the amount of the impairment loss recognized is the difference between the asset’s carrying amount and the present value of estimated future cash flows, discounted at the financial asset’s original effective interest rate.

For financial assets measured at amortized cost, if, in a subsequent period, the amount of the impairment loss decreases and the decrease can be related objectively to an event occurring after the impairment was recognized, the previously recognized impairment loss is reversed through profit or loss to the extent that the carrying amount or the allowance account of the investment (at the date the impairment is reversed) does not exceed what the amortized cost would have been had the impairment not been recognized.

For all other financial assets, objective evidence of impairment could include significant financial difficulty of the issuer or counterparty, breach of contract such as a default or delinquency in interest or principal payments, it becoming probable that the borrower will enter bankruptcy or financial re-organization, or the disappearance of an active market for that financial asset because of financial difficulties.

The carrying amount of a financial asset is reduced by the impairment loss directly for all financial assets, with the exception of trade receivables, where the carrying amount is reduced through the use of an allowance account. When trade receivables are considered uncollectible, they are written off against the allowance account. Subsequent recoveries of amounts previously written off are credited against the allowance account. Changes in the carrying amount of the allowance account are recognized in profit or loss except for uncollectible trade receivables that are written off against the allowance account.

  • 154 -

  • c) Derecognition of financial assets

The Group derecognizes a financial asset only when the contractual rights to the cash flows from the asset expire or when it transfers the financial asset and substantially all the risks and rewards of ownership of the asset to another party.

Before 2018, on derecognition of a financial asset in its entirety, the difference between the asset’s carrying amount and the sum of the consideration received and receivable and the cumulative gain or loss which had been recognized in other comprehensive income is recognized in profit or loss. Starting from 2018, on derecognition of a financial asset at amortized cost in its entirety, the difference between the asset’s carrying amount and the sum of the consideration received and receivable is recognized in profit or loss.

  • 2) Financial liabilities

  • a) Subsequent measurement

All financial liabilities are measured at amortized cost using the effective interest method.

  • b) Derecognition of financial liabilities

The difference between the carrying amount of a financial liability derecognized and the consideration paid, including any non-cash assets transferred or liabilities assumed, is recognized in profit or loss.

  • 3) Derivative financial instruments

The Group enters into a variety of derivative financial instruments to manage its exposure to foreign exchange rate risks, including foreign exchange forward contracts.

Derivatives are initially recognized at fair value at the date on which the derivative contracts are entered into and are subsequently remeasured to their fair value at the end of each reporting period. The resulting gain or loss is recognized in profit or loss immediately unless the derivative is designated and effective as a hedging instrument, in which event, the timing of the recognition in profit or loss depends on the nature of the hedging relationship. When the fair value of a derivative financial instrument is positive, the derivative is recognized as a financial asset; when the fair value of a derivative financial instrument is negative, the derivative is recognized as a financial liability.

  • n. Revenue recognition

2018

The Group identifies contracts with customers, allocates the transaction price to the performance obligations and recognizes revenue when performance obligations are satisfied.

Revenue from the sale of goods

Revenue from the sale of goods comes from sales of Bio-organic and Bio-chemical fertilizers. Sales of fertilizers are recognized as revenue when the goods are delivered and shipped to the customer’s specific location because it is the time when the customer has full discretion over the manner of distribution and price to sell the goods, has the primary responsibility bears the risks of obsolescence. Trade receivables are recognized currently. The transaction price received is recognized as a contract liability until the good have been delivered to the customer.

  • 155 -

2017

Revenue is measured at the fair value of the consideration received or receivable. Revenue is reduced for estimated customer returns, rebates and other similar allowances.

  • 1) Sale of goods

Revenue from the sale of goods is recognized when all the following conditions are satisfied:

  • a) The Group has transferred to the buyer the significant risks and rewards of ownership of the goods;

  • b) The Group retains neither continuing managerial involvement to the degree usually associated with ownership nor effective control over the goods sold;

  • c) The amount of revenue can be measured reliably;

  • d) It is probable that the economic benefits associated with the transaction will flow to the Group; and

  • e) The costs incurred or to be incurred in respect of the transaction can be measured reliably.

2) Interest income

Interest income from a financial asset is recognized when it is probable that the economic benefits will flow to the Group and the amount of income can be measured reliably. Interest income is accrued on a time basis by reference to the principal outstanding and at the applicable effective interest rate.

  • o. Leasing

Leases are classified as finance leases whenever the terms of a lease transfer substantially all the risks and rewards of ownership to the lessee. All other leases are classified as operating leases.

  • 1) The Group as lessor

Rental income from operating leases is recognized on a straight-line basis over the term of the relevant lease.

  • 2) The Group as lessee

Assets held under finance leases are initially recognized as assets of the Group at their fair value at the inception of the lease or, if lower, at the present value of the minimum lease payments. The corresponding liability to the lessor is included in the consolidated balance sheets as a finance lease obligation.

Finance expenses implicit in lease payments for each period are recognized immediately in profit or loss, unless they are directly attributable to qualifying assets; in which case, they are capitalized.

Operating lease payments are recognized as expenses on a straight-line basis over the lease term.

  • 156 -

p. Borrowing costs

Borrowing costs directly attributable to an acquisition, construction or production of qualifying assets are added to the cost of those assets, until such time as the assets are substantially ready for their intended use or sale.

Investment income earned on the temporary investment of specific borrowings pending their expenditure on qualifying assets is deducted from the borrowing costs eligible for capitalization.

Other than that which is stated above, all other borrowing costs are recognized in profit or loss in the period in which they are incurred.

  • q. Government grants

Government grants are not recognized until there is reasonable assurance that the Group will comply with the conditions attached to them and that the grants will be received.

Government grants that are receivable as compensation for expenses or losses already incurred or for the purpose of giving immediate financial support to the Group with no future related costs are recognized in profit or loss in the period in which they become receivable.

  • r. Employee benefits

  • 1) Short-term employee benefits

Liabilities recognized in respect of short-term employee benefits are measured at the undiscounted amount of the benefits expected to be paid in exchange for the related services.

2) Retirement benefits

Payments to defined contribution retirement benefit plans are recognized as expenses when employees have rendered services entitling them to the contributions.

  • s. Share-based payment arrangements - employee share options

Equity-settled share-based payment arrangements granted to employee

The fair value at the grant date of the employee share options is expensed on a straight-line basis over the vesting period, based on the Group’s best estimates of the number of shares or options that are expected to ultimately vest, with a corresponding increase in capital surplus - employee share options. It is recognized as an expense in full at the grant date if vested immediately.

At the end of each reporting period, the Group revises its estimate of the number of employee share options expected to vest. The impact of the revision of the original estimates is recognized in profit or loss such that the cumulative expenses reflect the revised estimate, with a corresponding adjustment to capital surplus - employee share options.

  • t. Taxation

Income tax expense represents the sum of the tax currently payable and deferred tax.

  • 1) Current tax

Adjustments of prior years’ tax liabilities are added to or deducted from the current year’s tax provision.

  • 157 -

  • 2) Deferred tax

Deferred tax is recognized on temporary differences between the carrying amounts of assets and liabilities and the corresponding tax bases used in the computation of taxable profit.

Deferred tax liabilities are generally recognized for all taxable temporary differences. Deferred tax assets are generally recognized for all deductible temporary differences and unused loss carryforwards to the extent that it is probable that taxable profits will be available against which those deductible temporary differences can be utilized.

Deferred tax liabilities are recognized for taxable temporary differences associated with investments in subsidiaries and associates, except where the Group is able to control the reversal of the temporary difference and it is probable that the temporary difference will not reverse in the foreseeable future. Deferred tax assets arising from deductible temporary differences associated with such investments and interests are only recognized to the extent that it is probable that there will be sufficient taxable profits against which to utilize the benefits of the temporary differences and they are expected to reverse in the foreseeable future.

The carrying amount of deferred tax assets is reviewed at the end of each reporting period and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the assets to be recovered. A previously unrecognized deferred tax asset is also reviewed at the end of each reporting period and recognized to the extent that it has become probable that future taxable profit will allow the deferred tax asset to be recovered.

Deferred tax liabilities and assets are measured at the tax rates that are expected to apply in the period in which the liabilities are settled or the assets are realized, based on tax rates (and tax laws) that have been enacted or substantively enacted by the end of the reporting period. The measurement of deferred tax liabilities and assets reflects the tax consequences that would follow from the manner in which the Group expects, at the end of the reporting period, to recover or settle the carrying amount of its assets and liabilities.

  • 3) Current and deferred taxes for the year

Current and deferred taxes are recognized in profit or loss, except when they relate to items that are recognized in other comprehensive income or directly in equity, in which case, the current and deferred taxes are also recognized in other comprehensive income or directly in equity.

5. CRITICAL ACCOUNTING JUDGMENTS AND KEY SOURCES OF ESTIMATION UNCERTAINTY

In the application of the Group’s accounting policies, management is required to make judgments, estimations and assumptions about the carrying amounts of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognized in the period in which the estimates are revised if the revisions affect only that period or in the period of the revisions and future periods if the revisions affect both current and future periods.

  • 158 -

  • a. Estimated impairment of financial assets - 2018

The provision for impairment of trade receivables is based on assumptions about risk of default and expected loss rates. The Group uses judgment in making these assumptions and in selecting the inputs to the impairment calculation, based on the Group’s historical experience. For details of the key assumptions and inputs used, see Note 8. Where the actual future cash inflows are less than expected, a material impairment loss may arise.

  • b. Estimated impairment of trade receivables - 2017

When there is objective evidence of impairment loss, the Group takes into consideration the estimation of the future cash flows of the assets. The amount of impairment loss is measured as the difference between an asset’s carrying amount and the present value of its estimated future cash flows (excluding future credit losses that have not been incurred) discounted at the financial asset’s original effective interest rate. Where the actual future cash flows are less than expected, a material impairment loss may arise.

6. CASH AND CASH EQUIVALENTS

CASH AND CASH EQUIVALENTS
Cash on hand

Checking accounts and demand deposits
Cash equivalent
Time deposits (with original maturities less than 3 months)

**December 31 **


2018
$ 288

574,381

16,836

$ 591,505
2017
$ 406
933,012

60,411
$ 993,829

The market rate intervals of cash in bank at the end of the reporting period were as follows:

Time deposits (with original maturities less than 3 months)
FINANCIAL INSTRUMENTS AT FVTPL
Financial assets at FVTPL-current
Financial assets held for trading
Non-derivative financial assets
Mutual funds
Financial assets mandatorily classified as at FVTPL
Derivative financial assets (not under hedge accounting)
Foreign exchange forward contracts
Non-derivative financial assets
Mutual funds
**December 31 ** **December 31 **
2018
2017
3.20%
3.00%-4.10%
December 31
2018
$ -
1,137

30,454
$ 31,591
2017
$ 22,152
-

-
$ 22,152

7. FINANCIAL INSTRUMENTS AT FVTPL

  • 159 -

At the end of the reporting period, outstanding foreign exchange forward contracts not under hedge accounting were as follows:

Notional Amount
Currency Maturity Date
(In Thousands)
December 31, 2018
Buy USD/MYR January 15, 2019 USD100/MYR424
USD/MYR January 15, 2019 USD60/MYR255
USD/MYR January 18, 2019 USD200/MYR848
USD/MYR January 18, 2019 USD200/MYR848
USD/MYR January 18, 2019 USD200/MYR848
USD/MYR January 18, 2019 USD100/MYR424
USD/MYR February 15, 2019 USD100/MYR424
USD/MYR February 19, 2019 USD80/MYR340
USD/MYR February 22, 2019 USD200/MYR848
USD/MYR February 22, 2019 USD200/MYR848
USD/MYR February 22, 2019 USD200/MYR848
USD/MYR February 22, 2019 USD200/MYR848
USD/MYR February 22, 2019 USD200/MYR848
USD/MYR February 22, 2019 USD100/MYR424
USD/MYR March 22, 2019
USD200/MYR848

The Group entered into foreign exchange forward contracts to manage exposures to exchange rate fluctuations of foreign currency denominated assets and liabilities.

8. NOTES RECEIVABLE, TRADE RECEIVABLES AND OTHER RECEIVABLES

Trade receivables
At amortized cost
Gross carrying amount

Less: Allowance for impairment loss


Other receivables
GST refund receivables

Interest receivable
Others

**December 31 ** **December 31 **





2018
$ 835,048


(47,088)

$ 787,960

$ 17,293

1,149

1,864

$ 20,306
2017
$ 564,294

(21,826)
$ 542,468
$ 3,382
1,406

1,749
$ 6,537
  • 160 -

a. Trade receivables

In 2018

The average credit period of sales of goods was 60 to 90 days. No interest was charged on trade receivables. The Group adopted a policy of only dealing with entities that are rated the equivalent of investment grade or higher and obtaining sufficient collateral, where appropriate, as a means of mitigating the risk of financial loss from defaults. The Group uses other publicly available financial information or its own trading records to rate its major customers.

The Group applies the simplified approach to providing for expected credit losses prescribed by IFRS 9, which permits the use of lifetime expected loss provision for all trade receivables. The expected credit losses on trade receivables are estimated using a provision matrix by reference to past default experience of the debtor and an analysis of the debtor’s current financial position, adjusted for general economic conditions of the industry in which the debtors operate and an assessment of both the current as well as the forecast direction of economic conditions at the reporting date. As the Group’s historical credit loss experience does not show significantly different loss patterns for different customer segments, the provision for loss allowance based on past due status is not further distinguished according to the Group’s different customer base.

The Group writes off a trade receivable when there is information indicating that the debtor is in severe financial difficulty and there is no realistic prospect of recovery. For trade receivables that have been written off, the Group continues to engage in enforcement activity to attempt to recover the receivables due. Where recoveries are made, these are recognized in profit or loss.

The following table details the loss allowance of trade receivables based on the Group’s provision matrix.

December 31, 2018

Not Past Due
Less than 90
Days
91 to 180
Days
Expected credit loss rate
1.12%
2.62%
7.52%

Gross carrying amount
$ 291,165 $ 258,463 $ 199,112
Loss allowance (Lifetime
ECL)

(3,271)

(6,769)

(14,971)


Amortized cost
$ 287,894
$ 251,694
$ 184,141

The movements of the loss allowance of trade receivables were as
Balance at January 1, 2018 per IAS 39
Adjustment on initial application of IFRS 9
Balance at January 1, 2018 per IFRS 9
Add: Net remeasurement of loss allowance
Foreign exchange gains and losses
Balance at December 31, 2018
181 to 365
Days
21.81%
$ 82,145

(17,914)

$ 64,231

follows:
Over 365
Days
100%
$ 4,163

(4,163)
$ -




Total
-
$ 835,048

(47,088)
$ 787,960
2018
$ 21,826

-
21,826
25,440

(178)
$ 47,088
  • 161 -

In 2017

The Group applied the same credit policy in 2018 and 2017. The Group recognized an allowance for impairment loss of 100% against all receivables over 365 days because historical experience was that receivables that are past due beyond 365 days are not recoverable. Allowance for impairment loss was recognized against trade receivables between 90 days and 365 days based on the estimated irrecoverable amounts determined by reference to past default experience of the counterparties and an analysis of their current financial position.

For some trade receivables balances that were past due at the end of the reporting period, the Group did not recognize an allowance for impairment loss because there was no significant change in credit quality and the amounts were still considered recoverable.

The aging of receivables was as follows:

The aging of receivables was as follows:
December 31,
2017
Up to 90 days $ 392,895
91-180 days
149,836
181-365 days
16,641
Over 365 days
4,922

$ 564,294

The above aging schedule was based on the number of past due days from the invoice date.

The aging of receivables that were past due but not impaired was as follows:

The aging of receivables that were past due but not impaired was as follows:
December 31,
2017
Up to 90 days
$ 53,290
91-180 days
2,780
181-365 days
250
Over 365 days

231


$ 56,551

The above aging schedule was based on the number of past due days from the end of the credit term.

The movements of the allowance for doubtful trade receivables were as follows:

Balance at January 1, 2017
Less: Impairment losses reversed
Foreign exchange translation gains and losses
Balance at December 31, 2017
Total
$ 25,062
(3,671)

435
$ 21,826
  • 162 -

b. Other receivables

In 2018

Other receivables primarily included interest receivables, GST refund receivables and others. The Group continuously monitors past default experience of the counterparties and analyzes their current financial position. Based on the information above, the Group then assesses the expected credit loss and considers whether credit risk has been a significant increase since the last period to the reporting date. As of December 31, 2018, the Group estimated the expected credit loss rate of other receivables to be 0%.

In 2017

Other receivables primarily included interest receivables. Historical experience revealed no previously stated receivables were unrecoverable. The Group also considered past default experience of the counterparties and had analyzed their current financial position. No allowance for impairment loss was recognized.

9. INVENTORIES

INVENTORIES
Merchandise

Finished goods
Work in progress
Raw materials
Inventory in transit

**December 31 **


2018
$ 12,964

56,740
24,921
517,828

-

$ 612,453
2017
$ 4,519
78,781
12,650
150,668

1,519
$ 248,137

The cost of inventories recognized as cost of goods sold for the years ended December 31, 2018 and 2017 was $1,912,987 thousand and $1,512,131 thousand, respectively. The cost of goods sold included reversals of inventory write-downs of $(189) thousand and inventory write-downs of $1,826 thousand.

10. SUBSIDIARIES

  • a. Subsidiaries included in the consolidated financial statements
Investor
Investee
Nature of Activities
The Company
All Cosmos Industries Sdn. Bhd.
(ACI)
Manufacturing and sales of Bio-organic
and Bio-chemical compound
fertilizers
Sabah Softwoods Hybrid
Fertiliser Sdn. Bhd.
Manufacturing and sales of Bio-organic
and Bio-chemical compound
fertilizers
PT All Cosmos Indonesia
Sales of Bio-organic and Bio-chemical
compound fertilizers
The Company
PT All Cosmos Biotek
Manufacturing and sales of Bio-organic
and Bio-chemical compound
fertilizers
Proportion of
Ownership (%)
December 31
2018
2017
Remark
100
100
55
55
99
99
60
-
Note 4
(Continued)
  • 163 -
Investor
Investee
Nature of Activities
ACI
PT All Cosmos Indonesia
Sales of Bio-organic and Bio-chemical
compound fertilizers
Arif Efektif Sdn. Bhd.
Research and development of effective
microorganisms for Bio-organic and
Bio-chemical compound fertilizers
Kinabalu Life Sciences Sdn. Bhd. Research and development of effective
microorganisms for waste disposal of
oil-palm
Cosmos Biowood Sdn. Bhd.
Forest plantation and research
GK Bio International Sdn. Bhd.
Wholesale of probiotics
Proportion of
Ownership (%)
December 31
2018
2017
Remark
1
1
49
49
Note 1
60
60
Note 2
80
-
Note 3
100
-
Note 5
(Concluded)
  • Note 1: The Group and its substantive related party separately hold 49% and 26% interest in Arif Efektif Sdn. Bhd. Their combined holding exceeded 50% of the total shares outstanding. Hence, the Group has substantive control over Arif Efektif Sdn. Bhd. and has included it as part of the consolidated entity.

  • Note 2: The Company and Sawit Kinabalu Sdn. Bhd. entered into a joint venture agreement and established Kinabalu Life Sciences Sdn. Bhd. on December 8, 2017. As of December 31, 2018, there was no capital injection from the Company.

  • Note 3: ACI resolved to acquire 75% equity interest of Cosmos Biowood Sdn. Bhd., and make a capital injection in the subsidiary. After the capital injection, ACI’s proportion of ownership in Cosmos Biowood Sdn. Bhd. from 75% to 80%. Refer to Notes 28 and 29 for the relevant disclosures.

  • Note 4: The Company and YPJ Plantation Sdn. Bhd. entered into a joint venture agreement and established PT All Cosmos Biotek on July 19, 2018. The Company and YPJ Plantation Sdn. Bhd. invested IDR8,400,000 thousand and IDR5,600,000 thousand, respectively.

  • Note 5: It was established on October 11, 2018.

  • b. Details of subsidiaries that have material non-controlling interests

Name of Subsidiary

Sabah Softwoods Hybrid Fertiliser Sdn. Bhd.

Proportion of Ownership and
Voting Rights Held by
Non-controlling Interests
**December 31 **
2018
2017
45%
45%

Refer to Table 6 for the information on principal places of business and countries of incorporation.

Name of Subsidiary
Sabah Softwoods Hybrid
Fertiliser Sdn. Bhd.
Profit Allocated to
Non-controlling Interests

For the Year Ended
December 31
2018
2017
$ 42,444
$ 71,673
Accumulated Non-controlling
Interests
Accumulated Non-controlling
Interests
Accumulated Non-controlling
Interests
December 31
2018
$ 42,444
2018
$ 342,848
2017
$ 299,547
  • 164 -

Summarized financial information of the subsidiary that has material non-controlling interests is set out below. The summarized financial information below represents amounts before intragroup eliminations.

Sabah Softwoods Hybrid Fertiliser Sdn. Bhd.

Current assets

Non-current assets
Current liabilities
Non-current liabilities

Equity

Equity attributable to:
The Company

Non-controlling interests of Sabah Softwoods Hybrid Fertiliser
Sdn. Bhd.




Revenue

Profit for the year

Other comprehensive income for the year

Total comprehensive income for the year

Profit attributable to:
The Company

Non-controlling interests of Sabah Softwoods Hybrid Fertiliser
Sdn. Bhd.


Total comprehensive income attributable to:
The Company

Non-controlling interests of Sabah Softwoods Hybrid Fertiliser
Sdn. Bhd.


Net cash inflow from:
Operating activities

Investing activities
Financing activities
Effect of foreign currency exchange

Net cash (outflow) inflow
**December 31 ** **December 31 **
2018
$ 577,130

304,682
(80,665)

(39,262)

$ 761,885

$ 419,037


342,848

$ 761,885

**For the Year Ended **
2017
$ 494,878
287,600
(62,100)

(54,717)
$ 665,661
$ 366,114

299,547
$ 665,661
**December 31 **













2018

$ 787,860

$ 94,320


-

$ 94,320

$ 51,876


42,444

$ 94,320

$ 51,876


42,444

$ 94,320

$ 7,378

(29,662)
8,437

1,186

$ (12,661)
2017
$ 854,114
$ 159,274

-
$ 159,274
$ 87,601

71,673
$ 159,274
$ 87,601

71,673
$ 159,274
$ 137,183
(5,038)
(69,679)

6,338
$ 68,804
  • 165 -

11. INVESTMENTS ACCOUNTED FOR USING THE EQUITY METHOD

Investments in Associates

Investments in Associates
December 31,
2018
Associates that are not individually material
Sawit Ecoshield Sdn. Bhd.
$
14,768
For the Year
Ended
December 31,
2018
The Group’s share of:
Loss from continuing operations
$

(20)

Refer to Table 6 “Information on Investees” for the nature of activities, principal places of business and countries of incorporation of the associates.

Investments were accounted for using the equity method and the share of profit or loss and other comprehensive income of those investments were calculated based on financial statements which have not been audited. Management believes there is no material impact on the equity method accounting or the calculation of the share of profit or loss from the financial statements of Sawit Ecoshield Sdn. Bhd. which has not been audited.

12. PROPERTY, PLANT AND EQUIPMENT

Cost
Balance at January 1, 2017
Additions
Reclassified
Disposals
Effect of foreign currency
exchange differences

Balance at December 31,
2017

Accumulated depreciation
and impairment
Balance at January 1, 2017
Depreciation expenses
Disposals
Effect of foreign currency
exchange differences

Balance at December 31,
2017

Carrying amounts at
December 31, 2017

Cost
Balance at January 1, 2018
Additions
Disposals
Reclassified
Effect of foreign currency
exchange differences

Balance at December 31,
2018
Building
$ 328,585

567
-
-

7,611

$ 336,763

$ 38,270

6,250
-

1,129

$ 45,649

$ 291,114

$ 336,763

184
-
4,471

834

$ 342,252
Machinery
and
Equipment

$ 309,162

19,954
-

(3,028 )

7,805

$ 333,893

$ 160,055

26,201

(2,548 )

4,624

$ 188,332

$ 145,561

$ 333,893

16,005
(1,332 )
1,368

1,292

$ 351,226
Transportation
Equipment

$ 5,349

5,108
1,502

(1,093 )

338

$ 11,204

$ 3,875

2,381

(911 )

147

$ 5,492

$ 5,712

$ 11,204

2,282

(673 )
4,019

(10)

$ 16,822
Furniture,
Fixture and
Equipment

$ 3,310

635
-

-

101

$ 4,046

$ 1,752

498

-

60

$ 2,310

$ 1,736

$ 4,046

845

-
-

8

$ 4,899
Lease Assets
Leasehold
Improvements
$ 14,156
$ 531

-
-
(1,502 )
-
(2,019 )
-

188

12

$ 10,823
$ 543

$ 7,051
$ 265

1,124
22
(2,019 )
-

127

6

$ 6,283
$ 293

$ 4,540
$ 250

$ 10,823
$ 543

708
-
-
-
-
-

42

2

$ 11,573
$ 545
Other
Equipment

$ 36,565

4,782
-
(9 )

1,033

$ 42,371

$ 17,400

3,486
(5 )

539

$ 21,420

$ 20,951

$ 42,371

24,735
(99 )
-

(79)

$ 66,928
Property
under
Construction
Total
$ -
$ 697,658
5,867
36,913
-
-

-
(6,149 )

230

17,318
$ 6,097
$ 745,740
$ -
$ 228,668
-
39,962

-
(5,483 )

-

6,632
$ -
$ 269,779
$ 6,097
$ 475,961
$ 6,097
$ 745,740
5,337
50,296

-
(2,104 )
(9,858 )
-

73

2,162
$ 1,849
$ 796,094
(Continued)
  • 166 -
Accumulated depreciation
and impairment
Balance at January 1, 2018
Depreciation expenses
Disposals
Effect of foreign currency
exchange differences

Balance at December 31,
2018

Carrying amounts at
December 31, 2018
Building
$ 45,649

6,599
-

128

$ 52,376

$ 289,876
Machinery
and
Equipment

$ 188,332

29,321
(1,261 )

525

$ 216,917

$ 134,309
Transportation
Equipment

$ 5,492

1,391

(653 )

17

$ 6,247

$ 10,575
Furniture,
Fixture and
Equipment

$ 2,310

472

-

5

$ 2,787

$ 2,112
Lease Assets
Leasehold
Improvements
$ 6,283
$ 293

2,539
23
-
-

-

1

$ 8,822
$ 317

$ 2,751
$ 228
Other
Equipment

$ 21,420

4,962
(86 )

41

$ 26,337

$ 40,591
Property
under
Construction
Total
$ -
$ 269,779
-
45,307

-
(2,000 )

-

717
$ -
$ 313,803
$ 1,849
$ 482,291
(Concluded)

The above items of property, plant and equipment are depreciated on a straight-line basis over the estimated useful lives as follows:

Building Main Buildings 50-52 years Others 50 years Machinery and equipment 5-10 years Transportation equipment 5 years Furniture, fixture and equipment 10 years Lease assets 5-10 years Leasehold improvements 25 years Other Equipment 5-10 years

Property, plant and equipment pledged as collateral for bank borrowings is set out in Note 35.

13. GOODWILL

GOODWILL


Cost

Balance at January 1
Additional amounts recognized from business combinations
occurring during the year (Note 28)
Effect of foreign currency exchange differences
Balance at December 31
Accumulated impairment losses
Balance at January 1
Effect of foreign currency exchange differences
Balance at December 31
Carrying amounts at December 31
For the Year Ended December 31








2018
$ 385

5,383

(101)

$ 5,667

$ -


-

$ -

$ 5,667
2017
$ 376
-

9
$ 385
$ -

-
$ -
$ 385

The Group recognized goodwill on the acquisition of Arif Efektif Sdn. Bhd. and Cosmos Biowood Sdn. Bhd. The amount represents the cost of investment in excess of the equity in the fair value of assets and liabilities assumed.

  • 167 -

14. OTHER INTANGIBLE ASSETS

OTHER INTANGIBLE ASSETS
Computer
Software
Cost
Balance at January 1, 2017 $ 5,611
Additions 202
Effect of foreign currency exchange differences 137
Balance at December 31, 2017 $ 5,950
Accumulated amortization
Balance at January 1, 2017 $ 3,270
Amortization expenses 876
Effect of foreign currency exchange differences 110
Balance at December 31, 2017 $ 4,256
Carrying amounts at December 31, 2017 $ 1,694
Cost
Balance at January 1, 2018 $ 5,950
Additions 2,133
Effect of foreign currency exchange differences 3
Balance at December 31, 2018 $ 8,086
Accumulated amortization
Balance at January 1, 2018 $ 4,256
Amortization expenses 908
Effect of foreign currency exchange differences 9
Balance at December 31, 2018 $ 5,173
Carrying amounts at December 31, 2018 $ 2,913
Computer software is amortized over 5 years on a straight-line basis.
Computer software is amortized over 5 years on a straight-line basis.

An analysis of amortization by function
General and administrative expenses
**For the Year Ended December 31 **
2018
$ 908
2017
$ 876
  • 168 -

15. PREPAYMENTS FOR LEASES

PREPAYMENTS FOR LEASES
Current

Non-current

**December 31 **


2018
$ 4,103


171,888

$ 175,991
2017
$ 2,263

120,769
$ 123,032

Prepayments for leases include land use rights which are located in Malaysia and Indonesia. The Group has obtained the certificates of land use rights.

Refer to Note 35 for the carrying amounts of the land use rights pledged by the Group to secure bank borrowings.

16. OTHER FINANCIAL ASSETS

OTHER FINANCIAL ASSETS
Current
Bank deposit - original maturity of more than 3 months

Non-current
Restricted bank deposit

Market rate intervals
**December 31 **
2018
2017
$ 921
$ 889
$ 125,025
$ 120,796
2.95%-3.35%
2.55%-3.15%

The Group's exposure and the external credit ratings are continuously monitored. The Group reviews changes in bond yields and other public information and makes an assessment whether there has been a significant increase in credit risk since the last period to the reporting date. The Group assesses that there is no expected credit losses on other financial assets.

Refer to Note 35 for the carrying amounts of other financial assets pledged by the Group to secure bank borrowings.

17. OTHER ASSETS

OTHER ASSETS
Current
Prepayments
Prepaid insurance expense

Prepayments for purchase
Office supplies
Input tax
**December 31 **
2018
2017
$ 537
$ 1,714
19,034
75,983
17,451
9,598
1,654
3,262
(Continued)
  • 169 -
Prepayments for equipment

Others


Non-current
Refundable deposits
**December 31 ** **December 31 **



2018
$ 1,966


20,564

$ 61,206

$ 9,823
2017
$ 5,507

23,672
$ 119,736
$ 12,852
(Concluded)

18. BORROWINGS

a. Short-term borrowings

Secured borrowings (Note 35)
Bank loans
**December 31 ** **December 31 **
2018
$ 146,785
2017
$ 60,204

The range of interest rates on bank loans was 4.37%-4.72% and 3.85%-4.41% per annum as of December 31, 2018 and 2017, respectively.

  • b. Long-term borrowings
Secured borrowings (Note 35)
Bank loans
Less: Current portion
Long-term borrowings
**December ** **31 **
2018
$ 45,212
(23,995)
$ 21,217
2017
$ 67,670
(22,701)
$ 44,969
  • 170 -

The details of the long-term borrowings are as follows:

Effective
Rate
Variable rate
AmIslamic Bank medium-term bank loan with a
total amount of MYR5,000 thousand, from
May 2, 2014 to May 1, 2021, repayable in
monthly installments of principal and interest
4.95%

AmIslamic Bank medium-term bank loan with a
total amount of MYR3,580 thousand, from
March 31, 2013 to May 1, 2020, repayable in
monthly installments of principal and interest
4.95%
AmIslamic Bank medium-term bank loan with a
total amount of MYR5,000 thousand, from
March 31, 2013 to December 1, 2020, repayable
in monthly installments of principal and interest
4.95%
AmIslamic Bank medium-term bank loan with a
total amount of MYR6,500 thousand, from
March 31, 2013 to December 1, 2020, repayable
in monthly installments of principal and interest
5.70%

**December 31 ** **December 31 **


2018
$ 10,790

5,533
12,436

16,453

$ 45,212
2017
$ 17,483
9,687
17,469

23,031
$ 67,670

19. FINANCE LEASE PAYABLES

FINANCE LEASE PAYABLES
Minimum lease payments
Not later than 1 year
Later than 1 year and not later than 5 years
Less: Future finance charges
Present value of minimum lease payments
Present value of minimum lease payments
Not later than 1 year
Later than 1 year and not later than 5 years
**December ** **31 **






2018
$ 1,023


589

1,612

(81)

$ 1,531

$ 964


567

$ 1,531
2017
$ 834

1,112
1,946

(99)
$ 1,847
$ 768

1,079
$ 1,847

The Group leased vehicles under financial leases. The average lease terms for the years ended December 31, 2018 and 2017 were both 3 to 5 years. Interest rates underlying all obligations under financial leases fixed on contract dates were 2.40%-4.00% and 2.40% per annum at December 31, 2018 and 2017, respectively.

Refer to Note 35 for the details of the collaterals of the above obligations.

  • 171 -

20. OTHER LIABILITIES

Current
Other payables
Payable for salaries and bonuses (including compensation to
employees and remuneration to directors)

Payable for land use right
Payable for pension fees
Payable for professional service fees
Payable for utilities
Payable for purchase of equipment
Payable for taxes
Payable for royalties
Payable for marketing expenses
Payable for repairs and maintenance
Payable for freight
Payable for welfare
Others


Other liabilities
Receipts in advance

Deferred revenue - arising from government grants (Note)
Others


Non-current
Guarantee deposits received
**December 31 ** **December 31 **






2018
$ 42,399

38,353
3,067
2,373
1,864
671
873
2,240
22,185
2,383
5,333
5,663

19,654

$ 147,058

$ -

4,034

6

$ 4,040

$ 22
2017
$ 51,357
-
2,957
2,233
3,428
8,474
251
4,361
12,478
2,203
13,662
5,588

16,125
$ 123,117
$ 6,796
5,252

1
$ 12,049
$ 30

Note: The Group applied for a research and development grant sponsored by the Malaysia government. The grant spans over a two-year period and divided into two payments, $2,715 thousand and $3,556 thousand in 2014 and 2016, respectively. The associated income was recognized proportionally according to the progress of the research and development project.

21. RETIREMENT BENEFIT PLANS

The subsidiaries are required to contribute a specified percentage of payroll costs to the retirement benefit scheme to fund the benefits in accordance with local regulation. Except for the abovementioned, the Group does not have any other retirement or pension plans for employees.

  • 172 -

22. EQUITY

  • a. Share capital

Ordinary shares

Ordinary shares
Number of shares authorized (in thousands)

Shares authorized

Number of shares issued and fully paid (in thousands)

Shares issued
December 31



2018
600,000

$ 6,000,000

64,034

$ 640,340
2017
600,000
$ 6,000,000
64,034
$ 640,340

Fully paid ordinary shares, which have a par value of $10, carry one vote per share and carry a right to dividends.

On December 20, 2016, for the purpose of initial public offering, the Company’s board of directors resolved to issue 7,534 thousand ordinary shares, with a par value of $10. The issuance raised the total amount of $440,454 thousand for 64,034 thousand new shares; the subscription base day was June 6, 2017. As of April 21, 2017, the above issuance was approved by the FSC by approval letter No. 10617012821.

  • b. Capital surplus
May be used to offset a deficit, distributed as cash dividends, or
transferred to share capital (1)
Issuance of ordinary shares

May be used to offset deficit only
Employee share options (2)
May not be used for any purpose
Others

**December 31 ** **December 31 **


2018
$ 775,964

5,537

337

$ 781,838
2017
$ 775,964
5,537

337
$ 781,838
  • 1) Such capital surplus may be used to offset a deficit; In addition, when the Company has no deficit, such capital surplus may be distributed as cash dividends or transferred to share capital (limited to a certain percentage of the Company’s capital surplus and to once a year).

  • 2) The cost of employees’ compensation recognized for the year ended December 31, 2017 was $5,537 thousand, including $2,675 thousand reclassified to capital surplus - issuance of ordinary shares due to exercise of employee share options.

  • 173 -

  • c. Retained earnings and dividend policy

In accordance with the Articles of Incorporation of Company, where the Company made profit in a fiscal year, the profit shall be first utilized for paying taxes, offsetting losses of previous years, setting aside as legal reserve 10% of the remaining profit, setting aside or reversing a special reserve in accordance with the laws and regulations, and then any remaining profit together with any undistributed retained earnings shall be used by the Company’s board of directors as the basis for proposing a distribution plan, which should be resolved in the shareholders’ meeting for distribution of dividends and bonus to shareholders. For the employees’ compensation and remuneration of directors paid and the amounts recognized, refer to employees’ compensation and remuneration of directors in Note 24 (f).

According to the Articles of Incorporation of Company, dividend can be paid by stock or cash. Cash dividends should be no less than 50% of the total dividends distributed.

Appropriation of earnings to the legal reserve shall be made until the legal reserve equals the Company’s paid-in capital. The legal reserve may be used to offset deficits. If the Company has no deficit and the legal reserve has exceeded 25% of the Company’s paid-in capital, the excess may be transferred to capital or distributed in cash.

The appropriations of earnings for 2017 and 2016 approved in the shareholders’ meetings on June 12, 2018 and May 12, 2017, respectively, were as follows:

Legal reserve

Special reserve
Cash dividends
Appropriation of Earnings

For the Year Ended
December 31
2017
2016
$ 32,287
$ 24,322

(58,709)
88,506
169,690
121,475
Dividends Per Share ($)
For the Year Ended
**December 31 **
2017
2016
$ - $ -
-
-
2.65
2.15

The appropriations of earnings for 2018 had been proposed by the Company’s board of directors on March 26, 2019. The appropriations and dividends per share were as follows:

Appropriation Appropriation Dividends Per Dividends Per
of Earnings Share ($)
Legal reserve $
30,506
$
-
Special reserve 1,665 -
Cash dividends 153,682 2.40

The appropriations of earnings for 2018 are subject to the resolution by the shareholders in their meeting to be held on June 19, 2019.

d. Special reserve

Special reserve

Balance at January 1

Appropriation in respect of
Debit to other equity items
Reversal of the debit to other equity items

Balance at December 31
**For the Year Ended ** **December 31 **


2018
$ 369,143

-

(58,709)

$ 310,434
2017
$ 280,637
88,506

-
$ 369,143
  • 174 -

According to the Articles of Incorporation of Company, special reserve should be appropriated for the amount equal to the difference between net debit balance reserve of other equity items and the balance of special reserve appropriated on the reporting date. Any special reserve appropriated may be reversed to the extent that the net debit balance reverses and thereafter, distributed.

  • e. Other equity items

Exchange differences on translating the financial statements of foreign operations


Balance at January 1

Exchange differences on translating the financial statements of
foreign operations
Related income tax
Exchange differences on translating to the presentation currency
Balance at December 31
For the Year Ended For the Year Ended December 31


2018
$ (310,434)

(1,508)
362

(519)

$ (312,099)
2017
$ (369,143)
(358)
86

58,981
$ (310,434)

f. Non-controlling interests


Balance at January 1

Share in profit for the year
Other comprehensive income during the year
Exchange differences on translating the financial statements of
foreign operations
Non-controlling interests arising from issuance of ordinary
shares
Acquisition of non-controlling interests in subsidiaries
(Note 28)
Changes in percentage of ownership interests in subsidiaries
(Note 29)

Balance at December 31
**For the Year Ended ** **For the Year Ended ** **December 31 **


2018
$ 306,371

43,629
88
12,566
754

269

$ 363,677
2017
$ 224,743
73,550
8,078
-
-

-
$ 306,371
23. REVENUE

Revenue from sale of goods

a. Contact balances
Trade receivables (included related parties)
Contract liabilities - current (Note 34)
**For the Year Ended December 31 ** **For the Year Ended December 31 **
2018
2017
$ 2,687,581
$ 2,263,652
December 31,
2018
$ 808,203
$ 9,867
  • 175 -

The amount of contract liabilities recognized as revenue on January 1, 2018 was $6,796 thousand.

  • b. Disaggregation of revenue

Refer to Note 38 for details of disaggregation of revenue.

24. NET PROFIT FROM CONTINUING OPERATIONS

  • a. Other income

Rental income
Interest income
Others
**For the Year Ended December 31 ** **For the Year Ended December 31 ** **For the Year Ended December 31 **


2018
$ 32

12,614

8,330

$ 20,976
2017
$ 33
11,970

2,201
$ 14,204
  • b. Other gains and losses

Gain on disposal of property, plant and equipment
Net foreign exchange gains (losses)
Gain on disposal of financial assets
Financial assets held for trading
Financial assets mandatorily classified as at FVTPL
Others
**For the Year Ended December 31 ** **For the Year Ended December 31 ** **For the Year Ended December 31 **


2018
$ 73

30,076
-
10,020

(213)

$ 39,956
2017
$ 661
(8,371)
7,964
-

(727)
$ (473)
  • c. Finance costs

Interest on bank loans
Interest on obligations under finance leases
**For the Year Ended December 31 ** **For the Year Ended December 31 ** **For the Year Ended December 31 **


2018
$ 18,587


79

$ 18,666
2017
$ 13,407

110
$ 13,517
  • 176 -

d. Depreciation and amortization


Property, plant and equipment
Intangible assets
An analysis of depreciation by function
Operating costs
Operating expenses
An analysis of amortization by function
Operating expenses
**For the Year Ended December 31 ** **For the Year Ended December 31 ** **For the Year Ended December 31 **
2018
$ 45,307

908
$ 46,215
$ 33,556

11,751
$ 45,307
$ 908
2017
$ 39,962

876
$ 40,838
$ 30,761

9,201
$ 39,962
$ 876
  • e. Employee benefits expense

Post-employment benefits
Defined contribution plans

Other employee benefits
Share-based payments

Total employee benefits expense

An analysis of employee benefits expense by function
Operating costs

Operating expenses

**For the Year Ended ** **For the Year Ended ** **December 31 **





2018
$ 9,868

184,854

-

$ 194,722

$ 63,562


131,160

$ 194,722
2017
$ 8,476
164,690

5,537
$ 178,703
$ 51,245

127,458
$ 178,703

f. Employees’ compensation and remuneration of directors

According to the Articles of Incorporation of the Company, the Company accrued employees’ compensation and remuneration of directors at rates of no less than 1% and no higher than 10%, respectively, of net profit before income tax, employees’ compensation, and remuneration of directors. The employees’ compensation and the remuneration of directors for the years ended December 31, 2018 and 2017, which were approved by the Company’s board of directors on March 26, 2019 and March 16, 2018, respectively, are as follows:

Accrual rate


Employees’ compensation
Remuneration of directors
**For the Year Ended December 31 **
2018
2017
3%
5%
2%
3%
  • 177 -

Amount

Amount
Employees’ compensation

Remuneration of directors
**For the Year Ended December 31 **
2018
Cash
Shares
$ 9,628
$ -

6,419
-
2017
Cash
Shares
$ 17,547
$ -
10,528
-

If there is a change in the amounts after the annual consolidated financial statements are authorized for issue, the differences are recorded as a change in the accounting estimate.

There is no difference between the actual amounts of employees’ compensation and remuneration of directors paid and the amounts recognized in the consolidated financial statements for the years ended December 31, 2017 and 2016.

Information on the employees’ compensation and remuneration of directors resolved by the Company’s board of directors in 2019 and 2018 is available at the Market Observation Post System website of the Taiwan Stock Exchange.

  • g. Gains and losses on foreign currency exchange

Foreign exchange gains
Foreign exchange losses
**For the Year Ended December 31 ** **For the Year Ended December 31 ** **For the Year Ended December 31 **


2018
$ 50,900

(20,824)

$ 30,076
2017
$ 57,298
(65,669)
$ (8,371)

25. INCOME TAXES RELATING TO CONTINUING OPERATIONS

  • a. Major components of income tax expense recognized in profit or loss

Current tax
In respect of the current year
Adjustments for prior years
Deferred tax
In respect of the current year
Income tax expense recognized in profit or loss
**For the Year Ended December 31 ** **For the Year Ended December 31 ** **For the Year Ended December 31 **


2018
$ 72,919

629
(23,220)

$ 50,328
2017
$ 19,859
(1,577)

(7,770)
$ 10,512
  • 178 -

A reconciliation of accounting profit and income tax expenses is as follows:


Profit before tax from continuing operations

Income tax expense calculated at the statutory rate (24%)

Nondeductible expenses in determining taxable income
Tax-exempt income
Utilisation of unrecognized loss carryforwards
Utilisation of unrecognized temporary differences
Unrecognized investment credit
Adjustments for prior years’ income tax
Effect of different tax rate of group entities operating in other
jurisdictions
Other

Income tax expense recognized in profit or loss
**For the Year Ended ** **For the Year Ended ** **December 31 **



2018
$ 399,015

$ 95,764

2,062
(38,233)

439
-
(12,667)
629
2,334

-

$ 50,328
2017
$ 406,935
$ 97,664
4,518
(100,758)
186
(5,094)
(2,891)
(1,577)
18,407

57
$ 10,512

The applicable income tax rate used by the Group in Malaysia was both 24% in 2018 and 2017. Tax rates used by other entities operating in other jurisdictions are based on the tax laws in each jurisdiction.

  • b. Income tax recognized in other comprehensive income

Deferred tax
In respect of the current period
Exchange differences arising on translating of the financial
statements of foreign operations
**For the Year Ended December 31 ** **For the Year Ended December 31 ** **For the Year Ended December 31 **
2018
$ (362)
2017
$ (86)

c. Current tax assets and liabilities

Current tax assets and liabilities
Current tax assets
Tax refund receivables
Current tax liabilities
Income tax payable
**December ** **31 **
2018
$ 3,628
$ 9,876
2017
$ -
$ 4,107
  • 179 -

d. Deferred tax assets and liabilities

The movements of deferred tax assets and deferred tax liabilities were as follows:

For the year ended December 31, 2018

Opening
Balance
Recognized in
Profit or Loss
Recognized in
Other
Comprehensiv
e Income
Exchange
Differences
Deferred tax assets
Temporary differences
Exchange differences on
translating the financial
statements of foreign
operations
$ 228
$ -
$ 362
$ (3)

Unrealized exchange loss
4
104
-
(1)
Allowance for ECL
7,251
6,273
-
(35)

Allowance for impairment
loss on inventory
1,671
175
-
5
Investments tax credits

3,082

9,537

-

(89)

$ 12,236
$ 16,089
$ 362
$ (123)

Deferred tax liabilities
Temporary differences
Depreciation of property,
plant and equipment
$ 31,836
$ (6,300)
$ -
$ 206

Unrealized exchange gains
1,186
(799)
-
14
Capitalized expense

32

(32)

-

-

$ 33,054
$ (7,131)
$ -
$ 220

For the year ended December 31, 2017
Opening
Balance
Recognized in
Profit or Loss
Recognized in
Other
Comprehensiv
e Income
Exchange
Differences
Deferred tax assets
Temporary differences
Exchange differences on
translating the financial
statements of foreign
operations
$ 136
$ -
$ 86
$ 6

Unrealized exchange loss
806
(790)
-
(12)
Allowance for bad debts
-
6,977
-
274
Allowance for impairment
loss on inventory
-
1,608
-
63
Investments tax credits

-

2,966

-

116

$ 942
$ 10,761
$ 86
$ 447

Deferred tax liabilities
Temporary differences
Depreciation of property,
plant and equipment
$ 29,246
$ 1,842
$ -
$ 748

Unrealized exchange gains
-
1,145
-
41
Capitalized expense

27

4

-

1

$ 29,273
$ 2,991
$ -
$ 790
Closing
Balance
$ 587
107
13,489
1,851
12,530

$ 28,564

$ 25,742
401

-
$ 26,143

Closing
Balance
$ 228
4
7,251
1,671

3,082

Deferred tax assets
Temporary differences
Exchange differences on
translating the financial
statements of foreign
operations

Unrealized exchange loss
Allowance for bad debts
Allowance for impairment
loss on inventory
Investments tax credits


Deferred tax liabilities
Temporary differences
Depreciation of property,
plant and equipment

Unrealized exchange gains
Capitalized expense


$ 12,236

$ 31,836
1,186

32
$ 33,054
  • 180 -

  • e. Deductible temporary differences and unused loss carryforwards for which no deferred tax assets have been recognized in the consolidated balance sheets

Deductible temporary differences
Allowance for impairment loss on inventory
Loss carryforwards
December 31

2018
$ 6,656

$ 5,144
2017
$ 3,783
$ 2,577
  • f. ACI is making research and development investment which, under the regulation of Income Tax Exemption No. 17, is qualified for tax exemption. With the approval of the Minister of Finance of Malaysia, it acquired 100% tax exemption for a period of 10 years, from March 27, 2008 to March 26, 2018. Within 10 years after the end of tax exemption period, the preferential income tax rate of 20% is still applicable to ACI.

  • g. Sabah Softwoods Hybrid Fertiliser Sdn. Bhd. had been making investments on production equipment which satisfied the tax credit regulation. With the approval of the Malaysian Investment Development Authority, 60% of the investment on capital expenditure during the period from May 2012 to May 2017 could be counted as tax credit.

  • h. Income tax assessments

As of December 31, 2018, the Group did not have any claim or litigation regarding tax assessment.

26. EARNINGS PER SHARE

EARNINGS PER SHARE

Basic earnings per share
Diluted earnings per share
For the Year Ended December 31
2018
$ 4.76
$ 4.75
2017
$ 5.31
$ 5.30

The earnings and weighted average number of ordinary shares outstanding used in the computation of earnings per share calculation were as follows:

Net Profit for the Year

Net Profit for the Year

Profit for the period attributable to owners of the Company
For the Year Ended December 31
2018
$ 305,058
2017
$ 322,873

Weighted Average Number of Ordinary Shares Outstanding (In Thousand Shares)


Weighted average number of ordinary shares used in computation of
basic earnings per share
Effect of potentially dilutive ordinary shares
Employees’ compensation
Weighted average number of ordinary shares used in the
computation of diluted earnings per share
For the Year Ended December 31 For the Year Ended December 31 For the Year Ended December 31

2018
64,034

207


64,241
2017
60,793

159

60,952
  • 181 -

If the Group can offer to settle compensation or bonuses paid to employees in cash or shares, the Group should assume the entire amount of the compensation or bonuses will be settled in shares, and the resulting potential shares were included in the weighted average number of shares outstanding used in the computation of diluted earnings per share, as the effect is dilutive. Such dilutive effect of the potential shares is included in the computation of diluted earnings per share until the number of shares to be distributed to employees is resolved in the following year.

27. SHARE-BASED PAYMENT ARRANGEMENTS

Issuance of Ordinary Shares under the Employee Share Option Plan of the Company

In accordance with the Company Act, qualified employees of the Company were granted 1,130 options when the Group resolved to issue ordinary shares on June 6, 2017. Each option entitles the holder to subscribe for one thousand ordinary shares of the Company. All options have vested at the grant date.

Information on employee share options was as follows:

Balance at January 1
Options granted
Options exercised
Options expired
Balance at December 31
Options exercisable, end of year
Weighted-average fair value of options granted ($)
For the Year Ended
December 31, 2017
Number of
Options (In
Thousands)
Weighted-
average
Exercise Price
($)
-
$ -
1,130
59.85
(546)
59.85

(584)
59.85

-
-

-
-
$ 4.9
-

Options granted in May 2017 were priced using the Black-Scholes pricing model and the inputs to the model were as follows:


model were as follows:
Issuance of
Ordinary
Shares under
the Share
Option Plan in
May 2017
Grant-date share price
$59.85
Exercise price $55
Expected volatility 18.07%
Expected life 1 day
Expected dividend yield -
Risk-free interest rate 0.40%

Compensation cost recognized was $5,537 thousand for the year ended December 31, 2017.

  • 182 -

28. BUSINESS COMBINATIONS

In order to develop the sugar business and obtain the right of use for forest plantation, the Group acquired a 75% equity interest in Cosmos Biowood Sdn. Bhd. on May 28, 2018 for $2,261 thousand (MYR 300 thousand).

a. Assets acquired and liabilities assumed at the date of acquisition

Assets acquired and liabilities assumed at the date of acquisition
Cosmos
Biowood Sdn.
Bhd.
Current assets
Cash and cash equivalents $
161
Other current assets 1
Current liabilities
Other payables (2,530)
$ (2,368)
Goodwill recognized on acquisitions
Cosmos
Biowood Sdn.
Bhd.
Consideration transferred $
2,261
Plus: Non-controlling interests (25% in Cosmos Biowood Sdn. Bhd.) 754
Plus: Fair value of identifiable net assets acquired 2,368
Goodwill recognized on acquisitions $
5,383
Net cash inflow on the acquisition of subsidiaries
Cosmos
Biowood Sdn.
Bhd.
Consideration paid in cash $ (2,261)
Plus: Cash and cash equivalent balances acquired 161
$ (2,100)
  • b. Goodwill recognized on acquisitions

  • c. Net cash inflow on the acquisition of subsidiaries

  • d. The results of the acquirees since the acquisition date included in the consolidated statements of comprehensive income


comprehensive income
Cosmos
Biowood Sdn.
Bhd.
Revenue $ -
Net loss $ (910)
  • 183 -

Had these business combinations been in effect at the beginning of the annual reporting period, the Group’s revenue from continuing operations would have been $2,687,581 thousand, and the profit from continuing operations would have been $347,343 thousand for the year ended December 31, 2018. This pro-forma information is for illustrative purposes only and is not necessarily an indication of the revenue and results of operations of the Group that actually would have been achieved had the acquisition been completed on January 1, 2018, nor is it intended to be a projection of future results.

29. EQUITY TRANSACTIONS WITH NON-CONTROLLING INTERESTS

On May 28, 2018, the Group subscribed for additional new shares of Cosmos Biowood Sdn. Bhd. at a percentage different from its existing ownership percentage, increasing its continuing interest from 75% to 80%.


80%.
Cosmos
Biowood Sdn.
Bhd.
Cash consideration paid
$
754
The proportionate share of the carrying amount of the net assets of the subsidiary
(1,023)
Differences recognized from equity transactions
$

(269)
Line items adjusted for equity transactions
Retained earnings

$

(269)

30. CASH FLOWS INFORMATION

  • a. Non-cash transaction

For the years ended December 31, 2018 and 2017, the Group entered into the following non-cash investing and financing activities which were not reflected in the consolidated statements of cash flows:

  • 1) As of December 31, 2018 and 2017, the payable for purchasing equipment (recognized as other payables) were $671 thousand and $8,474 thousand, respectively.

  • 2) As of December 31, 2018, the payable amount on acquired prepayment of lease was (recognized as other payables) $38,353 thousand.

  • b. Changes in liabilities arising from financing activities

For the year ended December 31, 2018

Short-term borrowings

Long-term borrowings
Guarantee deposits
received
Finance lease payables

Opening
Balance
Cash Flows
$ 60,204 $ 87,255
67,670
(23,002)
30
(8)

1,847

(1,117)

$ 129,751
$ 63,128
Non-cash Changes
New Leases
Interest
Expenses
Exchange
Differences
$ - $ - $ (674)

-
-
544

-
-
-

708

79

14

$ 708
$ 79
$ (116)
Closing
Balance
$ 146,785

45,212

22

1,531
New Leases
$ -

-

-

708

$ 708

$ 193,550
  • 184 -

31. OPERATING LEASE ARRANGEMENTS

The Group as Lessee

Operating leases relate to leases of office and vehicle with lease terms between 1 and 2 years. The Group does not have a bargain purchase option to acquire the leased asset at the expiration of the lease periods.

The future minimum lease payments of non-cancellable operating lease are as follows:

Not later than 1 year
Later than 1 year and not later than 5 years
**December ** **31 **


2018
$ 1,798


644

$ 2,442
2017
$ 1,608

275
$ 1,883

32. CAPITAL MANAGEMENT

The Group manages its capital to ensure that entities in the Group will be able to continue as going concerns while maximizing the return to stakeholders through the optimization of the debt and equity balance. The Group’s overall strategy remains unchanged as of December 31, 2018.

The management of the Group periodically reviews its capital structure. As part of the review, the management considers the cost of capital, and the risks associated with each borrowings and the financial ratio required to determine the reasonable scale of capital structure of the Group. The Group balances its overall capital structure by distributing dividend, issuing new shares and obtaining loans.

33. FINANCIAL INSTRUMENTS

  • a. Fair value of financial instruments that are not measured at fair value

The Group’s management believes that the book value of financial asset and financial liability that are not measured at fair value approximates the fair value.

  • b. Fair value of financial instruments that are measured at fair value on a recurring basis

  • 1) Fair value hierarchy

December 31, 2018

Financial assets at FVTPL
Derivative financial assets

Mutual funds

Level 1
$ -


30,454

$ 30,454
Level 2
$ 1,137


-

$ 1,137
Level 3
$ -


-

$ -
Total
$ 1,137

30,454
$ 31,591
  • 185 -

December 31, 2017

Financial assets at FVTPL
Non-derivative financial assets
held for trading
Level 1
$ 22,152
Level 2
$ -
Level 3
$ -
Total
$ 22,152

There were no transfers between Levels 1 and 2 for the years ended December 31, 2018 and 2017.

  • 2) Valuation techniques and inputs applied for the purpose of measuring Level 2 fair value measurement

measurement
Financial Instruments
Derivatives - foreign exchange
forward contracts
Valuation Techniques and Inputs
Fair values of foreign exchange derivative products are
measured on the basis of quotations provided by financial
institutions.
  • c. Categories of financial instruments
Financial assets
Financial assets at FVTPL
Held for trading

Mandatorily classified as at FVTPL
Loans and receivables (Note 1)
Financial assets at amortized cost (Note 2)
Financial liabilities
Amortized cost (Note 3)
**December 31 **
2018
2017
$ -
$ 22,152
31,591
-
-
1,680,795
1,538,505
-
341,008
236,562
  • Note 1: The balances included loans and receivables measured at amortized cost, which comprise cash and cash equivalents, trade receivables, trade receivables from related parties, other receivables (excluding GST refund receivable), other financial assets and refundable deposits.

  • Note 2: The balances included financial assets at amortized cost, which comprise cash and cash equivalents, trade receivables, trade receivables from related parties, other receivables (excluding GST refund receivable), other receivables from related parties, other financial assets and refundable deposits.

  • Note 3: The balances included financial liabilities at amortized cost, which comprise short-term borrowings, trade payables, other payables (excluding payable for salaries and bonuses, payable for pension fees and payable for taxes), other payables to related parties, current portion of long-term borrowings, long-term borrowings, financial lease payables and guarantee deposits received.

  • d. Financial risk management objectives and policies

The Group’s major financial instruments include trade receivables, trade payables and borrowings. The Group’s corporate treasury function provides services to the business, coordinates access to domestic and international financial markets, monitors and manages the financial risks relating to the operations

  • 186 -

of the Group through internal risk reports which analyze exposures by degree and magnitude of risks. These risks include market risk (including foreign currency risk, interest rate risk and other price risk), credit risk and liquidity risk.

The Group seeks to minimize the effects of these risks by using derivative financial instruments to hedge risk exposures. The use of financial derivatives is governed by the Group’s policies approved by the board of directors, which provided written principles on foreign currency risk, interest rate risk, credit risk, the use of derivatives and non-derivative financial instruments, and the investment of excess liquidity. Compliance with policies and exposure limits is reviewed by the internal auditors on a continuous basis. The Group did not enter into or trade financial instruments, including derivative financial instruments, for speculative purposes.

1) Market risk

The Group’s activities exposed it primarily to the financial risks of changes in foreign currency exchange rates, interest rates and other price risk. The Group entered into forward foreign exchange contracts to hedge the exchange rate risk arising from the importations denominated in United States dollar.

a) Foreign currency risk

The Group’s involvement in foreign currency denominated transactions exposed it to excessive risk arising from volatility of the exchange difference. The Group’s risk management policy on foreign exchange is within standard, utilizing derivative - foreign currency forward contract - to manage risks.

Please refer to Note 36 for the amount of the Group’s non-functional currency denominated monetary assets and liabilities on the balance sheet date (including those eliminated on consolidation).

Sensitivity analysis

The Group was mainly exposed to the changes in the exchange rate of USD.

The following table details the Group’s sensitivity to a 5% increase and decrease in the functional currency against the relevant foreign currencies.

The sensitivity rate used when reporting foreign currency risk internally to key management personnel and represents management’s assessment of the reasonably possible change in foreign exchange rates is 5%. The sensitivity analysis included only outstanding foreign currency denominated monetary items (e.g. trade receivables, trade payables and borrowing from external entities), and adjusts their translation at the end of the reporting period for a 5% change in foreign currency rates. A positive number below indicates an increase in pre-tax profit and other equity associated with functional currency strengthened by 5% against the relevant foreign currency. For a 5% weakening of functional currency against the relevant foreign currency, there would be an equal and opposite impact on pre-tax profit and other equity and the balances below would be negative.


below would be negative.

Profit or loss
**USD Impact **
**For the Year Ended December 31 **
2018
2017
$ 7,903 *
$ 19,558 *
  • This was mainly attributable to the exposure of bank deposits, trade receivables, trade payables and borrowings in USD which were not hedged at the end of the reporting period.

  • 187 -

The Group’s sensitivity to foreign currency decreased during the current period mainly due to the decreases of the foreign financial assets

b) Interest rate risk

The Group was exposed to interest rate risk because entities in the Group borrowed funds at both fixed and floating interest rates.

The carrying amounts of the Group’s financial assets and financial liabilities with exposure to interest rates at the end of the reporting period were as follows.

Fair value interest rate risk
Financial assets

Financial liabilities
Cash flow interest rate risk
Financial assets
Financial liabilities
**December 31 **
2018
2017
$ 125,946
$ 165,868
1,531
1,847
113,924
324,810
191,997
127,874

Sensitivity analysis

The sensitivity analysis below were determined based on the Group’s exposure to interest rates for both derivatives and non-derivative instruments at the end of the reporting period. For floating rate liabilities, the analysis was prepared assuming the amount of the liability outstanding at the end of the reporting period was outstanding for the whole year. Sensitivity rate of 1% increase or decrease was used when reporting interest rate risk internally to key management personnel and represents management’s assessment of the reasonably possible change in interest rates.

If interest rates had been 1% higher/lower and all other variables were held constant, the Group’s pre-tax profit for the years ended December 31, 2018 and 2017 would decrease/increase by $781 thousand and increase/decrease $1,969 thousand, respectively, which was mainly a result of the Group’s exposure to the change in interest rate on its floating rate bank borrowings and bank deposits.

The Group’s sensitivity to interest rates decreased during the current period mainly due to the decreases in financial assets of cash flow interest rate risk.

c) Other price risk

The Group was exposed to price risk relating to its investments in money market fund instruments which were classified as financial assets at FVTPL. The investments are held for strategic purposes. The Group manages this exposure by maintaining a portfolio of investments with lower risks.

Sensitivity analysis

The sensitivity analysis below was based on the exposure to money market funds price risks at the end of the reporting period.

  • 188 -

If money market funds prices had been 1% higher/lower, pre-tax profit for the years ended December 31, 2018 and 2017 would have increased/decreased by $305 thousand and $222 thousand, respectively, as a result of the changes in fair value of financial assets at FVTPL.

The Group’s sensitivity to price risk increased during the current period mainly due to the increases of currency investment fund.

  • 2) Credit risk

Credit risk refers to the risk that counterparty will default on its contractual obligations resulting in financial loss to the Group. As at the end of the reporting period, the Group’s maximum exposure to credit risk which would cause a financial loss to the Group due to failure of counterparties to discharge their obligations and financial guarantees could be equal to the carrying amount of the respective recognized financial assets as stated in the balance sheets.

In order to minimize credit risk, the management of the Group has delegated a team responsible for determining credit limits, credit approvals and other monitoring procedures to ensure that follow-up action is taken to recover overdue receivables.

  • 3) Liquidity risk

The Group manages liquidity risk by monitoring and maintaining a level of cash and cash equivalents deemed adequate to finance the Group’s operations and mitigate the effects of fluctuations in cash flows. In addition, management monitors the utilization of bank borrowings and ensures compliance with loan covenants.

The Group relies on bank borrowings as a significant source of liquidity. As of December 31, 2018 and 2017, the Group had available unutilized short-term bank loan facilities set out in (c) below.

  • a) Liquidity and interest rate risk tables for non-derivative financial liabilities

The following tables detail the Group’s remaining contractual maturity for its non-derivative financial liabilities with agreed repayment periods. The tables had been drawn up based on the undiscounted cash flows of financial liabilities from the earliest date on which the Group can be required to pay. The tables included both interest and principal cash flows.

Specifically, bank loans with a repayment on demand clause were included in the earliest time band regardless of the probability of the banks choosing to exercise their rights. The maturity dates for other non-derivative financial liabilities were based on the agreed repayment dates.

To the extent that interest flows are at floating rates, the undiscounted amount was derived from the interest rate curve at the end of the reporting period.

December 31, 2018

On Demand
or Less than
1 Month
1-3 Months
3 Months to
1 Year
Non-derivative financial
liabilities
Non-interest bearing
$ 73,724
$ 62,541
$ 12,724

Finance lease liabilities
82
248
693
Floating interest rate
instruments

88,967

36,360

47,247

$ 162,773
$ 99,149
$ 60,664
1-5 Years
$ 22

589

21,835

$ 22,446
5+ Years
$ -
-

-
$ -
  • 189 -

December 31, 2017

On Demand
or Less than
1 Month
1-3 Months
3 Months to
1 Year
Non-derivative financial
liabilities
Non-interest bearing
$ 80,330
$ 27,962
$ 366

Finance lease liabilities
70
139
625
Floating interest rate
instruments

2,125

6,958

76,634

$ 82,525
$ 35,059
$ 77,625
1-5 Years
$ 30

1,112

47,263

$ 48,405
5+ Years
$ -
-

-
$ -

The amount included above for variable interest rate instruments for both non-derivative financial assets and liabilities was subject to change if changes in variable interest rates differ from those estimates of interest rates determined at the end of the reporting period.

b) Liquidity and interest rate risk tables for derivative financial liabilities

The following table detailed the Group’s liquidity analysis for its derivative financial instruments. The table was based on the undiscounted contractual net cash inflows and outflows on derivative instruments that settle on a net basis, and the undiscounted gross inflows and outflows on those derivatives that require gross settlement. When the amount payable or receivable is not fixed, the amount disclosed was determined by reference to the projected interest rates as illustrated by the yield curves at the end of the reporting period.

December 31, 2018

December 31, 2018
c) On
Demand or
Less than
1 Month 1-3 Months
Net settled
Foreign exchange
forward contracts
$ 373
$ 764

Financing facilities
3 Months
to 1 Year
$ -
1-5 Years
$ -
5+ Years
$ -
Financing facilities
Secured bank loan facility:
Amount used

Amount unused

**December 31 **


2018
$ 193,528

894,819

$ 1,088,347
2017
$ 129,721
959,072
$ 1,088,793
  • 190 -

34. TRANSACTIONS WITH RELATED PARTIES

Balances, transactions, revenue and expenses between the Company and its subsidiaries, which are related parties of the Company, have been eliminated on consolidation and are not disclosed in this note. Details of transactions between the Group and other related parties are disclosed below.

  • a. Related party names and categories
Related party names and categories
Related Names
Sabah Softwoods Berhad
Sawit Kinabalu Seeds Sdn. Bhd.
Borneo Samudera Sdn. Bhd.
Bongalio Development Sdn. Bhd.
Kalabakan Plantation Sdn. Bhd.
Oscar Kinabalu Sdn. Bhd.
Bagahak Plantation Sdn. Bhd.
Saplantco Sdn. Bhd.
Sawit Ecoshield Sdn. Bhd.
Peng Sheng Ching
Tan Chek Yen
Peng Shih Hao
Related Party Categories
Substantive related party
Substantive related party (Note)
Substantive related party (Note)
Substantive related party (Note)
Substantive related party (Note)
Substantive related party (Note)
Substantive related party (Note)
Substantive related party (Note)
Associate
Substantive related party
Substantive related party
Key management personnel

Note: The related parties are the associates of Sawit Kinabalu Ecotech Sdn. Bhd., which is the shareholder of Kinabalu Life Sciences Sdn. Bhd. The Group recognized the associate as substantive related party since December 8, 2017.

  • b. Operating revenue
Operating revenue

Line Items
Related Party
Categories/Name

Sales
Substantive related party
Sabah Softwoods Berhad
Borneo Samudera Sdn.
Bhd. (Note)
Others (Note)

**For the Year Ended ** **December 31 **



2018
$ 235,165

186,773

59,936

$ 481,874
2017
$ 238,431
-

-
$ 238,431

Note: The entities were not classified as related parties for the year ended December 31, 2017.

The selling price for related parties is calculated with reference to the applicable market price. The credit terms for the related parties are comparable to those for unrelated parties.

  • c. Contract liabilities
Contract liabilities
Related Party Category/Name

Associate

Sawit Ecoshield Sdn. Bhd.
**December 31 **


2018
$ 8,443
2017
$ -
  • 191 -

  • d. Receivables from related parties (excluding loans to related parties)

Line Items
Related Party
Categories/Name

Trade receivables
Substantive related party
Sabah Softwoods Berhad
Borneo Samudera Sdn.
Bhd. (Note)
Less: Allowance for
impairment loss


Other receivables
Associate
**December 31 ** **December 31 **




2018
$ 2,381

18,464


20,845

(602)

$ 20,243

$ 15
2017
$ 6,806
-

6,806

-
$ 6,806
$ -

Note: The entities were not classified as related parties for the year ended December 31, 2017.

In 2018

The outstanding trade receivables from related parties are unsecured.

The Group applies the simplified approach to providing for expected credit losses prescribed by IFRS 9, which permits the use of lifetime expected loss provision for all trade receivables from related parties. The expected credit losses on trade receivables from related parties are estimated using a provision matrix by reference to past default experience of the debtor and an analysis of the debtor’s current financial position.

The following table details the loss allowance of trade receivables from related parties based on the Group’s provision matrix.

December 31, 2018

Not Past Due
Less than 90
Days
Expected credit loss rate
1.43%
4.25%

Gross carrying amount
$ 10,502
$ 10,330

Loss allowance (Lifetime
ECL)

(150)

(439)


Amortized cost
$ 10,352
$ 9,891
91 to 180
Days
181 to 365
Days
-
100%
$ -
$ 12


-

(12)

$ -
$ -
Over 365
Days
100%
$ 1


(1)

$ -
Total
-
$ 20,845

(602)
$ 20,243

The movements of the loss allowance of trade receivables from related parties were as follows:


Balance at January 1, 2018 per IAS 39
Adjustment on initial application of IFRS 9
Balance at January 1, 2018 per IFRS 9
Add: Net remeasurement of loss allowance
Foreign exchange gains and losses
Balance at December 31, 2018
2018
$ -

-
-
608

(6)
$ 602
  • 192 -

In 2017

The outstanding trade receivables from related parties are unsecured. For the years ended December 31, 2017, no impairment loss was recognized for trade receivables from related parties.

  • e. Payables to related parties (excluding loans from related parties)
Payables to related parties (excluding loans from related parties)
Line Items
Related Party
Category/Name

Other payables to related parties
Key management personnel
**December 31 **

2018
$ 7
2017
$ -

The outstanding payables to related parties are unsecured.

  • f. Others

The Group leased an employees’ dormitory from substantive related parties under operating lease arrangements with rentals paid monthly. For the year ended December 31, 2018 and 2017, the rental expenses were $314 thousand and $298 thousand, respectively.

  • g. Compensation of key management personnel

Line Items

Short-term employee benefits
Share-based payments
For the Year Ended December 31 For the Year Ended December 31 For the Year Ended December 31
2018
$ 55,014

-
$ 55,014
2017
$ 57,362

5,537
$ 62,899

The remuneration to directors and key executives was determined by the remuneration committee based on the performance of individuals and market trends.

35. ASSETS PLEDGED AS COLLATERAL OR FOR SECURITY

The following assets were provided as collateral for bank borrowings:

Prepayment for leases

Other financial assets - non-current
Lease assets, net
Buildings, net

**December 31 ** **December 31 **


2018
$ 121,659

125,025
2,751

289,876

$ 539,311
2017
$ 123,032
120,796
4,540

291,114
$ 539,482
  • 193 -

36. SIGNIFICANT ASSETS AND LIABILITIES DENOMINATED IN FOREIGN CURRENCIES

The Group entities’ significant financial assets and liabilities denominated in foreign currencies aggregated by the foreign currencies other than functional currencies and the related exchange rates between foreign currencies and respective functional currencies were as follows:

December 31, 2018

December 31, 2018
Foreign Carrying
Currencies Exchange Rate Amount
Financial assets
Monetary items
USD $
5,469
4.2350 (USD:MYR)
$ 171,240
USD 410 14,860 (USD:IDR) 12,861
Financial liabilities
Monetary items
USD 831 4.2350 (USD:MYR) 26,033
December 31, 2017
Foreign Carrying
Currencies Exchange Rate Amount
Financial assets
Monetary items
USD $
14,527
4.1400 (USD:MYR)
$ 442,759
Financial liabilities
Monetary items
USD 1,693 4.1400 (USD:MYR) 51,602

The significant realized and unrealized foreign exchange gains (losses) were as follows:

Foreign
Currencies
USD
**For the Year Ended December 31 ** **For the Year Ended December 31 **
2018
Exchange Rate
Net Foreign
Exchange Gains
(Losses)
4.0432 (USD:MYR)
$ 28,125
2017
Exchange Rate
Net Foreign
Exchange Gains
(Losses)
4.2988 (USD:MYR)
$ (8,598)

37. SEPARATELY DISCLOSED ITEMS

  • a. Information about significant transactions and b. investees:

  • 1) Financing provided to others (Table 1)

  • 2) Endorsements/guarantees provided (Table 2)

  • 194 -

  • 3) Marketable securities held (excluding investments in subsidiaries, associates and joint ventures) (Table 3)

  • 4) Marketable securities acquired and disposed of at costs or prices of at least $300 million or 20% of the paid-in capital (None)

  • 5) Acquisition of individual real estate at costs of at least $300 million or 20% of the paid-in capital (None)

  • 6) Disposal of individual real estate at prices of at least $300 million or 20% of the paid-in capital (None)

  • 7) Total purchases from or sales to related parties amounting to at least $100 million or 20% of the paid-in capital (Table 4)

  • 8) Receivables from related parties amounting to at least $100 million or 20% of the paid-in capital (None)

  • 9) Trading in derivative instruments (Notes 7 and 33)

  • 10) Intercompany relationships and significant intercompany transactions (Table 5)

  • 11) Information on investees (Table 6)

  • c. Information on investments in mainland China

  • 1) Information on any investee company in mainland China, showing the name, principal business activities, paid-in capital, method of investment, inward and outward remittance of funds, ownership percentage, net income of investees, investment income or loss, carrying amount of the investment at the end of the period, repatriations of investment income, and limit on the amount of investment in the mainland China area. (None)

  • 2) Any of the following significant transactions with investee companies in mainland China, either directly or indirectly through a third party, and their prices, payment terms, and unrealized gains or losses (None):

    • a) The amount and percentage of purchases and the balance and percentage of the related payables at the end of the period.

    • b) The amount and percentage of sales and the balance and percentage of the related receivables at the end of the period.

    • c) The amount of property transactions and the amount of the resultant gains or losses.

    • d) The balance of negotiable instrument endorsements or guarantees or pledges of collateral at the end of the period and the purposes.

    • e) The highest balance, the end of period balance, the interest rate range, and total current period interest with respect to financing of funds.

    • f) Other transactions that have a material effect on the profit or loss for the period or on the financial position, such as the rendering or receipt of services.

  • 195 -

38. SEGMENT INFORMATION

Information reported to the chief operating decision maker for the purpose of resource allocation and assessment of segment performance focuses on the types of goods or services delivered or provided. Specifically, the Group’s reportable segments were identified as All Cosmos Industries Sdn. Bhd. (ACI), Sabah Softwoods Hybrid Fertiliser Sdn. Bhd. (SSHF) and others.

The details of the Group’s reportable segments were as follows:

a. Segment revenues and results

The following is an analysis of the Group’s revenue and results from continuing operations by reportable segments.


reportable segments.
ACI

SSHF
Others

Continuing operations

Other income
Other gains and losses
Finance costs
Share of loss of associates
General administration costs
and remuneration of directors
Profit before tax (continuing
operations)
Segment Revenue
For the Year Ended
December 31
2018
2017
$ 1,860,224 $ 1,403,875
775,038
841,680

52,319

18,097

$ 2,687,581
$ 2,263,652

Segment Income
For the Year Ended
December 31



2018
$ 1,860,224
775,038

52,319

$ 2,687,581




2018
$ 274,438

101,204

20,127

395,769
20,976
39,956
(18,666)
(20)

(39,000)

$ 399,015
2017
$ 290,662

160,485

20,257

471,404

14,204

(473)

(13,517)

-

(64,683)
$ 406,935

Segment revenue reported above represents revenue generated from external customers. The inter-segment sales for the years ended December 31, 2018 and 2017 have both been eliminated.

Segment profit represented the profit before tax earned by each segment without allocation of general administration costs and remuneration of directors, share of loss of associates, other income, other gains and losses, finance costs and income tax expense. This was the measure reported to the chief operating decision maker for the purpose of resource allocation and assessment of segment performance.

b. Segment total assets and liabilities

Segment total assets and liabilities are not provided to the chief operating decision maker and not required to be disclosed.

  • 196 -

c. Revenue from major products

The following is an analysis of the Group’s revenue from continuing operations from its major products.


products.

Bio-chemical fertilizers

Others

**For the Year Ended December 31 **


2018
$ 2,650,533

37,048

$ 2,687,581
2017
$ 2,222,892
40,760
$ 2,263,652

d. Geographical information

The Group operates mainly in Malaysia.

The Group’s revenue from continuing operations from external customers by location of customers and information about its non-current assets by location of assets are detailed below:

Malaysia

Others

Revenue from External
Customers
For the Year Ended
December 31
2018
2017
$ 2,448,563 $ 2,175,593

239,018

88,059

$ 2,687,581
$ 2,263,652
Non-current Assets Non-current Assets
**December 31 **


2018
$ 2,448,563

239,018

$ 2,687,581


2018
$ 624,214

53,313

$ 677,527
2017
$ 598,797

12
$ 598,809

Non-current assets exclude other financial assets, deferred tax assets and refundable deposits.

  • e. Information about major customers

Single customers that contributed 10% or more to the revenue in the consolidated statements of comprehensive income for the years ended December 31, 2018 and 2017 were as follows:

Company A

Company B

Company C

Company D
**For the Year Ended December 31 ** **For the Year Ended December 31 **
2018
Amount
%
NA (Note)
-
NA (Note)
-
NA (Note)
-
$ 339,365
15
2017
Amount
%
$ 242,947
11

238,431
11

231,050
10
NA (Note)
-

Note: The annual income amount does not reach 10% of the total income of the Group.

  • 197 -